Report Adverse Event or Product Quality Complaint   US Site   Global Site             

Header Logo
  • Prescribing Information
  • Therapy areas
    • All Therapeutic Areas
    • Cardiovascular, Renal and Metabolism
    • Immunology
    • Infection
    • Oncology
    • Rare Disease (Alexion)
    • Respiratory
  • Disease Education
  • Resources
    • Congress Library
    • Clinical Trials
    • Continuing Education
    • Patient Support
    • Pipeline
  • Connect
    • Connect with an MSL
    • Connect with an MSL
    • Submit an MIR
    • Give Feedback

Search Medical Information

Login

Request a field medical follow-up

  • Home
  • Continuing Education

Continuing Education

  1. All (346)
  2. Cardiovascular, Renal and Metabolism (9)
  3. Immunology (4)
  4. Infection (1)
  5. Oncology (312)
  6. Respiratory (20)
E-LEARNING

ACC.25 Spotlight Session

American College of Cardiology Foundation

18-Apr-2025 to 18-Apr-2026

 

Meeting on Demand

Learn More
E-LEARNING

Enduring Webcast

National Association For Continuing Education, LLC

29-Aug-2025 to 28-Aug-2026

 

Enduring CME Webcast

Learn More
E-LEARNING

Balancing GDMT and Hyperkalemia – Expert Insights into Optimal Heart Failure Care

Partners for Advancing Clinical Education

19-Nov-2025 to 19-Nov-2026

 

Originally presented at the HFSA Annual Scientific Meeting 2025 - this interactive session explores strategies to optimize guideline-directed medical therapy for heart failure while effectively managing hyperkalemia.

Learn More
E-LEARNING

Best Practices for Managing Intracerebral Hemorrhage

Voxmedia LLC

14-Mar-2025 to 14-Mar-2026

 

90 minute video with expert panel discussion

Learn More
E-LEARNING

Best Practices for Managing Hyperkalemia in Patients with Heart Failure and Chronic Kidney Disease

Voxmedia LLC

30-May-2025 to 30-May-2026

 

On-Demand 1.5 hour video enduring material

Learn More
E-LEARNING

Management of RAAS Inhibitor Therapy After Hyperkalemia in Patients with CKD and Heart Failure

American Society of Nephrology, Inc.

17-Nov-2025 to 31-Dec-2026

 

Symposium posting on ASN eLearning Center. Credit is not awarded for viewing the online content.

Learn More
E-LEARNING

Taking the Updated CKD Guidelines From Paper to Practice

PeerVoice America Limited

06-Sep-2024 to 05-Sep-2026

 

30 minutes video, with expert panel discussion

Learn More
E-LEARNING

Facing the Challenges: Managing Hyperkalemia in Heart Failure Patients W hile Maintaining RAASi Therapy

Voxmedia LLC

09-Jul-2025 to 09-Jul-2026

 

60 minute video with expert panel

Learn More
E-LEARNING

Managing Hyperkalemia in Heart Failure: Implementing Strategies to Reduce Patient Risk

Voxmedia LLC

29-Jul-2025 to 29-Jul-2026

 

1-hour video with panel discussion

Learn More
E-LEARNING

NCCN 2025 Annual Conference

National Comprehensive Cancer Network, Inc.

15-Jun-2025 to 01-Mar-2026

 

NCCN will offer 33 educational sessions from this activity as archived endured webcasts posted on NCCN’s continuing education portal, http://education.nccn.org.  

Learn More
E-LEARNING

Live 2025-2026 Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care

National Comprehensive Cancer Network, Inc.

15-Jun-2025 to 31-May-2026

 

NCCN will offer nine (9) live multidisciplinary case-based webinars focusing on the care of patients with various types of cancer

Learn More
E-LEARNING

Web Critical Clues: Identifying and Managing Interstitial Lung Disease in Patients With Breast Cancer

PRIME Education, LLC

17-Feb-2025 to 16-Feb-2026

 

1-hour Multi-Accredited, On-Demand Enduring Webcast with Downloadable POC Resource

Learn More
E-LEARNING

Web Nurse-Led Strategies for Optimizing PARP Inhibitor Therapies in Veterans With Prostate Cancer: Insights for Practical Care Delivery

PVI, PeerView Institute for Medical Education

30-Oct-2024 to 29-Oct-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Ablative modalities: tried and true, and up and coming for HCC

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions on frequently used modality, descriptions on how each ablative modality works, the transition to histotripsy. 

Learn More
E-LEARNING

How to dose: understanding Y-90 dosimetry from simple to complex

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions on what makes sense, where are we headed and how to simplify things regarding dosimetry.

Learn More
E-LEARNING

How to build an IO practice

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions on PP vs Academics, what does your support staff look like, finding referrals, greatest successes and failures in year 1.

Learn More
E-LEARNING

Advanced HCC: Combination therapy and Clinical trials: what they really mean

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions on Immunotherapy in HCC, what are the impactful immunotherapy trials in HCC, and immunotherapy medications.

Learn More
E-LEARNING

Transplant approach from the transplant surgeon and hepatologist

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions on pre/peri/post transplant.

Learn More
E-LEARNING

The “grey” zone, BCLC B and complex patients

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions and review on BCLC guidelines, role of ablation, TACE, TARE and systemic therapies, Grey Zone/complex patients scenarios and post-treatment patients.

Learn More
E-LEARNING

Surgical Approach to HCC

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions on surgical approaches, downstaging and bridging and community practice.

Learn More
E-LEARNING

Tumor Board Collaboration: Disease Progression

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Case-based discussions with a multidisciplinary approach/team to treating HCC. 

Learn More
E-LEARNING

Patient flow - too many cooks in the kitchen?

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions on the benefits of multidisciplinary clinic and navigating the patient experience

Learn More
E-LEARNING

Web Gynecologic Oncology at the Best of ASCO

Binaytara

01-Jul-2025 to 01-Jul-2026

 

Enduring recorded webcast of the live session

Learn More
E-LEARNING

Web Thoracic Oncology at the Best of ASCO 2025

Binaytara

01-Jul-2025 to 01-Jul-2026

 

Enduring recorded webcast of the live session

Learn More
E-LEARNING

Live Critical Conversations for Surgeons & Oncologists in Resectable Gastric/GEJ Cancer

PVI, PeerView Institute for Medical Education, Inc.

14-Oct-2025 to 14-Oct-2025

 

Join PeerView for a Critical Conversations event as experts discuss immunotherapy in resectable GC/GEJC, share real-world cases, and explore strategies for multidisciplinary collaboration.

Learn More
E-LEARNING

2024-2025 Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient

National Comprehensive Cancer Network, Inc.

30-Aug-2024 to 29-Jun-2026

 

In order to extend the reach of this program, NCCN will archive the webinars from this activity on NCCN’s Learning Management System found at http://education.nccn.org. The archived recordings will consist of slides and audio.

Learn More
E-LEARNING

Behind the Guidelines: Insights into the Standard of Care in Oncology 2025

National Comprehensive Cancer Network, Inc.

10-Jan-2025 to 31-Dec-2026

 

This activity consists of twelve NCCN Guidelines Insights articles 

Learn More
E-LEARNING

Live NCCN 2025 Webinar Series - Optimizing Patient Outcomes: Collaborative Perspectives in Oncology

National Comprehensive Cancer Network, Inc.

01-Feb-2025 to 31-Dec-2025

 

This activity is a series of 9 webinars on a variety of oncopharmacology topics that will be presented from February 2025 - December 2025. 

Learn More
E-LEARNING

Web NCCN 2025 Webinar Series - Optimizing Patient Outcomes: Collaborative Perspectives in Oncology

National Comprehensive Cancer Network, Inc.

01-Feb-2025 to 30-Dec-2026

 

This activity is a series of 9 webinars on a variety of oncopharmacology topics that will be presented from February 2025 - December 2025. 

Learn More
E-LEARNING

Web enduring NCCN 2025 Breast Cancer Congress with Updates from the 2024 San Antonio Breast Cancer Symposium

National Comprehensive Cancer Network, Inc.

15-Mar-2025 to 14-Mar-2026

 

National Comprehensive Cancer Network (NCCN) plans to conduct a one-day live-in-person educational activity.NCCN will offer the eight (8) sessions from this activity as archived endured webcasts 

Learn More
E-LEARNING

Web enduring 2025-2026 Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care

National Comprehensive Cancer Network, Inc.

01-Aug-2025 to 29-Jun-2027

 

NCCN will offer nine (9) live multidisciplinary case-based webinars focusing on the care of patients with various types of cancer 

Learn More
E-LEARNING

Behind the Guidelines: Insights into the Standard of Care in Oncology 2024

National Comprehensive Cancer Network, Inc.

10-Jan-2024 to 31-Dec-2025

 

This activity consists of twelve NCCN Guidelines Insights articles.  10 in print, 2 electronically 

Learn More
E-LEARNING

Web Antibody Drug Conjugates and Adverse Events: Improving Identification and Management Among Oncology Nurses Serving Rural and Underserved Communities

Talem Health, LLC

02-Jun-2025 to 02-Jun-2026

 

An online, on-demand enduring CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com; marketed to the target audience nationally.

Learn More
E-LEARNING

Web Advancing Precision Medicine in Breast Cancer: Targeted Therapies and the Role of Managed Care Pharmacy

Academy of Managed Care Pharmacy

14-Aug-2025 to 31-Dec-2026

 

1-hour recording with expert presentation and Q&A

Learn More
E-LEARNING

We Can Make a Difference: Metastatic Breast Cancer Updates

Texas Pharmacy Association

07-Feb-2025 to 06-Feb-2027

 

1-hour recorded Zoom webinar, with expert oncology pharmacist

Learn More
E-LEARNING

Oral Therapy Adherence: PARP Inhibitors, TKIs, and PIK3/AKT/mTOR Inhibitors

Practicing Clinicians Exchange, LLC

16-Jun-2025 to 15-Dec-2025

 

30 On-demand webcast AAPA/ANCC/ACPE-certified microlearning educational video module w/slidedeck

Learn More
E-LEARNING

Oral Therapy Adherence in Breast Cancer: SERDs, SERMs, and CDK4/6 Inhibitors

Practicing Clinicians Exchange, LLC

16-Jun-2025 to 15-Dec-2025

 

30 On-demand webcast-AAPA/ANCC/ACPE-certified microlearning educational video module w/slidedeck

Learn More
E-LEARNING

Addressing Challenges With Adherence and Persistence to Oral Anticancer Therapies in Patients With Breast Cancer

Practicing Clinicians Exchange, LLC

19-May-2025 to 18-Nov-2025

 

Downloadable Slidset from :90 live/virtual AAPA/ANCC/ACPE- Certified Intensive Training

Learn More
E-LEARNING

Global Perspectives and Clinical Resources to Guide Treatment Decisions and Management of Adverse Events With BTK Inhibitor Therapy in CLL

Clinical Care Options, LLC

25-Oct-2024 to 6-Jan-2026

 

1 CME-Certified Text Module

2 Interactive Decision Support Tools

1 Slide Player

Learn More
E-LEARNING

NCCN 2025 Annual Congress: Hematologic Malignancies™

National Comprehensive Cancer Network, Inc.

10-Oct-2025 to 11-Oct-2025

 

NCCN plans to conduct a one and one-half-day educational activity consisting of live in-person and virtual sessions with moderator-facilitated Q&A sessions on 

October 10-11, 2025, at the Hilton San Diego Bayfront, San Diego, CA

Learn More
E-LEARNING

Chronic Lymphocytic Leukemia: Evaluating Targeted Therapeutic Strategies and Optimizing Outcomes Throughout the Cancer-Care Continuum

HMP Education, LLC

25-Aug-2025 to 25-Feb-2026

 

To extend program reach to individuals unable to participate in the live event, HMP Education developed an enduring on-demand archive of the live session featuring downloadable slides.

Learn More
E-LEARNING

(2025 Great Debates in Solid Tumors) Target Over Tissue: The Rise of Tumor-Agnostic Cancer Therapies

HMP Education, LLC

10-Oct-2025 to 10-Apr-2026

 

An enduring on-demand archive of the live session

Learn More
E-LEARNING

Estrogen Receptor Mutations in HR+ Advanced Breast Cancer: Next-Generation Practice Recommendations on Mutation Screening to Guide Therapeutic Decisions

Clinical Care Options, LLC  

13-Nov-2024 to 30-Dec-2025

 

Online Activities:

•      An on-demand CME/ABIM MOC–certified webcast

•       Downloadable PowerPoint slidesets on the CCO website

•       Podcast featuring panel discussion from the live symposium

Learn More
E-LEARNING

Estrogen Receptor Mutations in HR+ Advanced Breast Cancer: Next-Generation Practice Recommendations on Mutation Screening to Guide Therapeutic Decisions

Clinical Care Options, LLC  

29-Feb-2024 to 29-Aug-2025

 

CME-certified initiative informed by a “Collaborative Learning Experience Study” designed to educate healthcare professionals on the clinical integration of TROP-2–targeted antibody–drug conjugates (ADCs) in non-small-cell lung cancer treatment.

Learn More
E-LEARNING

(NAVREF 2024 Annual Conference) Prostate Cancer Care in the Veterans Administration (VA) Health System: Adapting and Integrating Evolving Innovation in the Treatment of De Novo mHSPC

HMP Education, LLC

16-Oct-2024 to 16-Oct-2025

 

To extend the reach to learners who are unable to attend the 2024 NAVREF Satellite Symposium, HMP Education will capture and archive the recorded session proceedings for a chapterized on-demand CME/CE-certified web viewing.

Learn More
E-LEARNING

Improving Outcomes for Advanced/Unresectable Hepatocellular Carcinoma: Immune Checkpoint Inhibitor-Based Strategies in First-Line Therapy

HMP Education, LLC

19-Nov-2024 to 19-Nov-2025

 

Enduring web archive of the live session 

Learn More
E-LEARNING

Targeting HER2 Overexpression in Gastroesophageal and Colorectal Cancers: Novel and Emerging Options

HMP Education, LLC

19-Nov-2024 to 19-Nov-2025

 

To extend program reach to learners unable to participate in the live events, HMP Education developed an enduring on-demand archive of the live curriculum

Learn More
E-LEARNING

Hot Topics in Bladder and Prostate Cancer: Latest Treatments and Case-Based Learnings

HMP Education, LLC

06-Jan-2025 to 06-Jan-2026

 

HMP Education produced a CME/CE-certified enduring on-demand archive based on the live session proceedings

Learn More
E-LEARNING

Optimizing Therapy for Patients with Chronic Lymphocytic Leukemia: First Line Decision-Making and Beyond

HMP Education, LLC

20-Nov-2024 to 19-Nov-2025

 

To extend program reach to learners unable to participate in the live events, HMP Education developed an enduring on-demand archive of the live curriculum.

Learn More
E-LEARNING

CLL Landscape: Research and Clinical Advances

HMP Education, LLC

10-Mar-2025 to 10-Mar-2026

 

This initiative was designed to address the latest advancements and practical insights in CLL through dynamic discussions with leading experts and peers.

Learn More
E-LEARNING

Lymphoma Landscape: Research and Clinical Advances

HMP Education, LLC

10-Mar-2025 to 10-Mar-2026

 

This initiative was designed to address the latest advancements and practical insights in lymphoma, drawn from recent global research and developments through dynamic discussions with leading experts and peers.

Learn More
E-LEARNING

Targeted Approaches for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

HMP Education, LLC

29-Aug-2024 to 29-Aug-2025

 

Enduring on-demand web archive of the session held at the 2024 GDU in Hematologic Malignancies event series.

Learn More
E-LEARNING

Web HR+/HER2- Metastatic Breast Cancer: Addressing Unmet Needs and Endocrine Therapy Resistance in Frontline Treatment

HMP Education, LLC

02-Dec-2024 to 02-Dec-2025

 

Chapterized Enduring On-Demand Archive of the live session

Learn More
E-LEARNING

(2024 GDU Lung) Targeting HER2-Mutant NSCLC: A Focus on Biomarker Testing and Targeted Therapies

HMP Education, LLC

05-Nov-2024 to 05-Nov-2025

 

To extend program reach to individuals unable to participate in the live events, HMP Education will develop an enduring on-demand live session archive.

Learn More
E-LEARNING

Web Enduring Best of SABCS On-Demand

The University of Texas Health Science Center at San Antonio

01-Mar-2025 to 01-Nov-2025

 

The on demand format offers d peer-to-peer discussion. The programs also include clinical case scenarios for interactivity with the audience, providing a valuable educational resource for the practicing clinician

Learn More
E-LEARNING

Optimizing the Use of BTK Inhibitors in the Treatment of Chronic Lymphocytic Leukemia (CLL): Informed Managed Care Decision Making in an Evolving Landscape

National Association of Managed Care Physicians, Inc.

01-Nov-2023 to 01-Nov-2025

 

CLL Enduring Webcasts

Learn More
E-LEARNING

Informed Managed Care Decision-Making in the Management of Chronic Lymphocytic Leukemia (CLL): Optimizing Clinical and Economic Outcomes with BTK Inhibitors

National Association of Managed Care Physicians, Inc.

01-Aug-2024 to 01-Aug-2025

 

Enduring Webcast

Learn More
E-LEARNING

Web Best Practices in the Treatment and Management of HER2-Positive Advanced Breast Cancer: Expert Managed Care Strategies for Improved Clinical and Economic Outcomes

National Association of Managed Care Physicians, Inc.

01-Aug-2024 to 01-Aug-2025

 

Enduring Webcast

Learn More
E-LEARNING

Innovative Approaches in the Treatment and Management of Mantle Cell Lymphoma (MCL): A Closer Look at the Evolving Role of BTK Inhibitors

National Association of Managed Care Physicians, Inc.

01-Oct-2024 to 01-Oct-2026

 

Enduring Webcast

Learn More
E-LEARNING

Best Practices in the Treatment and Management of Chronic Lymphocytic Leukemia (CLL): Improving Clinical and Economic Outcomes with BTK Inhibitors and Their Combinations

National Association of Managed Care Physicians, Inc.

01-Aug-2025 to 01-Aug-2026

 

Enduring Webcast

Learn More
E-LEARNING

Keeping Pace with Rapid Advancements in the Management of Mantle Cell Lymphoma (MCL): Managed Care Insights on Evolving Role of BTK Inhibitors

National Association of Managed Care Physicians, Inc.

01-Aug-2025 to 01-Aug-2026

 

Enduring Webcast

Learn More
E-LEARNING

web enduring Best Practices in the Treatment and Management of Metastatic HR+/HER2- Breast Cancer: Managed Care Considerations on the Evolving Role of Antibody Drug Conjugates

National Association of Managed Care Physicians, Inc.

01-Aug-2025 to 01-Aug-2026

 

Enduring Webcast

Learn More
E-LEARNING

Web enduring Evolving Considerations in the Treatment and Management of HER2-Negative Early Breast Cancer: Optimizing Targeted Therapy for Improved Patient Outcomes

National Association of Managed Care Physicians, Inc.

01-Mar-2025 to 01-Mar-2026

 

Enduring Webcast

Learn More
E-LEARNING

Web enduring Best Practices in the Treatment and Management of Ovarian Cancer: Expert Managed Care Strategies on the Evolving Role of PARP Inhibitors

National Association of Managed Care Physicians, Inc.

01-Mar-2025 to 01-Mar-2026

 

Enduring Webcast

Learn More
E-LEARNING

Evolving Considerations in the Treatment and Management of Chronic Lymphocytic Leukemia (CLL): Managed Care Insights on Evolving Role of BTK Inhibitors

National Association of Managed Care Physicians, Inc.

01-Mar-2025 to 01-Mar-2026

 

Enduring Webcast

Learn More
E-LEARNING

Web enduring Innovative Approaches in the Treatment and Management of HER2-Positive and HER2-Low Breast Cancer: Managed Care Insights in an Evolving Paradigm

National Association of Managed Care Physicians, Inc.

01-Mar-2025 to 01-Mar-2026

 

Enduring Webcast

Learn More
E-LEARNING

Keeping Pace with the Rapid Advancements in the Treatment and Management of Chronic Lymphocytic Leukemia (CLL): Expert Managed Care Strategies on the Role of BTK Inhibitors and Their Combinations

National Association of Managed Care Physicians, Inc.

16-Jul-2025 to 23-Jul-2025

 

Live Web activiy

Learn More
E-LEARNING

Web Questions From the Community: Examining the Application of Recent Research AdvancesInto the Current Management of PatientsWith HR+/HER2- Breast Cancer

Purdue University

21-Feb-2025 to 21-Feb-2026

 

A 45-minute enduring activity designed to prepare clinicians to identify molecular alternations, sequence novel therapies,and manage treatment-associated toxicities to improve long-term outcomes for patients with HR+/HER2- advanced or metastatic BC

Learn More
E-LEARNING

Web enduring The Human Side of Breast Cancer: Using Novel Data and Patient Voices to Optimize Patient-Centered Care in HER2-Positive Breast Cancer Brain Metastases

Efficient LLC

23-Jul-2025 to 23-Jul-2026

 

60-minute multimedia activity enduring expert roundtable

Learn More
E-LEARNING

An Evolving Standard of Care in Chronic Lymphocytic Leukemia: Patient Perspectives and Clinical Insights on Novel Therapeutic Strategies Across the Disease Continuum

Efficient LLC

23-Jul-2025 to 23-Jul-2026

 

60-minute multimedia activity expert roundtable

Learn More
E-LEARNING

The Emergence of a New Subtype: HER2-Low Breast Cancer

PRIME Education, LLC

02-Aug-2024 to 01-Aug-2025

 

(One) 0.5-hour Enduring Webcast #2

Learn More
E-LEARNING

Antibody-Drug Conjugates in Breast Cancer

PRIME Education, LLC

23-Aug-2024 to 22-Aug-2025

 

(One) 1.0-hour Enduring Webcast #3 w/ whiteboard animation video

Learn More
E-LEARNING

Web Optimizing Use of PARP Inhibitors in Early-Stage and Metastatic Breast Cancer Patients With DNA Damage Repair Pathway Mutations

PRIME Education, LLC

13-Nov-2024 to 12-Nov-2025

 

1.0-hour Clinical Connections Webcast

Learn More
E-LEARNING

Web Improving Outcomes for Patients With HR+/HER2- Advanced Breast Cancer

PRIME Education, LLC

22-May-2025 to 21-May-2026

 

1.0-hour Enduring Webcast with Downloadable HR+/HER2- Advanced Breast Cancer Pocket Guide

Learn More
E-LEARNING

Web enduring Integrating Novel and Emerging ADCs Into Advanced/Metastatic HR+/HER2- Breast Cancer Care

PRIME Education, LLC

11-Jul-2025 to 10-Jul-2026

 

1.0-hour Multi-Accredited Enduring Webcast

Learn More
E-LEARNING

Web Meeting the Moment: Improving Care for Patients With HER2-Low Breast Cancer

PRIME Education, LLC

09-May-2025 to 08-May-2026

 

One (1) 1.0-hour Multi-Accredited On-Demand Video

Learn More
E-LEARNING

Not as Easy as ADC: Selecting and Sequencing Antibody-Drug Conjugates in Advanced Breast Cancer

PRIME Education, LLC

31-Jul-2025 to 01-Aug-2026

 

Webinar #4 (1.0-hour) Not as Easy as ADC: Selecting and Sequencing Antibody-Drug Conjugates in Advanced Breast Cancer

Learn More
E-LEARNING

Unlocking the Power of Novel Therapies in HER2+ Breast Cancer Treatment

PRIME Education, LLC

19-Aug-2025 to 20-Aug-2026

 

Webinar #5 (1.5-hours) Unlocking the Power of Novel Therapies in HER2+ Breast Cancer Treatment

Learn More
E-LEARNING

Addressing Disparities in Breast Cancer: Special Considerations for Marginalized Populations

PRIME Education, LLC

11-Sep-2025 to 12-Sep-2026

 

Webinar #6 (1.0-hour) Addressing Disparities in Breast Cancer: Special Considerations for Marginalized Populations – featuring real-world patient perspectives and a Clinician Spotlight

Learn More
E-LEARNING

Breast Cancer Case Competition: Test Your Knowledge on Integrating Novel Therapies Into Practice

PRIME Education, LLC

30-Sep-2025 to 01-Oct-2026

 

Webinar #7 (1.0-hour) Breast Cancer Case Competition: Test Your Knowledge on Integrating Novel Therapies into Practice  – featuring real-world patient perspectives and a Clinician Spotlight

Learn More
E-LEARNING

Individualizing Early Breast Cancer Care Based on Risk Assessment and Patient-Specific Factors

PRIME Education, LLC

28-May-2025 to 27-May-2026

 

Webcast 1 (1.0-hour) Individualizing Early Breast Cancer Care Based on Risk Assessment and Patient-Specific Factors – featuring a Clinician Spotlight

Learn More
E-LEARNING

Tailoring Early Breast Cancer Management Using the Latest Clinical Evidence

PRIME Education, LLC

28-May-2025 to 27-May-2026

 

0.25-hour Clinical Case Challenge

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

11-Jul-2025 to 10-Jul-2026

 

0.25-hour Clinical Case Challenge

Learn More
E-LEARNING

Novel and Emerging Treatment Strategies in Triple-Negative Breast Cancer: Antibody-Drug Conjugates, Immunotherapy, and Targeted Therapies

PRIME Education, LLC

11-Jul-2025 to 10-Jul-2026

 

Webinar #2 (1.5-hours) Novel and Emerging Treatment Strategies in Triple Negative Breast Cancer: Antibody-Drug Conjugates, Immunotherapy, and Targeted Therapies – featuring a Clinician Spotlight

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

28-Jul-2025 to 27-Jul-2026

 

Webcast #3 (1.5-hours) Navigating Endocrine Resistance in HR+/HER2- Breast Cancer: Novel SERDS, SERMS, and Targeted Therapies

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

22-Aug-2025 to 21-Aug-2026

 

0.50-hour Clinical Case Challenge

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

22-Aug-2025 to 21-Aug-2026

 

Webcast #4 (1.0-hour) Not as Easy as ADC: Selecting and Sequencing Antibody-Drug Conjugates in Advanced Breast Cancer

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

12-Sep-2025 to 11-Sep-2026

 

0.25-hour Clinical Case Challenge

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

12-Sep-2025 to 11-Sep-2026

 

Webcast #5 (1.5-hours) Unlocking the Power of Novel Therapies in HER2+ Breast Cancer Treatment

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

03-Oct-2025 to 02-Oct-2026

 

Webcast #6 (1.0-hour) Addressing Disparities in Breast Cancer: Special Considerations for Marginalized Populations – featuring real-world patient perspectives and a Clinician Spotlight

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

24-Oct-2025 to 23-Oct-2026

 

Webcast #7 (1.0-hour) Breast Cancer Case Competition: Test Your Knowledge on Integrating Novel Therapies into Practice  – featuring real-world patient perspectives and a Clinician Spotlight

Learn More
E-LEARNING

Web enduring Precision Medicine in NSCLC: Optimizing Biomarker Testing for Personalized Treatment Selection

PRIME Education, LLC

01-Apr-2025 to 31-Mar-2026

 

Webcast #1 (1.0-hour): Precision Medicine in NSCLC: Optimizing Biomarker Testing for Personalized Treatment Selection (features 'Clinician Spotlight' from PRIME QI project)

Learn More
E-LEARNING

Web enduring From Guidelines to Practice: Exploring Immunotherapy in Limited-Stage Small Cell Lung Cancer

PRIME Education, LLC

30-Dec-2024 to 30-Jan-2026

 

0.25-hour Multi-Accredited Booster Quiz

Learn More
E-LEARNING

Web Applying the Latest Evidence to Overcome Endocrine Resistance in HR+/HER2- Breast Cancer

PRIME Education, LLC

28-Jun-2024 to 03-Oct-2025

 

0.25-Hour Booster Quiz

Learn More
E-LEARNING

Web enduring Management of Brain Metastases in Patients With HER2+ Advanced Breast Cancer

PRIME Education, LLC

30-Dec-2024 to 29-Dec-2025

 

Clinical Case Challenge 1 (0.25-hour)

Learn More
E-LEARNING

Web enduring Advancing Risk-Based, Personalized Care for Veterans With mCRPC

PRIME Education, LLC

19-Nov-2024 to 18-Nov-2025

 

1.0-hour Multi-Accredited On-Demand Video

Learn More
E-LEARNING

Exploring the Evolving Role of HER2 for the Treatment of Gynecologic Cancers

PRIME Education, LLC

09-May-2025 to 08-May-2026

 

One (1) 0.5-hour Multi-Accredited, On-Demand Webcast 3-Part Series (1 of 3)

Learn More
E-LEARNING

Latest Evidence for HER2-Directed Therapies in Hepatobiliary Cancers

PRIME Education, LLC

30-May-2025 to 29-May-2026

 

One (1) 0.5-hour Multi-Accredited, On-Demand Webcast 3-Part Series (2 of 3)

Learn More
E-LEARNING

Emerging Clinical Data for Targeting HER2 in Bladder Cancer

PRIME Education, LLC

13-Jun-2025 to 12-May-2026

 

One (1) 0.5-hour Multi-Accredited, On-Demand Webcast 3-Part Series (3 of 3)

Learn More
E-LEARNING

Web enduring Reimagining Lung Cancer Treatment: A Journey Through New and Emerging Therapeutics Related to the Care of Patients with Small Cell and Non-Small Cell Lung Cancer

Efficient LLC

23-Jun-2025 to 23-Jun-2026

 

9-part microlearning series (4-7 minutes each; 75 mins total). Each episode to highlight critical, recent therapeutic advances across indications and disease subtypes in SCLC and NSCLC

Learn More
E-LEARNING

Live ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer

USH Axis Holdings Inc.

29-Jul-2025 to 29-Jul-2026

 

In this Virtual Case Clinic, explore three patient case examples with Dr. Mahtani as she demonstrates the application of the latest clinical evidence in HER2-positive, HER2-low, and HER2-ultralow metastatic breast cancer.

Learn More
E-LEARNING

Web enduring Improving HR+/HER2- Breast Cancer Outcomes with TROP2 Antibody-Drug Conjugates

USH Axis Holdings Inc.

18-Apr-2025 to 18-Apr-2026

 

online enduring Chairman's Perspective

Learn More
E-LEARNING

Think Tank Live: Collaborative Insights to Solve the Puzzle of Bladder Cancer

Global Learning Collaborative, Inc.

14-Mar-2025 to 14-Mar-2026

 

This online educational activity reviews molecular profiling, clinical trial data, therapy sequencing, and AE management to support evidence-based, personalized treatment strategies and improve outcomes in bladder cancer care.

Learn More
E-LEARNING

Web enduring Redefining Treatment Across the Spectrum of HR+ HER2-Expressing Metastatic Breast Cancer

USH Axis Holdings Inc.

26-Sep-2025 to 26-Sep-2026

 

enduring program from grand rounds series

Learn More
E-LEARNING

Web enduring HER2-Expressing MBC In Depth: The Latest Advances in Targeted Therapies and Brain Metastases Management

Global Learning Collaborative, Inc.

06-Feb-2025 to 06-Feb-2026

 

MinuteCE

Learn More
E-LEARNING

Web enduring Improving Equity in Endometrial Cancer Care and Treatment: Accelerating Change to Improve Patient Outcomes in Rural and Underserved Communities

Talem Health, LLC

15-Dec-2024 to 15-Dec-2025

 

An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com and marketed to the target audience nationally

Learn More
E-LEARNING

Web enduring Evolving Treatment Paradigms in HR+/HER2- Early Breast Cancer: Advancing Equitable Care in Rural and Underserved Communities

Talem Health, LLC

15-Dec-2024 to 15-Dec-2025

 

An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com and marketed to the target audience nationally

Learn More
E-LEARNING

Web enduring Targeting the PI3K/AKT/PTEN Pathway for Treatment of Breast Cancer: Innovative Solutions for Equitable Care

Talem Health, LLC

15-Dec-2024 to 15-Dec-2025

 

An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com and marketed to the target audience nationally

Learn More
E-LEARNING

Update on Surveillance and Management of HCC for Primary Care Clinicians: A Guide for Improving Outcomes in Rural and Underserved Communities

Talem Health, LLC

28-Feb-2025 to 28-Feb-2026

 

Online enduring activity: An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com and marketed to the target audience nationally. (1.0 AMA/ANCC credit)

Learn More
E-LEARNING

Web Enduring Official Best of San Antonio Breast Cancer Symposium 2024 Video Highlights

Encore Medical Education, LLC

11-Dec-2024 to 01-Dec-2025

 

This educational program includes original presentation slides accompanied by commentary from key opinion leaders (KOLs) in a micro-learning video format available for viewing within 12hours of the original presentation

Learn More
E-LEARNING

Enduring Materials: Precision Medicine in Practice Primer Recordings and Evaluation

Beckman Research Institute of City of Hope

01-Aug-2025 to 30-Jul-2026

 

upload, dissemination and outcomes tracking of 10 recorded modules addressing key elements of cancer genomics and precision medicine in practice

Learn More
E-LEARNING

Expert Perspectives: The Role of Immunotherapy in Advancing the Treatment of HCC and BTC

The France Foundation

24-Sep-2024 to 03-Sep-2025

 

Tumor-board case based online learning activity

Learn More
E-LEARNING

Addressing HER2 Alterations in Advanced NSCLC With Antibody-Drug Conjugate Therapy: Updates for The Community Oncologist

Med Learning Group, LLC

21-Nov-2024 to 21-Nov-2025

 

1-hr enduring activity of the live TeleECHOs of the same grant

Learn More
E-LEARNING

Are You Up to Date in the Management of HER2-Positive Solid Tumors? Focusing on Gastric and GEJ Cancer From Evaluation to Clinical Efficacy and Adverse Event Monitoring

Med Learning Group, LLC

12-Dec-2024 to 12-Dec-2025

 

Interactive enduring Grand Rounds program focusing on advanced HER2-expressing GC or GEJ cancers providing critical review of clinical trial findings and practical guidance on multidisciplinary monitoring.

Learn More
E-LEARNING

Are You Up to Date on the Latest Data on HER2-Targeted Antibody-Drug Conjugates for HER2-Expressing Solid Tumors?

Med Learning Group, LLC

02-Jan-2025 to 02-Jan-2026

 

A 1 Hour endured presentation of the Live Grand Rounds associated with this grant. 

Learn More
E-LEARNING

web Case by Case: Optimizing a Multidisciplinary Approach for Front-Line Maintenance Therapy in Advanced Ovarian Cancer

Med Learning Group, LLC

21-May-2025 to 21-May-2026

 

The activity is comprised of 3 interactive, video-based modules that escalate in complexity. Each module includes a brief clinical primer, followed by case presentation and discussion. 

Learn More
E-LEARNING

Chronic Lymphocytic Leukemia: An Evolving Treatment Landscape

Med Learning Group, LLC

06-Dec-2024 to 06-Dec-2025

 

1-hr enduring activity of TeleECHO session from this grant

Learn More
E-LEARNING

Live Comprehensive Care with HER2 ADCs Across Solid Tumors: Strategies to Enhance Efficacy and Minimize Toxicity

Med Learning Group, LLC

30-Jun-2025 to 30-Jun-2026

 

2 SmartCast Micro-learning podcasts, one on adverse event monitoring and management and another on integrating with pathology across HER2+ malignancies

Learn More
E-LEARNING

Web Comprehensive Care with HER2 ADCs Across Solid Tumors: Strategies to Enhance Efficacy and Minimize Toxicity

Med Learning Group, LLC

15-Jul-2025 to 15-Jul-2026

 

A smart reach reply enduring version of the ASCO virtual symposium presented on 5/30

Learn More
E-LEARNING

Web Managing Ocular Toxicity Associated with TROP2-Directed ADCs: Multidisciplinary Solutions

Med Learning Group, LLC

17-Jul-2025 to 17-Jul-2026

 

1-hr enduring program aiming to increase treatment team's awareness and knowledge of prophylactic management, ID/treatment strategies for ocular adverse events associated with TROP2-directed ADCs.

Learn More
E-LEARNING

web enduring Optimizing HER2 Testing for Advanced Breast Cancer: Guiding Treatment with HER2-Targeted Antibody-Drug Conjugates

Med Learning Group, LLC

20-Dec-2024 to 20-Dec-2025

 

Enduring focused on HER2-directed ADCs for HER2+/HER2-low advanced/metastatic BC, practical guidance to incorporate testing & best practices, clinical guidelines, trial findings, and monitoring & management of key treatment-related adverse events

Learn More
E-LEARNING

Web Overcoming Challenges for HER2-Low Testing in Metastatic Breast Cancer: A Multidisciplinary Effort

Med Learning Group, LLC

30-May-2025 to 30-May-2026

 

1-Hr Enduring Case-Based Educational program designed for Oncologists and Pathologists focused on HER2 testing in metastatic breast cancer.

Learn More
E-LEARNING

Clinical Conversations Online Replay

Med Learning Group, LLC

30-May-2025 to 30-May-2026

 

This enduring, case-based educational program is designed for oncologists and pathologists. 

Learn More
E-LEARNING

Live Online Enduring Program

Med Learning Group, LLC

29-Nov-2024 to 29-Nov-2025

 

Online Enduring Program of recorded Grand Round available for 1 year.

Learn More
E-LEARNING

Web enduring Recognizing the Role of TROP2 in NSCLC Management: Biologic Rationale, Clinical Data, and Community Oncologists as Champions of Multidisciplinary Care

Med Learning Group, LLC

29-Nov-2024 to 29-Nov-2025

 

1-hr enduring activity of live Grand Rounds under this grant

Learn More
E-LEARNING

Web enduring Smart Reach Replay Enduring

Med Learning Group, LLC

30-Oct-2024 to 30-Oct-2025

 

This interactive program combines didactic instruction with case-based discussions and illustrative animations.

Learn More
E-LEARNING

Session 2: Transforming CLL Management – Leveraging Emerging Data

Partners for Advancing Clinical Education

28-Jan-2025 to 28-Jul-2025

 

Get up to speed with key findings from the 2024 ASH® Annual Meeting. These two expert-led sessions provide critical updates on MCL and CLL

Learn More
E-LEARNING

Session 1: Advancing MCL Care – From Clinical Insights to Practical Applications

Partners for Advancing Clinical Education

07-Feb-2025 to 07-Aug-2025

 

Get up to speed with key findings from the 2024 ASH® Annual Meeting. These two expert-led sessions provide critical updates on MCL and CLL

Learn More
E-LEARNING

Patient Priorities for CLL Care

UMA Education Inc. dba Global Education Group

03-Feb-2025 to 06-Sep-2025

 

As targeted therapies have become the standard of care in chronic lymphocytic leukemia (CLL), it is increasingly important to refine therapy selection based on risk stratification.

Learn More
E-LEARNING

Guideline Recommendations for the Front-line Setting

UMA Education Inc. dba Global Education Group

03-Feb-2025 to 06-Sep-2025

 

As targeted therapies have become the standard of care in chronic lymphocytic leukemia (CLL), it is increasingly important to refine therapy selection based on risk stratification.

Learn More
E-LEARNING

Guideline Recommendations for the Relapsed/Refractory Setting

UMA Education Inc. dba Global Education Group

03-Feb-2025 to 06-Sep-2025

 

As targeted therapies have become the standard of care in chronic lymphocytic leukemia (CLL), it is increasingly important to refine therapy selection based on risk stratification.

Learn More
E-LEARNING

Module 1: Cytogenetic Testing for Patients with CLL/SLL

UMA Education Inc. dba Global Education Group

03-Feb-2025 to 06-Sep-2025

 

Hear from expert clinicians, Dr. Danielle Brander and Dr. Nilanjan Ghosh, as they explore current data and the patient and care-team factors that influence selection of therapy for CLL in the community setting. 

Learn More
E-LEARNING

Immunotherapy for Small-Cell Lung Cancer: Addressing Treatment Challenges

Plexus Communications LLC

15-Nov-2024 to 15-Nov-2025

 

This educational program aims to equip the healthcare team with the latest advancements and key insights into the treatment of small-cell lung cancer (SCLC).

Learn More
E-LEARNING

Web enduring Improving Patient Outcomes via Antibody-Drug Conjugates in Non-Small Cell Lung Cancer

Plexus Communications LLC

24-Jan-2025 to 24-Jan-2026

 

This activity focuses on the latest developments in antibody-drug conjugates (ADCs) for NSCLC and their expanding role in patient care.

Learn More
E-LEARNING

Novel Strategies in Mantle Cell Lymphoma: A Focus on BTK Inhibitors in the Front Line

Plexus Communications LLC

24-Jan-2025 to 24-Jan-2026

 

This activity focuses on the latest developments in antibody-drug conjugates (ADCs) for NSCLC and their expanding role in patient care.

Learn More
E-LEARNING

Optimizing Mantle Cell Lymphoma Management: Innovative Strategies with BTK Inhibitors in Front-Line Therapy

Plexus Communications LLC

17-Jul-2025 to 17-Jul-2026

 

1 hour pre-recorded enduring activity

Learn More
E-LEARNING

Expanding Targets in NSCLC: Updates on HER2- and TROP-2-directed Therapies

Haymarket Medical Education

31-Mar-2025 to 31-Mar-2026

 

•60-minute (1.0 credit hour) infographic webcast

Learn More
E-LEARNING

Web enduring PARP Inhibitors for Metastatic Prostate Cancer in the VHA Health System: Integrating New Agents into Practice

Plexus Communications LLC

14-Feb-2025 to 14-Feb-2026

 

This program equips clinicians with the knowledge to optimize care for patients with metastatic prostate cancer (mPC) by integrating PARP inhibitors into practice.

Learn More
E-LEARNING

Optimizing Personalized Care of Patients with CLL or MCL Using BTK Inhibitors in the Frontline and Relapsed/Refractory Settings

Plexus Communications LLC

06-Jan-2025 to 06-Jan-2026

 

This course helps clinicians optimize CLL/MCL treatment with BTKi agents in frontline and R/R settings, focusing on personalized therapy planning, veteran-specific predispositions, comorbidities, and resistance patterns.

Learn More
E-LEARNING

Web enduring Targeting EGFR Alterations at Exons 19 and 21 in Veterans with Non-Small Cell Lung Cancer: Bringing Therapeutic Advances into the Clinic

Plexus Communications LLC

28-Feb-2025 to 08-Feb-2026

This program equips clinicians with the knowledge to optimize care for patients with NSCLC and EGFR exon 19 and 21 alterations. Participants will learn about current molecular testing strategies and how these inform treatment decisions.

Learn More
E-LEARNING

Web Hybrid Community/VHA Oncology Forums: EGFR Exons 19 and 21 Alterations in Non-Small Cell Lung Cancer: Recent Therapeutic Advances and Implications for Care

Plexus Communications LLC

22-Jan-2025 to 22-Jan-2026

 

This program offers comprehensive education for oncology and lung cancer MDC teams on managing NSCLC with EGFR exon 19 and 21 alterations.

Learn More
E-LEARNING

Web TROP2 ADCs in Breast Cancer: Updates on the Latest Clinical Trial Data and AE Management

Paradigm Medical Communications, LLC

06-Jun-2025 to 06-Jun-2026

 

1-hour on-demand news broadcast, with whiteboard animation

Learn More
E-LEARNING

Web Targeting TROP2 in Advanced NSCLC: What Do We Know From Recent Clinical Trials?

PeerVoice America Limited

31-Jul-2025 to 30-Jul-2026

 

In this activity, based on a recent virtual live event, lung cancer experts explore the evidence for novel TROP2-directed therapies for the management of advanced NSCLC.

Learn More
E-LEARNING

Live web Hybrid Community/VHA Oncology Forums: Improving Patient Outcomes via Antibody-Drug Conjugates in Non-Small Cell Lung Cancer

Plexus Communications LLC

05-Dec-2024 to 19-Nov-2025

 

1 hour live hospital-based meetings in hem/onc departments nationwide

Learn More
E-LEARNING

Hybrid VHA Oncology Clinical Forums: Optimizing Mantle Cell Lymphoma Management in the VHA: Innovative Strategies with BTK Inhibitors in Front-Line Therapy

Plexus Communications LLC

24-Mar-2025 to 28-Nov-2025

 

1 hour live hospital-based meetings in hem/onc departments nationwide

Learn More
E-LEARNING

Web enduring Inside the Issue: Managing Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

16-Sep-2025 to 16-Sep-2025

 

1-hour archived AUDIO (1 CME/MOC); 2 clinical investigators with an expertise and/or specialized interest in the management ocular toxicities associated with cancer therapy to serve as the faculty - moderated by Dr Neil Love

Learn More
E-LEARNING

Inside the Issue: Managing Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

12-Sep-2025 to 12-Sep-2025

 

1-hour archived VIDEO (1 CME/MOC); 2 clinical investigators with an expertise and/or specialized interest in the management ocular toxicities associated with cancer therapy to serve as the faculty - moderated by Dr Neil Love

Learn More
E-LEARNING

Oncology Today with Dr Neil Love: Optimal Management of Brain Metastases in Patients with HER2-Positive Breast Cancer

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

26-Aug-2025 to 26-Aug-2026

 

Audio and Video interview program reviewing the management of patients with HER2-positive metastatic breast cancer (mBC) and brain metastases.

Learn More
E-LEARNING

Web Oncology Today with Dr Neil Love: Optimal Management of Brain Metastases in Patients with HER2-Positive Breast Cancer

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

26-Aug-2025 to 26-Aug-2026

 

Audio and Video interview program reviewing the management of patients with HER2-positive metastatic breast cancer (mBC) and brain metastases.

Learn More
E-LEARNING

Web Practical Perspectives: Experts Review Actual Cases of Patients with Advanced Gastroesophageal Cancers

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

18-Jun-2025 to 18-Jun-2026

 

1-hour audio enduring program

Learn More
E-LEARNING

Practical Perspectives: Experts Review Actual Cases of Patients with Advanced Gastroesophageal Cancers

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

18-Nov-2025 to 18-Nov-2025

 

1-hour live webinar a webinar to be held on November 18, 2025, moderated by Dr Neil Love.

Learn More
E-LEARNING

SIO Meet the Data Podcast Series

Society of Interventional Oncology

13-Oct-2025 to 16-Oct-2026

 

This podcast-series with multidisciplinary faculty will cover topics such as a comparison of the LEAP-012 Study vs. EMERALD-1 Study and Local Therapy vs. Combination Therapy.

Learn More
E-LEARNING

SIO 2025 Annual Meeting

Society of Interventional Oncology

01-April-2025 to 03-Feb-2026

 

SIO 2025 will offer an innovative education program including didactic sessions, panel discussions, tumor boards, case-based reviews and lectures to meet the needs of attendees.

Learn More
E-LEARNING

Tweetorial Series

American Society for Clinical Pathology

22-Aug-2024 to 30-Aug-2025

 

Tweetorials (10 -15 threaded tweets) will reinforce concepts in pan-tumor HER2 testing and potential clinical implications around treatment planning.

Learn More
E-LEARNING

Web Updated Germline Testing Guidelines

Integrity CE LLC

15-Apr-2025 to 14-Apr-2026

 

Bi-directional social media activity that applies a thought-provoking call to action accompanied by a succinct summary image and a video of faculty discussing topic

Learn More
E-LEARNING

CME/NCPD-approved Virtual Tumor Board

i3 Health LLC

26-Jun-2025 to 25-Jun-2026

 

This activity will provide a collaborative platform for expert oncology, pathology, and nursing faculty to discuss comprehensive management strategies for prostate cancer, aiming to improve clinician competence and patient outcomes.

Learn More
E-LEARNING

Journey Through the Breast Cancer Clinic: A Spectrum of HER2 Expression to Guide Treatment Decisions

Partners for Advancing Clinical Education

15-Sep-2024 to 15-Sep-2025

 

On-demand video

Learn More
E-LEARNING

Web Navigating Treatment Selection for Newly Diagnosed and Relapsed/Refractory BTC in the Era of Personalized Oncology Care

Partners for Advancing Clinical Education

13-Nov-2024 to 13-Nov-2025

 

The proposed 60-minute on-demand CME activity will be led by two GI oncology specialists.

Learn More
E-LEARNING

Live Implementing Immuno-Oncology in Gynecologic Cancer Care for Veterans: Expert Insights on Personalized Treatment

PVI, PeerView Institute for Medical Education, Inc.

22-Aug-2025  to 22-Aug-2025

 

Join PeerView and the NAVREF for this live virtual symposium for expert insights on biomarker testing, integrating personalized treatment plans, and communicating with Veterans about their care.

Learn More
E-LEARNING

Rethinking and Refining Endometrial Cancer Care in the Modern Age of Precision Medicine: How to Translate Clinical Evidence into Meaningful Improvements for Patients

PVI, PeerView Institute for Medical Education, Inc.

02-Aug-2024  to 01-Aug-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Exceeding Expectations in CLL: Workshops on Targeted Standards, Sequential Options, and Emerging Therapeutics for Team-Based Care

Medical Learning Institute Inc

04-Sep-2024 to 03-Oct-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Personalized Care and Tailored Treatment Plans for Gynecologic Cancers Practical Nurse Guidance on Utilizing Modern Therapeutic Approaches

PVI, PeerView Institute for Medical Education, Inc.

31-Dec-2024  to 30-Dec-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Live Web Personalized Care and Tailored Treatment Plans for Gynecologic Cancers: Practical Nurse Guidance on Utilizing Modern Therapeutic Approaches

PVI, PeerView Institute for Medical Education, Inc.

19-Jan-2025  to 30-Dec-2025

 

In this activity, developed with NOCC and FWC, oncology nurse experts provide insights on managing gynecologic cancers, including diagnostic testing, treatment support, adverse event management, patient education, and actionable care strategies.

Learn More
E-LEARNING

Crafting Custom Care in CLL: Guidance on Upfront and Sequential Treatment Decisions With Targeted and Immune-Based Platforms

PVI, PeerView Institute for Medical Education, Inc.

06-Dec-2024  to 05-Jan-2026

 

In collaboration with the CLL Society, PeerView’s Candid Conversations & Clinical Consults event at the ASH Annual meeting provided expert-led discussions and practical case-based guidance to help learners address common clinical challenges in CLL.

Learn More
E-LEARNING

Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC

PVI, PeerView Institute for Medical Education, Inc.

08-Sep-2024 to 07-Oct-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Web Elevating Care in Resectable Stage I-III NSCLC: Targeted Therapy and Immunotherapy at the Forefront of Multimodal Treatment Strategies

PVI, PeerView Institute for Medical Education, Inc.

09-Sep-2024 to 08-Oct-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Web The Innovation Intersection in B-Cell Cancers: Navigating Choices With Modern Targeted Strategies, Cellular Therapy, and HCT

PVI, PeerView Institute for Medical Education, Inc.

13-Feb-2025 to 12-Mar-2026

 

On-demand activity, based on a 2025 Tandem Meetings symposium, explores advances in CLL and MCL. Experts discuss how targeted and immunotherapies have reshaped B-cell cancer management and impacted HCT use.

Learn More
E-LEARNING

Optimizing PARP Inhibitor Therapy in Veterans With Prostate Cancer: A Practical Guide for VA Pharmacists

PVI, PeerView Institute for Medical Education, Inc.

11-Nov-2024 to 10-Dec-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Web endurig Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways

PVI, PeerView Institute for Medical Education, Inc.

10-Oct-2024 to 09-Nov-2025

 

0.75 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Off-the-Shelf and On the Mark in NHL: Strategic Approaches With Bispecific Antibodies and ADCs for Enhanced DLBCL and FL Care

PVI, PeerView Institute for Medical Education, Inc.

31-Jul-2025 to 30-Jul-2026

 

In this on-demand enduring activity, faculty will explore real-world strategies for selecting, sequencing, and safely delivering modern and emerging off-the-shelf immunotherapies through engaging MasterClass lectures and practical case discussions.

Learn More
E-LEARNING

Web Enduring Reinforcing Precision Tactics in Genomically Altered Resectable NSCLC: Collaborative Workflows and Personalized Solutions for Integration of Adjuvant EGFR- and ALK-Targeted Therapies

PVI, PeerView Institute for Medical Education, Inc.

10-Oct-2024 to 09-Nov-2025

 

0.75 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Web A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical Impact

PVI, PeerView Institute for Medical Education, Inc.

28-Jan-2025 to 27-Jan-2026

 

PeerView on-demand activity delivering evidence on ADCs and novel therapies for HER2-positive, HER2-low, or HER2-ultralow breast cancer and guiding their integration into personalized treatment plans.

Learn More
E-LEARNING

Maximizing Therapeutic Innovations in Bladder Cancer: Expert Strategies for Comprehensive Care Across Disease Stages

PVI, PeerView Institute for Medical Education, Inc.

15-Feb-2025 to 14-Mar-2026

 

Join this CME/MOC/AAPA/IPCE-certified activity, held with BCAN alongside the 2025 ASCO® GU Cancers Symposium. Gain expert insights on selecting treatments, personalizing care, and integrating modern immunotherapy and targeted therapies.

Learn More
E-LEARNING

Fortifying the Framework for HER2+ GI Cancers: Precision Treatment Planning With Molecularly Targeted Therapies in GC/GEJC, CRC, and BTC

PVI, PeerView Institute for Medical Education, Inc.

24-Jan-2025 to 24-Jan-2025

 

This MasterClass & Practicum at ASCO GI 2025 offers GI care teams concise lectures with comprehensive guidance on evidence-based integration and practical use of validated targeted therapies for HER2+ GI malignancies.

Learn More
E-LEARNING

Web enduring “Experts vs AI” ADC Challenge—Lung Cancer Edition: Interpreting the Evidence, Exploring Practicalities

PVI, PeerView Institute for Medical Education, Inc.

21-Feb-2025 to 20-Mar-2026

 

n this interactive session, based on a live event and featuring ongoing audience engagement, the faculty panel present challenging questions and case scenarios to AI, then analyze and discuss the accuracy of its responses.

Learn More
E-LEARNING

Web enduring A New Era in Treating Advanced Ovarian Cancer: Practical Tips for Maximizing the Use of PARP Inhibitors, Immunotherapy, and ADCs

PVI, PeerView Institute for Medical Education, Inc.

15-Mar-2025 to 14-Apr-2026

 

This activity, recorded at SGO 2025 in collaboration with the Foundation for Women’s Cancer, offers expert insights on optimizing PARP inhibitors, immunotherapy, ADCs, and emerging targeted regimens.

Learn More
E-LEARNING

Precision Medicine Crafts a New Story for Metastatic Prostate Cancer: The Next Act of Therapeutic Intensification With AKT Inhibition and Beyond

PVI, PeerView Institute for Medical Education, Inc.

14-Feb-2025 to 13-Mar-2026

 

This on-demand activity, based on a live ASCO GU 2025 symposium, explores AKT inhibition’s role in targeting the PI3K/AKT/PTEN pathway and advancing personalized care in advanced prostate cancer.

Learn More
E-LEARNING

Accelerating Innovation in Biliary Tract Cancer: Restructuring Treatment Models With Immunotherapy & Targeted Platforms in Advanced Disease

PVI, PeerView Institute for Medical Education, Inc.

24-Jan-2025 to 23-Feb-2026

 

In collaboration with the Cholangiocarcinoma Foundation, this live event at the 2025 ASCO GI Cancers Symposium will offer expert guidance on treatment decisions, therapy selection, and personalized care with immunotherapy and targeted platforms.

Learn More
E-LEARNING

The Second Coming of Finite Therapy in CLL: Making Informed Treatment Decisions With Newer, Time-Limited BTKi Combinations

PVI, PeerView Institute for Medical Education, Inc.

23-Jun-2025 to 22-Jul-2026

 

Experts provide insights on the latest evidence with finite BTKi-BCL2i combinations and guidance on how to integrate these regimens into personalized upfront care.

Learn More
E-LEARNING

Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations

PVI, PeerView Institute for Medical Education, Inc.

23-Jun-2025 to 22-Jul-2026

 

Experts share frontline BTKi evidence and apply it through real-world cases, debating CIT, BTKi regimens, and ASCT strategies.

Learn More
E-LEARNING

Putting Precision Into Practice for Bladder Cancer Treatment: Insights for Individualized Care Across the Disease Continuum

PVI, PeerView Institute for Medical Education, Inc.

28-Apr-2025 to 27-May-2026

 

In this activity, expert faculty provide guidance on bringing scientific advances to patients with bladder cancer as they review the latest clinical data, guideline recommendations, and real-world applications of modern bladder cancer therapies.

Learn More
E-LEARNING

Refining the First Strike Against EGFR-Mutated Advanced NSCLC

PVI, PeerView Institute for Medical Education, Inc.

22-Nov-2024 to 21-Dec-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

ALL-in on Bispecific Innovation: Guidance on the Present and Future of Off-the-Shelf Immunotherapy in Acute Lymphoblastic Leukemia

PVI, PeerView Institute for Medical Education, Inc.

05-Jun-2025 to 04-Jul-2026

 

This activity provides perspectives on bispecific antibody standards in adult and pediatric ALL care while preparing for future innovation with novel TCE strategies.

Learn More
E-LEARNING

From Innovation to Implementation: Unlocking the Full Potential of Antibody-Drug Conjugates in Solid Tumors

PVI, PeerView Institute for Medical Education, Inc.

28-Apr-2025 to 27-May-2026

 

This activity covers the latest trial data on diverse ADC modalities in breast, lung, GI, GU, and other cancers.

Learn More
E-LEARNING

Web Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

PVI, PeerView Institute for Medical Education, Inc.

27-Jan-2025 to 26-Jan-2026

 

PeerView on-demand activity providing the latest evidence and guidelines on consolidation immunotherapy in LS-SCLC.

Learn More
E-LEARNING

Web enduring Mastering the Integration of Immunotherapy in Resectable NSCLC: Practical Considerations for Real-World Practice

PVI, PeerView Institute for Medical Education, Inc.

26-Jan-2025 to 25-Feb-2026

 

In this on-demand activity from the 2025 STS Annual Meeting, experts share insights on stage I-III rNSCLC via tumor board-style cases, guiding learners in identifying immunotherapy candidates, selecting optimal approaches, and supporting patients.

Learn More
E-LEARNING

Web Targeting Higher Standards in Resectable NSCLC: The Surgery-Oncology Coalition for Tailoring Care in EGFR & ALK TKI Therapy

PVI, PeerView Institute for Medical Education, Inc.

25-Jan-2025 to 24-Jan-2026

 

In this PeerView activity from the 2025 STS Annual Meeting, NSCLC experts discuss the latest evidence and guidelines on EGFR- & ALK-targeted therapies as adjuvant and neoadjuvant treatments for EGFR- & ALK-mutated NSCLC.

Learn More
E-LEARNING

Hope on the Horizon in Gastric Cancer: Breakthroughs in Personalized Care With Immunotherapy and Targeted Strategies

PVI, PeerView Institute for Medical Education, Inc.

01-Jun-2025 to 30-Jun-2026

 

Developed with Hope For Stomach Cancer, this ASCO 2025 recorded event shares patient perspectives and offers resources to support shared decision-making in stomach cancer care.

Learn More
E-LEARNING

Web Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies

PVI, PeerView Institute for Medical Education, Inc.

01-Jun-2025 to 30-Jun-2026

 

This educational activity with LUNGevity and the Oncology Brothers, recorded during ASCO 2025, offers insights on NSCLC biomarkers and targeted therapy strategies from early to advanced stages.

Learn More
E-LEARNING

Web Mission Possible in Prostate Cancer: Leveraging Genomics, Modern Therapeutics, and Individualized Patient Care

PVI, PeerView Institute for Medical Education, Inc.

01-Jun-2025 to 30-Jun-2026

 

In this educational activity from PeerView Live and ZERO Prostate Cancer recorded at ASCO 2025, a panel of experts will link the evidence.

Learn More
E-LEARNING

Purpose in Practice for HCC: Delivering Effective Care With Modern Systemic Platforms Across Disease Settings

PVI, PeerView Institute for Medical Education, Inc.

01-Jun-2025 to 30-Jun-2026

 

In collaboration with Blue Faery, this educational activity, recorded during the 2025 ASCO Annual Meeting, is designed to help clinicians deliver more effective care for HCC across the disease spectrum.

Learn More
E-LEARNING

Committing to Advances for CLL Care: Conversations on Modern Standards of Care and Next-Gen Innovation

PVI, PeerView Institute for Medical Education, Inc.

05-Sep-2025 to 04-Oct-2026

 

Join experts as they discuss the latest evidence and guidelines supporting targeted therapy platforms and immune-based strategies.

Learn More
E-LEARNING

Web Integrating Immunotherapy in Resectable NSCLC: How to Move From Complexity Toward Clarity

PVI, PeerView Institute for Medical Education, Inc.

14-May-2025 to 13-Jun-2026

 

Experts explore neoadjuvant, adjuvant, and perioperative immunotherapy advances and address key questions in this enduring activity based on a live thoracic oncology event.

Learn More
E-LEARNING

Web Harnessing Precision With EGFR-Targeted Therapy in Resectable NSCLC

PVI, PeerView Institute for Medical Education, Inc.

15-May-2025 to 14-Jun-2026

 

In this activity, based on a live event, experts share key evidence and case guidance on biomarker testing and targeted therapies for resectable NSCLC.

Learn More
E-LEARNING

The Clock Strikes Innovation in CLL: Upfront Care With Newer, Time-Limited BTKi Combinations

PVI, PeerView Institute for Medical Education, Inc.

14-Sep-2025 to 13-Oct-2026

 

Expert discussion on the advances in CLL frontline treatment recorded at the 2025 International Workshop on CLL.

Learn More
E-LEARNING

Web Implementing Immuno-Oncology in Gynecologic Cancer Care for Veterans: Expert Insights on Personalized Treatment

PVI, PeerView Institute for Medical Education, Inc.

23-Aug-2025  to 22-Sep-2026

 

An on-demand activity based on a live virtual symposium from PeerView and NAVREF, offering expert insights on biomarker testing, integrating personalized treatment plans, and communicating with Veterans about their care.

Learn More
E-LEARNING

Expert discussion on the advances in CLL frontline treatment recorded at the 2025 International Workshop on CLL.

PVI, PeerView Institute for Medical Education, Inc.

08-Sep-2025 to 07-Sep-2026

 

An on-demand self-study activity offering guidance on optimal healthcare team collaboration and clinical decision-making for patients with DLBCL.

Learn More
E-LEARNING

Achieving Excellence in Gastric/GEJ Cancer Care: Multidisciplinary Guidance on Immunotherapy Platforms in Resectable Disease

PVI, PeerView Institute for Medical Education, Inc.

17-Jun-2025  to 16-Jul-2026

 

This activity provides expert insights on immunotherapy advances and strategies for integrating them into personalized care for resectable GC/GEJC.

Learn More
E-LEARNING

Web Building a Precision-Centric Community for Patients with EGFRm NSCLC: Adopting Success Strategies with Targeted Standards, Potent Combinations, and Emerging Agents

PVI, PeerView Institute for Medical Education, Inc.

30-Oct-2025 to 29-Oct-2026

 

Stay up to date on the latest advances in EGFRm NSCLC with this CME/MOC/NCPD/AAPA-certified enduring activity.

Learn More
E-LEARNING

Immune to the Impossible in Hepatobiliary Malignancies: Expert Insights on Breakthrough Innovations for Immunotherapy Platforms in Advanced-Stage Disease

PVI, PeerView Institute for Medical Education, Inc.

29-Aug-2025  to 28-Aug-2026

 

On-demand activity featuring expert-led analyses of emerging immunotherapies paired with real-world clinical guidance through case-based discussions.

Learn More
E-LEARNING

Web enduring Critical Conversations for Surgeons & Oncologists in Resectable Gastric/GEJ Cancer

PVI, PeerView Institute for Medical Education, Inc.

14-Oct-2025 to 13-Oct-2026

 

In this activity, based on a PeerView Live Critical Conversations event at the 2025 AATS ITSOS, experts review evidence on immunotherapy in resectable GC/GEJC, share real-world cases, and highlight strategies for collaboration and best practices.

Learn More
E-LEARNING

Web ME Highlights: The Principles of Care in Advanced NSCLC: An Advanced Practitioners' Guide to Antibody Drug Conjugates

Answers in CME Inc.

09-Dec-2024  to 08-Dec-2025

 

Key takeaways, session highlights, complete recordings, and downloadable slides from the JADPRO live session

Learn More
E-LEARNING

Web enduring ME Highlights: TROP2-Directed ADCs in the Treatment of Advanced NSCLC: Answering Key Questions to Establish Evidence-Based Practices

Answers in CME Inc.

26-Dec-2024  to 25-Dec-2025

 

Summarize the most salient information from the Virtual Live, in a text- and slide-based format, divided into 5 sessions.

Learn More
E-LEARNING

Translating the Latest Evidence on First-Line Treatment for EGFR-Mutated NSCLC Into Practice: An Update for Community Clinicians

Answers in CME Inc.

26-Sep-2025 to 25-Sep-2026

 

Fast-paced, interactive web-based program including expert speaker feedback, current evidence, and best practices

Learn More
E-LEARNING

Keeping Pace With TROP2-Directed ADCs in HR-Positive, HER2-Negative/Low Advanced Breast Cancer

Answers in CME Inc.

19-Dec-2024  to 18-Dec-2025

 

Fast-paced, interactive, microburst sessions with expert faculty commentary.

Learn More
E-LEARNING

Web enduring Expanding Pathways of Care for HER2-Positive Metastatic NSCLC: Beyond Mutation to Overexpression

Answers in CME Inc.

19-Dec-2024  to 18-Dec-2025

 

An expert in NSCLC discusses testing for overexpression of HER2 in patients with metastatic NSCLC, as well as clinical skills related to treatment selection/management for HER2-overexpressing NSCLC

Learn More
E-LEARNING

Web enduring ME Highlights: Decoding HER2 Low and Ultralow in Breast Cancer: The Path to Precision Care With Antibody-Drug Conjugates

Answers in CME Inc.

06-May-2025  to 05-May-2026

 

Enduring initiative with content highlighting the most salient points from all 3 Virtual Live Micro Series events

Learn More
E-LEARNING

Web enduring ME Highlights: Staying Abreast of Shifting Paradigms in Advanced HR+, HER2- Breast Cancer: Updates on Novel Oral SERDs

Answers in CME Inc.

21-Jul-2025 to 20-Jul-2026

 

Summarize the most salient information from the Virtual Live, in a text- and slide-based format, divided into 5 sessions.

Learn More
E-LEARNING

Web enduring Keeping Pace with TROP2-Directed ADCs: Their Evolving Role in Advanced, Pretreated EGFR-Mutated NSCLC

Answers in CME Inc.

30-Jun-2025  to 29-Jun-2026

 

Fast-paced, interactive, microburst sessions with expert faculty commentary.

Learn More
E-LEARNING

From Theory to Practice: Integrating TROP2 ADCs in HR+/HER2- Breast Cancer

Answers in CME Inc.

13-Nov-2026  to 12-Nov-2027

 

Interactive case scenarios, followed by faculty-led explanation and discussion.

Learn More
E-LEARNING

Web enduring Ocular Safety in Breast Cancer Care: What Eye Clinicians Need to Know About Novel Oral Endocrine Therapies

Answers in CME Inc.

15-Oct-2025 to 14-Oct-2026

 

Interactive e-learning featuring clinical perspectives and discussion from 2 leading experts.

Learn More
E-LEARNING

Web ME Highlights: What’s Now and What’s Next for ADCs in NSCLC? Integrating HER2- and TROP2-Targeted Therapies Into the Evolving Treatment Landscape

Answers in CME Inc.

29-Dec-2025 to 28-Dec-2026

 

Key takeaways, session highlights, complete recordings, and downloadable slides from the IASLC NA live session

Learn More
E-LEARNING

Web Translating Trials to Treatment: Practical Strategies for Immunotherapy Integration in Limited Stage- and Extensive Stage-SCLC

Answers in CME Inc.

31-Dec-2025 to 30-Dec-2026

 

Fast-paced, interactive, microburst sessions with expert faculty commentary.

Learn More
E-LEARNING

Web enduring ME Highlights: Rapid Roundup 2025 in NSCLC: Keeping Up with ADC Therapies Driving Precision Lung Cancer Care

Answers in CME Inc.

16-Dec-2025 to 15-Dec-2026

 

Summarize the most salient information from the Virtual Live, in a text- and slide-based format, divided into 5 sessions.

Learn More
E-LEARNING

ME Replay: ADC-elerating Progress: Targeting TROP2 in Triple-Negative Breast Cancer to Improve Front-Line Care

Answers in CME Inc.

26-Jan-2026 to 13-Feb-2026

 

Full session recording from the 60-minute Virtual Live event

Learn More
E-LEARNING

Web enduring Bridging Clinic and OR: A Dialogue on the Emerging Role of Neoadjuvant HER2-Directed ADCs in HER2+ Breast Cancer

Answers in CME Inc.

26-Jan-2026 to 25-Jan-2027

 

Interactive e-learning featuring clinical perspectives and discussion from 2 leading experts.

Learn More
E-LEARNING

Evolving Care in B-ALL: From Questions to Answers on The Role of CD19 Bispecific T-Cell Engagers

Answers in CME Inc.

04-Mar-2026 to 03-Mar-2027

 

Fast-paced, interactive web-based program including expert speaker feedback, current evidence, and best practices

Learn More
E-LEARNING

Web Germline Testing in Cancer Patients: Molecular Diagnostic Considerations and Clinical Implications

Association for Molecular Pathology

30-Jan-2025 to 31-Dec-2026

 

This webinar addresses when genetic testing is indicated in cancer patients, laboratory considerations for genetic testing, identifying germline variants in tumor sequencing data, and how to treat when detecting germline pathogenic variants.

Learn More
E-LEARNING

On-Demand Recording of the ASCP Panel Discussion

American Society for Clinical Pathology

09-Jan-2026 to 11-Jan-2027

 

To further extend the reach of the Annual Meeting session, ASCP will develop one CME/CMLE-accredited on-demand recording from the Annual Meeting Session.

Learn More
E-LEARNING

Inside the Lab Podcast

American Society for Clinical Pathology

09-Jan-2026 to 11-Jan-2027

 

45-minute CME/CMLE-accredited podcast, titled “Advances in NSCLC Biomarker Testing.”

Learn More
E-LEARNING

Case-Based Microlearning Series

American Society for Clinical Pathology

03-Feb-2025 to 11-Jan-2027

 

An interactive, online CME/CMLE credit-bearing microlearning series consisting of 1 hour of case-based education on biomarker testing and treatment for NSCLC segmented into 4 easily consumable 15-minute segments.

Learn More
E-LEARNING

Web Pick the Best Path: Optimizing PI3KCA Mutation-Targeted HR+/HER2- PIK3CA-Mutated Therapy and Hyperglycemia Management

Annenberg Center for Health Sciences at Eisenhower

01-Jan-2026 to 31-Jan-2027

 

45-minute with 2 experts presenting and discussing; recording

Learn More
E-LEARNING

Downloadable Resource Guide

American Society for Clinical Pathology

24-Oct-2025 to 11-Jan-2027

 

A non-accredited Resource Guide to empower pathologists and laboratory professionals on ways to operationalize testing pathways that will lead to timely, effective, efficient, and equitable testing for patients diagnosed at their institutions.

Learn More
E-LEARNING

TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Significance of the Construct

PeerVoice America Limited

25-Jan-2024 to 24-Jan-2026

 

20 minute web enduring activity with experts discussing TROP2-directed antibody-drug conjugates (ADCs) for breast cancer.

Learn More
E-LEARNING

Web When They Need More Than Trastuzumab: Deciding on What’s Next for Patients With HER2+ Gastric Cancer

PeerVoice America Limited

11-Sep-2024 to 10-Sep-2026

 

5 Micro Episodes (5 mins each) with an expert's presentation

Learn More
E-LEARNING

Pathological Assessment of HER2 Status in Gastric and Gastroesophageal Cancers: Important Steps That Can Impact Outcomes

PeerVoice America Limited

27-Sep-2024 to 26-Sep-2026

 

5 Micro Episodes (5 min each) with an Experts presentation

Learn More
E-LEARNING

Web enduring Practical Protocols for Preventing and Managing Antibody-Drug Conjugate-Associated Nausea and Vomiting

PeerVoice America Limited

30-Sep-2024 to 29-Sep-2026

 

In this video CE activity, Karin Jordan, MD, PhD, explores strategies for preventing and managing antibody-drug conjugate-associated nausea and vomiting

Learn More
E-LEARNING

Applying Foresight to Optimise Emesis Control in Patients Receiving Antibody-Drug Conjugates

PeerVoice America Limited

31-Oct-2024 to 30-Oct-2026

 

In this two-part video CE activity, Karin Jordan, MD, PhD, and Erika Hamilton, MD, discuss strategies for controlling emesis in patients who are receiving antibody-drug conjugates.

Learn More
E-LEARNING

Testing Impacts Treatment: Applying Best Practices in HER2 Assessment in Solid Tumours

PeerVoice America Limited

08-Nov-2024 to 07-Nov-2026

 

An expert discusses HER2 assessment and therapeutic management in solid tumours.

Learn More
E-LEARNING

Live Enhancing Multidisciplinary Strategies for the Management of Ocular Toxicities From Novel Oncology Therapies

PRIME Education, LLC

29-Sep-2025 to 11-Feb-2026

 

Five (5) 1.0-hour Multi-Accredited Clinical Connections Regional Forums

Learn More
E-LEARNING

Web enduring Advanced NSCLC: Empowering Nurses to Improve Patient Care in Rural and Underserved Communities

Talem Health, LLC

02-Jun-2025 to 02-Jun-2026

 

An online, on-demand enduring CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com; marketed to the target audience nationally.

Learn More
E-LEARNING

Gastric Cancer ECHO – Linking Experts and Community Oncologists To Improve the Management of Gastric/GEJ Cancer in Rural and Underserved Communities

Talem Health, LLC

30-Sep-2025 to 30-Sep-2026

 

Community oncologists will connect with a multidisciplinary team of experts at a 'hub' site. Each monthly ECHO session will include a brief didactic presentation by expert faculty followed by participant-led case presentation and group discussion.

Learn More
E-LEARNING

Web Interdisciplinary Strategies for BRCA-Mutated EBC: Testing, Targeting, and Team-Based Care

USH Axis Holdings Inc.

15-Jan-2026 to 15-Jan-2027

 

1-hour Grand Rounds replay on molecular testing, evidence-based therapy, and team-based care for high-risk early-stage breast cancer with germline BRCA mutations. Covers BRCA testing, disparities, and case-based adjuvant strategies.

Learn More
E-LEARNING

Web ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer

USH Axis Holdings Inc.

29-July-2025 to 29-July-2026

 

Explore 3 cases with Dr. Mahtani showcasing how current evidence guides the use of antibody-drug conjugates in HER2-positive, HER2-low, and ultralow metastatic breast cancer to support optimal, evidence-based treatment selection.

Learn More
E-LEARNING

Web Video Webinar: HER2 Overexpression/Mutation as an Actionable Target in NSCLC

USF Health Professions Conferencing Corporation (HPCC)

11-July-2025 to 11-July-2026

 

1.0-hour, CE-certified, enduring video webinar of the live tumor board

Learn More
E-LEARNING

Web Roundtable: ADCs Targeting HER2 in NSCLC

USF Health Professions Conferencing Corporation (HPCC)

02-May-2025 to 02-May-2026

 

0.50-hour, CE-certified, on-demand expert roundtable webinar

Learn More
E-LEARNING

Oncology Congress: Navigating the Expanding Treatment Landscape in NSCLC: Addressing Key Targets to Improve Access and Outcomes in Rural and Underserved Communities

Talem Health, LLC

15-Jan-2026 to 15-Jan-2027

 

Online enduring activity: An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com; marketed to the target audience nationally. (1.0 AMA/ANCC credit)

Learn More
E-LEARNING

Web Oncology Congress – Navigating Advances in Early Breast Cancer: Improving Access in Rural and Underserved Settings

Talem Health, LLC

15-Jan-2026 to 15-Jan-2027

 

Online enduring activity: An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com; marketed to the target audience nationally. (1.0 AMA/ANCC credit)

Learn More
E-LEARNING

Sorting the Sequence in Multiple Myeloma: Making Personalized Choices With BCMA and non-BCMA Immunotherapies in Relapsed/Refractory Disease

PVI, PeerView Institute for Medical Education, Inc.

19-March-2026 to 18-April-2027

 

In this PeerView activity based on a live symposium at the 2026 Tandem Meetings of ASTCT and CIBMTR, myeloma experts use a series of interactive case-based workshops to model team-based care solutions for optimizing the RRMM treatment sequence.

Learn More
E-LEARNING

Synchronizing Success in Resectable Gastric/GEJ Cancer: Merging Expertise to Effectively Deliver Immunotherapy Platforms in the Surgical Setting

PVI, PeerView Institute for Medical Education, Inc.

29-Jan-2026 to 28-Feb-2027

 

Join this PeerView activity to gain the latest data and expert-approved strategies for delivering chemoimmunotherapy platforms in the surgical setting. This activity was recorded during a live event at the 2026 STS Annual Meeting.

Learn More
E-LEARNING

Web From Evidence to Impact: Harnessing PI3K/AKT/mTOR Pathway Inhibitors to Improve Outcomes in HR+/HER2– mBC

PVI, PeerView Institute for Medical Education, Inc.

23-March-2026 to 22-March-2027

 

Interactive PeerView inQuiry activity using question-driven self-assessment and expert discussion to strengthen clinicians’ understanding of PI3K/AKT/mTOR pathway alterations in HR+/HER2– metastatic breast cancer.

Learn More
E-LEARNING

Streamlining Multidirectional Care in HCC: Applying Groundbreaking Evidence on Systemic Treatment Approaches Across the Disease Spectrum

PVI, PeerView Institute for Medical Education, Inc.

09-Jan-2026 to 08-Feb-2027

 

Join PeerView Live and Blue Faery: The Adrienne Wilson Liver Cancer Association for this activity recorded at ASCO GI 2026 to gain insights and practical strategies for treating HCC.

Learn More
E-LEARNING

Web Innovative Approaches in Prostate Cancer: Bridging Genomics and Patient-Centric Treatment

PVI, PeerView Institute for Medical Education, Inc.

03-Dec-2025 to 02-Jan-2027

 

This activity from PeerView and ZERO Prostate Cancer, recorded during the SUO annual meeting, provides learners with the tools they need to ensure that their patients are benefiting from state-of-the-art prostate cancer therapeutics.

Learn More
E-LEARNING

Navigating Frontline CLL Care With Modern BTKi and BCL2i Strategies: Rising to the Global Challenge

PVI, PeerView Institute for Medical Education, Inc.

06-Nov-2025 to 25-Jan-2027

 

A clinician-directed assessment-based microlearning intervention targeting academic and community hematology-oncology professionals globally

Learn More
E-LEARNING

Web Harnessing the Power of ADCs in Gynecologic Cancers: Expert Insights for Practice Integration

PVI, PeerView Institute for Medical Education, Inc.

21-Nov-2025 to 20-Nov-2026

 

In this activity, experts review the latest evidence on approved and emerging ADCs presented at the 2025 ESMO Congress and the IGCS Annual Global Meeting and provide strategies for bringing these agents to clinical practice.

Learn More
E-LEARNING

Web Pathway to Precision in Ovarian Cancer: A Pathology-Informed Guide to Translating Biomarker Testing Results Into Actionable Treatment With ADCs

PVI, PeerView Institute for Medical Education, Inc.

23-Feb-2026 to 22-Feb-2027

 

This on-demand activity will focus on biomarker interpretation and the integration of relevant findings into personalized treatment plans.

Learn More
E-LEARNING

Dialing Up Precision in HR+, HER2- MBC With New Endocrine Agents, Targeted Therapies, and Combinations

PVI, PeerView Institute for Medical Education, Inc.

16-Dec-2025 to 15-Jan-2027

 

Join top experts in this SABCS 2025 PeerView/LBBC recorded activity for a cutting-edge, case-based look at applying precision evidence and key patient factors to guide nuanced breast cancer treatment decisions.

Learn More
E-LEARNING

Forging New Paths With Earlier Use of ADCs in Breast Cancer: From Clinical Breakthroughs to Improved Outcomes

PVI, PeerView Institute for Medical Education, Inc.

17-Dec-2025 to 16-Jan-2027

 

In this SABCS 2025 PeerView/GRASP recorded activity, explore evolving ADC science and real-world cases as experts translate emerging evidence into practical, individualized breast cancer care in a fast-moving field.

Learn More
E-LEARNING

Mapping Therapeutic Directions in DLBCL: Team Strategies for Prognostic Assessment & Implications for Targeted Therapy and Other Innovative Options

PVI, PeerView Institute for Medical Education, Inc.

08-Sep-2025 to 07-Sep-2026

 

An on-demand self-study activity offering guidance on optimal healthcare team collaboration and clinical decision-making for patients with DLBCL.

Learn More
E-LEARNING

Off the Shelf and in the Clinic for NHL: Leveraging Bispecific Antibody Strategies in DLBCL, FL, and Beyond

PVI, PeerView Institute for Medical Education, Inc.

05-Dec-2025 to 04-Jan-2027

 

In collaboration with the HealthTree Foundation for NHL, this expert-led, case-based activity—recorded during ASH 2025—is designed to model team-based care solutions for integrating bispecifics into clinical practice.

Learn More
E-LEARNING

Pathways to Personalized Remission in CLL: Leveraging Targeted Standards and Next-Gen Advances for Upfront and Sequential Care

PVI, PeerView Institute for Medical Education, Inc.

05-Dec-2025 to 04-Jan-2027

 

In collaboration with CLL Society, this expert-led activity recorded during ASH 2025, covers modern CLL pathways to remission through a series of interactive, case-based workshops focused on real-world challenges in CLL care.

Learn More
E-LEARNING

Moving Forward in B-ALL: Insights on Modern and Emerging Standards With Off-the-Shelf Bispecific Antibodies

PVI, PeerView Institute for Medical Education, Inc.

05-Dec-2025 to 04-Jan-2027

 

In collaboration with HealthTree Foundation for ALL, this expert-led activity recorded during ASH 2025, provides perspectives on modern clinical standards in modern ALL care

Learn More
E-LEARNING

Web Implementing Immuno-Oncology in Gynecologic Cancer Care for Veterans: Expert Insights on Personalized Treatment

PVI, PeerView Institute for Medical Education, Inc.

23-Aug-2025 to 22-Sep-2026

 

An on-demand activity based on a live virtual symposium from PeerView and NAVREF, offering expert insights on biomarker testing, integrating personalized treatment plans, and communicating with Veterans about their care.

Learn More
E-LEARNING

Redrawing Frontlines in MCL: The Upfront Expansion of BTKi Options & Modern Clinical Decision-Making in Newly Diagnosed Disease

PVI, PeerView Institute for Medical Education, Inc.

05-Dec-2025 to 04-Jan-2027

 

In collaboration with the HealthTree Foundation for MCL, this expert-led activity recorded during ASH 2025, demonstrates how the latest evidence on 1L BTKi platforms is impacting decision-making for different MCL presentations and patient cohorts.

Learn More
E-LEARNING

Turning the Tide in Gastric Cancer Management: Integrating Modern Systemic Therapies Across the Disease Continuum for Community-Based Clinicians

PVI, PeerView Institute for Medical Education, Inc.

22-Dec-2025 to 21-Dec-2026

 

This enduring activity features expert dialogue and case-based insights on biomarkers, molecular profiling, and updated immunotherapy and targeted options to guide personalized treatment selection and sequencing for gastric/GEJ cancer.

Learn More
E-LEARNING

Purpose in Practice for HCC: Delivering Effective Care With Modern Systemic Platforms Across Disease Settings

PVI, PeerView Institute for Medical Education, Inc.

01-June-2025 to 30-June-2026

 

In collaboration with Blue Faery, this educational activity, recorded during the 2025 ASCO Annual Meeting, is designed to help clinicians deliver more effective care for HCC across the disease spectrum.

Learn More
E-LEARNING

Precision Medicine Crafts a New Story for Metastatic Prostate Cancer: The Next Act of Therapeutic Intensification With AKT Inhibition and Beyond

PVI, PeerView Institute for Medical Education, Inc.

14-Feb-2025 to 13-Mar-2026

 

This on-demand activity, based on a live ASCO GU 2025 symposium, explores AKT inhibition’s role in targeting the PI3K/AKT/PTEN pathway and advancing personalized care in advanced prostate cancer.

Learn More
E-LEARNING

Web enduring A New Era in Treating Advanced Ovarian Cancer: Practical Tips for Maximizing the Use of PARP Inhibitors, Immunotherapy, and ADCs

PVI, PeerView Institute for Medical Education, Inc.

15-Mar-2025 to 14-April-2026

 

This activity, recorded at SGO 2025 in collaboration with the Foundation for Women’s Cancer, offers expert insights on optimizing PARP inhibitors, immunotherapy, ADCs, and emerging targeted regimens.

Learn More
E-LEARNING

Web The Innovation Intersection in B-Cell Cancers: Navigating Choices With Modern Targeted Strategies, Cellular Therapy, and HCT

PVI, PeerView Institute for Medical Education, Inc.

21-Mar-2025 to 20-April-2026

 

On-demand activity, based on a 2025 Tandem Meetings symposium, explores advances in CLL and MCL. Experts discuss how targeted and immunotherapies have reshaped B-cell cancer management and impacted HCT use.

Learn More
E-LEARNING

Advancing Evidence-Based Care for Veterans With mHSPC: Pathways, Personalization, and Team-Based Strategies

PRIME Education, LLC

13-Feb-2026 to 12-Feb-2027

 

1.0-hour Multi-Accredited Enduring Webcast (includes clinical trial pocket guide)

Learn More
E-LEARNING

Latest Clinical Data for Emerging Combination Strategies in mHSPC

PRIME Education, LLC

13-Feb-2026 to 12-Feb-2027

 

One (1) 0.25-hour Multi-Accredited Booster Quiz (includes clinical trial pocket guide)

Learn More
E-LEARNING

Biomarker to Bedside: Practical Approaches to HER2 Testing and Targeted Treatment in Gynecologic Cancers

PRIME Education, LLC

13-Feb-2026 to 12-Feb-2027

 

1.0-hr Multi-Accredited Enduring Webcast with HER2 Testing Toolkit Resource

Learn More
E-LEARNING

Web Integrating Real-World Patient Insights in Metastatic Breast Cancer Care: Personalizing Treatment With Novel Agents

PRIME Education, LLC

11-DEC-2026 to 10-Dec-2026

 

1.0-hour Multi-Accredited, On-Demand Enduring Webcast with downloadable Companion Guides

Learn More
E-LEARNING

Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer

PRIME Education, LLC

04-DEC-2025 to 03-Dec-2026

 

One (1) 0.5-hour On-Demand Webcast with Point-of-Care AE Management Guide

Learn More
E-LEARNING

Web Unlocking Precision: Genetic Testing and Counseling Essentials for Breast Cancer Care

PRIME Education, LLC

05-DEC-2025 to 04-Dec-2026

 

0.5-hour Corresponding Enduring Activities in Breast Cancer Genomics #1

Learn More
E-LEARNING

Translating Clinical Data Into Practice: Genetic Testing and PARP Inhibitors in Breast Cancer Management

PRIME Education, LLC

10-DEC-2025 to 09-Dec-2026

 

1.0-hour Multi-Accredited Enduring Webcast

Learn More
E-LEARNING

Web Translating Clinical Data Into Practice: Genetic Testing and PARP Inhibitors in Breast Cancer Management

PRIME Education, LLC

10-DEC-2025 to 09-Dec-2026

 

1.0-hour Multi-Accredited Enduring Webcast

Learn More
E-LEARNING

Beyond Positive and Negative: Redefining HER2 Testing and Treatment Pathways in Metastatic Breast Cancer

PRIME Education, LLC

18-Aug-2025 to 17-Aug-2026

 

1.0-hour Multi-Accredited Enduring Webcast

Learn More
E-LEARNING

Web HER2 Beyond the Binary: Navigating HER2-Low and HER2-Ultralow Metastatic Breast Cancer

PRIME Education, LLC

24-Nov-2025 to 23-Nov-2026

 

1.0-hour Multi-Accredited Enduring Webcast GME HER2-low mBC Early Career Clinicians

Learn More
E-LEARNING

Live web New Horizons in NSCLC: The Role of ADCs in Enhancing Personalized Care in HER2-Altered Disease

Plexus Communications LLC

01-Feb-2026 to 31-Aug-2026

 

1 hour live hospital-based meetings held in hem/onc departments nationwide

Learn More
E-LEARNING

Live Targeting EGFR Alterations: Precision Approaches to Frontline Treatment of Late-Stage Non-Small Cell Lung Cancer (NSCLC)

Plexus Communications LLC

31-Oct-2025 to 18-June-2026

 

1 hour live hospital-based meetings held in hem/onc departments nationwide

Learn More
E-LEARNING

Web enduring Advancing Metastatic NSCLC Care in the VA: The Role of HER2- and TROP2-Targeted Antibody-Drug Conjugates

Plexus Communications LLC

16-Dec-2025 to 16-Sep-2026

 

1 hour on-demand video presentation with slides and graphics; Polling interactivity

Learn More
E-LEARNING

Live Hybrid Community Oncology Forums: Advances in Perioperative Immunotherapy for Resectable NSCLC

Plexus Communications LLC

09-Oct-2025 to 09-March-2026

 

1 hour live hospital-based meetings held in hem/onc departments nationwide

Learn More
E-LEARNING

Subtype-Driven Therapy in DLBCL: The Emerging Role of Frontline BTK Inhibition

Plexus Communications LLC

05-Nov-2025 to 23-April-2026

 

1 hour live hospital-based meetings held in hem/onc departments nationwide

Learn More
E-LEARNING

Live Hybrid Community Oncology Forums: New Horizons in NSCLC: The Role of ADCs in Enhancing Personalized Care in HER2-Altered Disease

Plexus Communications LLC

15-Nov-2025 to 03-April-2026

 

1 hour live hospital-based meetings held in hem/onc departments nationwide

Learn More
E-LEARNING

Web enduring Emerging Therapies in Prostate Cancer: Key Insights for Urology Nurses

Plexus Communications LLC

11-Dec-2025 to 11-Sep-2026

 

1 hour on-demand video presentation with slides and graphics; Polling interactivity

Learn More
E-LEARNING

Web Making the Most of Maintenance Therapy for Ovarian Cancer: Optimizing the Use of PARP Inhibitors

Plexus Communications LLC

22-Oct-2025 to 22-Oct-2026

 

1 hour on-demand video presentation with slides and graphics; Polling interactivity

Learn More
E-LEARNING

Live Hybrid Oncology Forums: Making the Most of Maintenance Therapy for Ovarian Cancer: Optimizing the Use of PARP Inhibitors

Plexus Communications LLC

18-July-2025 to 10-March-2026

 

1 hour live hospital-based meetings held in hem/onc departments nationwide

Learn More
E-LEARNING

Web enduring Bridging the Gaps in PARP Inhibitor Use for Metastatic Prostate Cancer in the VHA System

Plexus Communications LLC

22-Dec-2025 to 22-Dec-2026

 

1 hour on-demand video presentation with slides and graphics; Polling interactivity

Learn More
E-LEARNING

Advancing Frontline Therapy in Mantle Cell Lymphoma: The Evolving Role of BTK Inhibitors

Plexus Communications LLC

19-Dec-2025 to 19-Sep-2026

 

1 hour on-demand video presentation with slides and graphics; Polling interactivity

Learn More
E-LEARNING

Optimizing Second- and Next-Generation BTK Inhibitor Use in the Management of Chronic Lymphocytic Leukemia

Plexus Communications LLC

30-July-2025 to 30-July-2026

 

1 hour pre-recorded enduring activity

Learn More
E-LEARNING

Web Integrating PARP Inhibitors for the Treatment of Metastatic Prostate Cancer: Optimizing Personalized Care in the VHA and Community Health Care Systems

Plexus Communications LLC

27-Aug-2025 to 27-Aug-2026

 

1 hour on-demand video presentation with slides and graphics; Polling interactivity

Learn More
E-LEARNING

Web The Emerging Nuances of Extensive Stage SCLC Treatment: Individualizing Care in the Immunotherapy Era

PeerVoice America Limited

03-March-2026 to 02-March-2028

 

Micro Episodes activity equips oncologists including community oncologists, and oncology midlevel providers, nurses and pharmacists to deliver individualized care and support shared clinical decision-making in SCLC as the treatment landscape evolves.

Learn More
E-LEARNING

Web Antibody-Drug Conjugates in Breast Cancer: Keeping Abreast of the Latest Data As They Emerge From ESMO

PeerVoice America Limited

27-Oct-2025 to 26-Oct-2026

 

In this activity, experts explore recently presented data on the management of breast cancer.

Learn More
E-LEARNING

Navigating Fixed-Duration Treatments in CLL

Partners for Advancing Clinical Education

03-April-2025 to 11-Aug-2026

 

30-minute online endured patient/caregiver activity. The education will increase patient awareness and understanding of available and novel treatments in CLL, while providing strategies to align with clinicians on goals of therapy.

Learn More
E-LEARNING

Real-world Application of Targeted Therapy for CLL: Insights for the Community Oncologist

Partners for Advancing Clinical Education

11-Aug-2025 to 11-Aug-2026

 

60-minute online endured CME activity. Four on-demand pre-recorded modules designed as part of a 60-minute HCP toolkit to improve practice integration. The content for this toolkit will be heavily informed by the data uncovered in phase 1

Learn More
E-LEARNING

Decoding Treatment Paradigms in CLL: Fixed-Duration vs Treat-to-Progression

Partners for Advancing Clinical Education

28-May-2025 to 11-Aug-2026

 

60-minute online endured CME activity. Experts will provide education on fixed-duration and treat-to-progression approaches including a snapshot of the community-based practice patterns uncovered

Learn More
E-LEARNING

Web TROP2 ADCs in Breast Cancer: Updates on the Latest Clinical Trial Data and AE Management

Paradigm Medical Communications, LLC

06-June-2025 to 06-June-2026

 

1-hour on-demand news broadcast, with whiteboard animation

Learn More
E-LEARNING

Web LUGPA 2025 Enduring CME Program

Opt-in CME, LLC

18-Dec-2025 to 18-Dec-2028

 

4.25 hours enduring video activity of the entire LUGPA CME day

Learn More
E-LEARNING

Web Expert Second Opinion: Investigators Discuss the Optimal Management of HER2-Positive Gastrointestinal Cancers

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

28-Jan-2026 to 18-Jan-2027

 

Video enduring progra

Learn More
E-LEARNING

Live Expert Second Opinion: Investigators Discuss the OptimLal Management of HER2-Positive Gastrointestinal Cancers

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

28-Jan-2026 to 18-Jan-2027

 

audio enduring program

Learn More
E-LEARNING

Web Integrating New Advances into the Care of Patients with Cancer — A Multitumor Symposium in Partnership with the American Oncology Network

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

13-Dec-2025 to 13-Dec-2026

 

audio enduring program

Learn More
E-LEARNING

Integrating New Advances into the Care of Patients with Cancer — A Multitumor Symposium in Partnership with the American Oncology Network

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

13-Dec-2025 to 13-Dec-2026

 

video enduring program

Learn More
E-LEARNING

Live Data + Perspectives: Clinical Investigators Explore the Application of Recent Data Sets in Current Oncology Care — Diffuse Large B-Cell Lymphoma and Follicular Lymphoma Module

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

13-Dec-2025 to 13-Dec-2026

 

Video enduring from a Live CME Symposium Hosted in Conjunction with Florida Cancer Specialists

Learn More
E-LEARNING

Web Data + Perspectives: Clinical Investigators Explore the Application of Recent Data Sets in Current Oncology Care — Prostate Cancer Module

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

13-Dec-2025 to 13-Dec-2026

 

Audio enduring from a Live CME Symposium Hosted in Conjunction with Florida Cancer Specialists

Learn More
E-LEARNING

Data + Perspectives: Clinical Investigators Explore the Application of Recent Data Sets in Current Oncology Care — Prostate Cancer Module

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

13-Dec-2025 to 13-Dec-2026

 

Video enduring from a Live CME Symposium Hosted in Conjunction with Florida Cancer Specialists

Learn More
E-LEARNING

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care - Breast Cancer Module

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

13-Dec-2025 to 13-Dec-2026

 

Audio enduring from live symposium in partnership with Florida Cancer Specialists

Learn More
E-LEARNING

Web Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care - Breast Cancer Module

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

13-Dec-2025 to 13-Dec-2026

 

Video enduring from live symposium in partnership with Florida Cancer Specialists

Learn More
E-LEARNING

Web audio programCases from the Community: Investigators Discuss the Optimal Management of HER2-Positive Breast Cancer

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

14-Jan-2026 to 14-Jan-2027

 

audio program

Learn More
E-LEARNING

Web video Cases from the Community: Investigators Discuss the Optimal Management of HER2-Positive Breast Cancer

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

14-Jan-2026 to 14-Jan-2027

 

video program

Learn More
E-LEARNING

Web The Implications of Recent Datasets for the Current and Future Management of Non-Hodgkin Lymphoma

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

07-Oct-2025 to 07-Oct-2026

 

Audio enduring

Learn More
E-LEARNING

Live The Implications of Recent Datasets for the Current and Future Management of Non-Hodgkin Lymphoma

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

07-Oct-2025 to 07-Oct-2026

 

Video enduring

Learn More
E-LEARNING

Cases from the Community: Investigators Discuss Available Research Guiding the Selection of Therapy for Patients with Chronic Lymphocytic Leukemia

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

07-Jan-2026 to 07-Jan-2027

 

video enduring program

Learn More
E-LEARNING

Cases from the Community: Investigators Discuss Available Research Guiding the Selection of Therapy for Patients with Chronic Lymphocytic Leukemia

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

07-Jan-2026 to 07-Jan-2027

 

audio enduring program

Learn More
E-LEARNING

NCCN 2026 Breast Cancer Congress with Updates from the 2025 San Antonio Breast Cancer Symposium

National Comprehensive Cancer Network, Inc.

06-Feb-2026 to 06-Feb-2027

 

a one-day live-in-person educational activity with livestreaming, real-time polling, and moderator-facilitated Q&A sessions.

Learn More
E-LEARNING

Behind the Guidelines: Insights into the Standard of Care in Oncology 2026

National Comprehensive Cancer Network, Inc.

10-Jan-2026 to 31-Dec-2027

 

This activity consists of twelve NCCN Guidelines Insights articles

Learn More
E-LEARNING

Transforming Gastric and GEJ Cancer Care With Perioperative Immunotherapy: Latest Updates From Chicago

Medscape LLC

11-July-2025 to 11-July-2026

 

Medscape Onsite: A 30-minute On Demand video discussion between 2 gastric oncology specialists offering data dissemination from ASCO 2025, May 30- June 3, 2025, in Chicago, IL

Learn More
E-LEARNING

Web TROP2 ADCs for NSCLC: What Community Oncologists Need to Know

Med Learning Group, LLC

20-Nov-2025 to 20-Nov-2026

 

1-hr endured TeleECHO meeting for US and global community oncologists in NSCLC to better understand TROP2 in pathophysiology

Learn More
E-LEARNING

The Emerging Role of Oral SERDs in Community Care for Frontline HR+/HER2- Metastatic Breast Cancer

Med Learning Group, LLC

21-Nov-2025 to 21-Nov-2026

 

15/20 min series of 3 SmartCast podcasts with Dr. Erica Mayer & renowned experts on oral ET in HR+ & HER2-negative MBC

Learn More
E-LEARNING

Web The Emerging Role of Oral SERDs in Community Care for Frontline HR+/HER2- Metastatic Breast Cancer

Med Learning Group, LLC

07-Nov-2025 to 07-Nov-2026

 

1-hr endured presentation of the Community Oncology Connection meetings on oral ET in HR+ & HER2-negative MBC

Learn More
E-LEARNING

(Enduring) Novel Targeted Therapeutics and Essential Strategies for Optimized Outcomes in Chronic Lymphocytic Leukemia

HMP Education, LLC

18-Nov-2025 to 18-May-2026

 

To extend program reach to learners unable to participate in LL&M, HMP Education will develop an enduring on-demand archive of the session

Learn More
E-LEARNING

Web (Enduring) Advances in R/R Follicular Lymphoma: Diagnostic Approaches and Novel Therapeutic Options

HMP Education, LLC

18-Nov-2025 to 18-May-2026

 

To extend program reach to learners unable to participate in LL&M, HMP Education will develop an enduring on-demand archive of the session

Learn More
E-LEARNING

Digital Pathology and AI in Cancer Diagnostics

Florida Society of Pathologists

30-May-2025 to 30-May-2026

 

1 hr on-demand webinar

Learn More
E-LEARNING

Effective Communication and Collaboration Across the Multidisciplinary Team

Florida Society of Pathologists

25-April-2025 to 25-April-2026

 

1 hr on-demand webinar

Learn More
E-LEARNING

Application of Molecular and Genomic Biomarker Testing in Hematopathology

Florida Society of Pathologists

13-March-2025 to 13-March-2026

 

1 hr on-demand webinar

Learn More
E-LEARNING

Application of Molecular and Genomic Biomarker Testing in Solid Tumors

Florida Society of Pathologists

01-March-2025 to 01-March-2026

 

1 hr on-demand webinar

Learn More
E-LEARNING

Web Case #1 - Aligning the Patient-Provider Therapeutic Connection to Improve Clinical Outcomes in Progressive HR+/HER2- Metastatic Breast Cancer

Clinical Care Options, LLC

19-Dec-2025 to 30-June-2026

 

AMA/ABIM MOC/AAPA/ANCC/ACPE Interactive Case Challenge (ICC) #1

Learn More
E-LEARNING

Slide Deck- Aligning the Patient-Provider Therapeutic Connection to Improve Clinical Outcomes in Progressive HR+/HER2- Metastatic Breast Cancer

Clinical Care Options, LLC

25-Nov-2025 to 30-June-2026

 

"Downloadable Living Slideset with Slide Notes (posting 11/21/25)"

Learn More
E-LEARNING

Web Case #2 - Aligning the Patient-Provider Therapeutic Connection to Improve Clinical Outcomes in Progressive HR+/HER2- Metastatic Breast Cancer

Clinical Care Options, LLC

31-Dec-2025 to 30-June-2026

 

AMA/ABIM MOC/AAPA/ANCC/ACPE Interactive Case Challenge (ICC) #2

Learn More
E-LEARNING

Live Aligning the Patient-Provider Therapeutic Connection to Improve Clinical Outcomes in Progressive HR+/HER2- Metastatic Breast Cancer

Clinical Care Options, LLC

14-Nov-2025 to 13-May-2026

 

6 CME/CE/CPE and ABIM-MOC certified InterAct Oncology Small-group interprofessional team trainings, 2 live CME/CE/CPE and ABIM MOC certified simulcasts, Enduring CME/CE/CPR and ABIM/MOC certified case simulation series, downloadable living slideset

Learn More
E-LEARNING

A Discussion on Strategies for New Therapies and Evolving Care in Chronic Lymphocytic Leukemia (CLL)

Blood Cancer United, Inc.

12-Nov-2025 to 17-Dec-2026

 

Join our webinar for a clinical update on CLL. Experts will review new therapies like BTK inhibitors and CAR T-cell therapy, offer patient selection guidance, and discuss treatment management, toxicity monitoring, and survivorship care.

Learn More
E-LEARNING

Interleukin-33 and Lower Tract Respiratory Diseases Moving From Pathophysiology to Management

Integritas Communications

23-Jun-2025 to 23-Jun-2026

 

Join experts Dr. Jonathan Hand, Prof. Dave Singh, and Prof. Tom Wilkinson as they discuss IL-33’s role in respiratory disease, its signaling pathways, therapeutic potential, and current clinical trials targeting IL-33-driven inflammation.

Learn More
E-LEARNING

Self Directed Data Dive, A New Target in Sight: Alarmin Cytokines and the Evolving Biologic Landscape in CRSwNP

Integrity CE, LLC

12-Dec-2025 to 12-Dec-2026

 

A Self-Directed/On-Demand activity

Learn More
E-LEARNING

Beyond the Airways: Recognizing Systemic Clues and Advancing Care with Emerging Therapies in Hypereosinophilic Syndromes

Integrity CE, LLC

28-Jan-2026 to 28-Jan-2027

 

On-Demand Data Dive Program

Learn More
E-LEARNING

Severe Asthma Bridge: Improving Clinical Outcomes For Patients with Severe or Uncontrolled Asthma

Montefiore Medical Center

12-Dec-2025 to 07-Feb-2026

 

Web-Based Program

Learn More
E-LEARNING

Stories Behind the Science in EGPA: Updated Strategies for Diagnosis, Treatment, and Reducing the Steroid Burden in Patients

PVI, PeerView Institute for Medical Education, Inc.

28-Feb-2025 to 27-Mar-2026

 

An on-demand enduring activity based on a recent live event, featuring expert faculty discussing the challenges of recognizing, diagnosing, and managing EGPA.

Learn More
E-LEARNING

Vasculitis 2025: Advances and Controversies

THE CLEVELAND CLINIC EDUCATIONAL FOUNDATION

10-Jul-2025 to 09-Jul-2027

 

This comprehensive education dives into the complexities and innovations in the treatment and diagnosis of various forms of vasculitis. 

Learn More
E-LEARNING

Rethinking CRSwNP: A Comprehensive Learning Experience for Optimized Patient Care

National Jewish Health

30-Jun-2025 to 30-Jun-2026

 

-Interactive infographic part of a three-part series
-Learners will review the definition and clinical features of CRSwNP, explore inflammatory pathways in a self-paced animation, and review management strategies and current and emerging therapies.

Learn More
E-LEARNING

Rethinking CRSwNP: A Visual Framework for Targeting Epithelial-Driven Inflammation

National Jewish Health

30-Jun-2025 to 30-Jun-2026

 

In this mobile-friendly, interactive infographic activity, learners will review the definition & clinical features of CRSwNP; explore inflammatory pathways in a self-paced animation of pathophysiology in CRSwNP; & review management strategies,

Learn More
E-LEARNING

Managing Upper and Lower Airway Diseases: The Role of Epithelial-Driven Inflammation

National Jewish Health

30-Jun-2025 to 30-Jun-2026

 

-1.5 online enduring activity

-Expert faculty from pulmonology, allergy, and otolaryngology explore the complexities of epithelial-driven inflammatory airway diseases.

-Clinical case scenarios

Learn More
E-LEARNING

Clinical Remission in Asthma: An Expert Consensus on the Current Criteria, Evidence, and Impact

National Jewish Health

29-Sep-2025 to 29-Sep-2026

 

Journal-based CME activity based on an article supplement from a panel of experts presenting the panel's definition of asthma remission and unresolved issues for further investigation.

Learn More
E-LEARNING

In Conversation: Multidisciplinary Perspectives on Chronic Airways Disease

National Jewish Health

19-Oct-2025 to 19-Oct-2025

 

Join National Jewish Health for a symposium where top pulmonologists and allergists explore new insights on chronic inflammatory airway diseases. Gain updates on treatment advances, immune cell roles, and strategies for managing airway conditions.

Learn More
E-LEARNING

Innovating Care for Chronic Respiratory Diseases: Targeting IL-33 and Epithelial Alarmins

National Jewish Health

20-Oct-2025 to 20-Oct-2025

 

This National Jewish Health program will explore IL-33 and epithelial alarmins in asthma, COPD, and viral infections. Faculty from multiple fields, will engage audiences through frontline perspectives and incorporate cases into their discussions.

Learn More
E-LEARNING

Rethinking Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): A Real-Time Clinical Decision-Making Tool

National Jewish Health

12-Sep-2025 to 30-Jun-2026

 

The decision aid component of the "Rethinking CRSwNP" education initiative is a case-based, algorithm-driven activity that simulates real-world patient encounters to enhance clinical decision-making.

Learn More
E-LEARNING

Medical Myth-busting: Unmasking the Role of Epithelial Cytokines and Emerging Biologics in CRSwNP

National Jewish Health

23-Dec-2025 to 23-Dec-2026

 

Experts bust common CRSwNP myths in an investigative-style program with interactive cases, animations, endoscopy footage, and patient videos—highlighting epithelial cytokines, guidelines, and emerging therapies.

Learn More
E-LEARNING

Web Transforming Asthma Management: The Role of Pharmacists in Implementing Combination Therapy

Postgraduate Healthcare Education, LLC

31-Mar-2025 to 31-Mar-2026

 

Monograph

Learn More
E-LEARNING

Tackling CRSwNP Management With Emerging Biologic Therapies Targeting Epithelial Cytokines: Game On!

PVI, PeerView Institute for Medical Education, Inc.

12-Dec-2025 to 12-Dec-2025

 

Interactive educational event held in conjunction with AAO-HNSF 2025 and focused on the role of epithelial cytokines in CRSwNP and the optimal use of biologic agents.

Learn More
E-LEARNING

Clearing the Way in CRSwNP: Targeting Upstream Drivers With Emerging Biologic Approaches

PVI, PeerView Institute for Medical Education, Inc.

06-Oct-2025 to 05-Oct-2025

 

This educational activity will test your knowledge and provide feedback on your skills for integrating available and emerging biologic agents into the management of CRSwNP.

Learn More
E-LEARNING

Addressing an Exacerbating Issue in COPD: Strategies for Individualized Targeted Biologic Therapy to Improve Quality of Life

PVI, PeerView Institute for Medical Education, Inc.

13-Nov-2025 to 12-Dec-2026

 

In this activity based on a live event at GOLD 2025, experts share the latest evidence that can guide the integration of highly efficacious, novel and emerging biologics into clinical practice.

Learn More
E-LEARNING

Use of Anti-Inflammatory Reliever (AIR) Therapy in Asthma for Healthcare Professionals in Primary Care and Specialty Practices

Regents of the University of Michigan

01-Nov-2025 to 31-Oct-2028

 

AIR therapy recommended by the worldwide GINA and US NAEPP asthma guidelines to better manage inflammation associated with respiratory symptoms and to reduce exacerbations. This is a paradigm change necessitating education of clinicians and patients

Learn More
E-LEARNING

ME Highlights: Navigating the Changing CRSwNP Landscape: From Mechanisms to Data-Driven Decisions in Biologic Therapy

Answers in CME Inc.

12-Dec-2025 to 11-Dec-2026

 

Summarize the most salient information from the Virtual Live, in a text- and slide-based format, divided into 5 sessions.

Learn More
E-LEARNING

Enhancing Care and Management of Transplant Recipients: Expert Strategies for Mitigating COVID-19 Risk

Clinical Care Options, LLC

01-Jun-2024 to 31-Jul-2025

 

Online Activities:

  • An on-demand webcast 
  • A downloadable PowerPoint slideset 
  • Timely ClinicalThought™ expert commentaries on developments and new clinical data
Learn More
E-LEARNING

Hot Topics in Systemic Lupus Erythematosus: Updates on the 2025 American College of Rheumatology Guidelines - Module 1: An Overview of New ACR Lupus Clinical Practice Guidelines

Integritas Communications

30-May-2025 to 1-Aug-2026

 

In this program, Dr. Maria Dall’Era reviews ACR guideline updates for SLE treatment, offering insights into disease activity evaluation and evidence-based strategies to optimize individualized patient care.

Learn More
E-LEARNING

Harnessing Biologics for SLE Management: Pathways to Remission

PVI, PeerView Institute for Medical Education, Inc.

30-Jul-2025 to 29-Jul-2026

 

This PeerView activity examines the critical role of initiating biologic therapy early in the course of systemic lupus erythematosus (SLE) to achieve low disease activity and remission.

Learn More
E-LEARNING

Web enduring 12th Annual Basic and Clinical Immunology for the Busy Clinician: Scientific Advances in Holistic and Integrative Care of Immune-Mediated Diseases

THE CLEVELAND CLINIC EDUCATIONAL FOUNDATION

19-Apr-2024 to 18-Apr-2026

 

This symposium will review recent immunologic advances to address knowledge gaps among busy clinicians regarding research in basic translational and clinical immunology

Learn More
E-LEARNING

Live 12th Annual Basic and Clinical Immunology for the Busy Clinician

THE CLEVELAND CLINIC EDUCATIONAL FOUNDATION

19-Apr-2024 to 18-Apr-2026

 

This symposium will review recent immunologic advances to address knowledge gaps among busy clinicians regarding research in basic translational and clinical immunology. 

Learn More
E-LEARNING

ACC.25 Spotlight Session

American College of Cardiology Foundation

18-Apr-2025 to 18-Apr-2026

 

Meeting on Demand

Learn More
E-LEARNING

Enduring Webcast

National Association For Continuing Education, LLC

29-Aug-2025 to 28-Aug-2026

 

Enduring CME Webcast

Learn More
E-LEARNING

Balancing GDMT and Hyperkalemia – Expert Insights into Optimal Heart Failure Care

Partners for Advancing Clinical Education

19-Nov-2025 to 19-Nov-2026

 

Originally presented at the HFSA Annual Scientific Meeting 2025 - this interactive session explores strategies to optimize guideline-directed medical therapy for heart failure while effectively managing hyperkalemia.

Learn More
E-LEARNING

Best Practices for Managing Intracerebral Hemorrhage

Voxmedia LLC

14-Mar-2025 to 14-Mar-2026

 

90 minute video with expert panel discussion

Learn More
E-LEARNING

Best Practices for Managing Hyperkalemia in Patients with Heart Failure and Chronic Kidney Disease

Voxmedia LLC

30-May-2025 to 30-May-2026

 

On-Demand 1.5 hour video enduring material

Learn More
E-LEARNING

Management of RAAS Inhibitor Therapy After Hyperkalemia in Patients with CKD and Heart Failure

American Society of Nephrology, Inc.

17-Nov-2025 to 31-Dec-2026

 

Symposium posting on ASN eLearning Center. Credit is not awarded for viewing the online content.

Learn More
E-LEARNING

Taking the Updated CKD Guidelines From Paper to Practice

PeerVoice America Limited

06-Sep-2024 to 05-Sep-2026

 

30 minutes video, with expert panel discussion

Learn More
E-LEARNING

Facing the Challenges: Managing Hyperkalemia in Heart Failure Patients W hile Maintaining RAASi Therapy

Voxmedia LLC

09-Jul-2025 to 09-Jul-2026

 

60 minute video with expert panel

Learn More
E-LEARNING

Managing Hyperkalemia in Heart Failure: Implementing Strategies to Reduce Patient Risk

Voxmedia LLC

29-Jul-2025 to 29-Jul-2026

 

1-hour video with panel discussion

Learn More
E-LEARNING

Hot Topics in Systemic Lupus Erythematosus: Updates on the 2025 American College of Rheumatology Guidelines - Module 1: An Overview of New ACR Lupus Clinical Practice Guidelines

Integritas Communications

30-May-2025 to 1-Aug-2026

 

In this program, Dr. Maria Dall’Era reviews ACR guideline updates for SLE treatment, offering insights into disease activity evaluation and evidence-based strategies to optimize individualized patient care.

Learn More
E-LEARNING

Harnessing Biologics for SLE Management: Pathways to Remission

PVI, PeerView Institute for Medical Education, Inc.

30-Jul-2025 to 29-Jul-2026

 

This PeerView activity examines the critical role of initiating biologic therapy early in the course of systemic lupus erythematosus (SLE) to achieve low disease activity and remission.

Learn More
E-LEARNING

Web enduring 12th Annual Basic and Clinical Immunology for the Busy Clinician: Scientific Advances in Holistic and Integrative Care of Immune-Mediated Diseases

THE CLEVELAND CLINIC EDUCATIONAL FOUNDATION

19-Apr-2024 to 18-Apr-2026

 

This symposium will review recent immunologic advances to address knowledge gaps among busy clinicians regarding research in basic translational and clinical immunology

Learn More
E-LEARNING

Live 12th Annual Basic and Clinical Immunology for the Busy Clinician

THE CLEVELAND CLINIC EDUCATIONAL FOUNDATION

19-Apr-2024 to 18-Apr-2026

 

This symposium will review recent immunologic advances to address knowledge gaps among busy clinicians regarding research in basic translational and clinical immunology. 

Learn More
E-LEARNING

Enhancing Care and Management of Transplant Recipients: Expert Strategies for Mitigating COVID-19 Risk

Clinical Care Options, LLC
01-Jun-2024 to 31-Jul-2025

 

Online Activities:

  • An on-demand webcast 
  • A downloadable PowerPoint slideset
  • Timely ClinicalThought™ expert commentaries on developments and new clinical data
Learn More
E-LEARNING

NCCN 2025 Annual Conference

National Comprehensive Cancer Network, Inc.

15-Jun-2025 to 01-Mar-2026

 

NCCN will offer 33 educational sessions from this activity as archived endured webcasts posted on NCCN’s continuing education portal, http://education.nccn.org.  

Learn More
E-LEARNING

Live 2025-2026 Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care

National Comprehensive Cancer Network, Inc.

15-Jun-2025 to 31-May-2026

 

NCCN will offer nine (9) live multidisciplinary case-based webinars focusing on the care of patients with various types of cancer

Learn More
E-LEARNING

Web Critical Clues: Identifying and Managing Interstitial Lung Disease in Patients With Breast Cancer

PRIME Education, LLC

17-Feb-2025 to 16-Feb-2026

 

1-hour Multi-Accredited, On-Demand Enduring Webcast with Downloadable POC Resource

Learn More
E-LEARNING

Web Nurse-Led Strategies for Optimizing PARP Inhibitor Therapies in Veterans With Prostate Cancer: Insights for Practical Care Delivery

PVI, PeerView Institute for Medical Education

30-Oct-2024 to 29-Oct-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Ablative modalities: tried and true, and up and coming for HCC

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions on frequently used modality, descriptions on how each ablative modality works, the transition to histotripsy. 

Learn More
E-LEARNING

How to dose: understanding Y-90 dosimetry from simple to complex

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions on what makes sense, where are we headed and how to simplify things regarding dosimetry.

Learn More
E-LEARNING

How to build an IO practice

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions on PP vs Academics, what does your support staff look like, finding referrals, greatest successes and failures in year 1.

Learn More
E-LEARNING

Advanced HCC: Combination therapy and Clinical trials: what they really mean

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions on Immunotherapy in HCC, what are the impactful immunotherapy trials in HCC, and immunotherapy medications.

Learn More
E-LEARNING

Transplant approach from the transplant surgeon and hepatologist

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions on pre/peri/post transplant.

Learn More
E-LEARNING

The “grey” zone, BCLC B and complex patients

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions and review on BCLC guidelines, role of ablation, TACE, TARE and systemic therapies, Grey Zone/complex patients scenarios and post-treatment patients.

Learn More
E-LEARNING

Surgical Approach to HCC

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions on surgical approaches, downstaging and bridging and community practice.

Learn More
E-LEARNING

Tumor Board Collaboration: Disease Progression

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Case-based discussions with a multidisciplinary approach/team to treating HCC. 

Learn More
E-LEARNING

Patient flow - too many cooks in the kitchen?

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

 

Discussions on the benefits of multidisciplinary clinic and navigating the patient experience

Learn More
E-LEARNING

Web Gynecologic Oncology at the Best of ASCO

Binaytara

01-Jul-2025 to 01-Jul-2026

 

Enduring recorded webcast of the live session

Learn More
E-LEARNING

Web Thoracic Oncology at the Best of ASCO 2025

Binaytara

01-Jul-2025 to 01-Jul-2026

 

Enduring recorded webcast of the live session

Learn More
E-LEARNING

Live Critical Conversations for Surgeons & Oncologists in Resectable Gastric/GEJ Cancer

PVI, PeerView Institute for Medical Education, Inc.

14-Oct-2025 to 14-Oct-2025

 

Join PeerView for a Critical Conversations event as experts discuss immunotherapy in resectable GC/GEJC, share real-world cases, and explore strategies for multidisciplinary collaboration.

Learn More
E-LEARNING

2024-2025 Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient

National Comprehensive Cancer Network, Inc.

30-Aug-2024 to 29-Jun-2026

 

In order to extend the reach of this program, NCCN will archive the webinars from this activity on NCCN’s Learning Management System found at http://education.nccn.org. The archived recordings will consist of slides and audio.

Learn More
E-LEARNING

Behind the Guidelines: Insights into the Standard of Care in Oncology 2025

National Comprehensive Cancer Network, Inc.

10-Jan-2025 to 31-Dec-2026

 

This activity consists of twelve NCCN Guidelines Insights articles 

Learn More
E-LEARNING

Live NCCN 2025 Webinar Series - Optimizing Patient Outcomes: Collaborative Perspectives in Oncology

National Comprehensive Cancer Network, Inc.

01-Feb-2025 to 31-Dec-2025

 

This activity is a series of 9 webinars on a variety of oncopharmacology topics that will be presented from February 2025 - December 2025. 

Learn More
E-LEARNING

Web NCCN 2025 Webinar Series - Optimizing Patient Outcomes: Collaborative Perspectives in Oncology

National Comprehensive Cancer Network, Inc.

01-Feb-2025 to 30-Dec-2026

 

This activity is a series of 9 webinars on a variety of oncopharmacology topics that will be presented from February 2025 - December 2025. 

Learn More
E-LEARNING

Web enduring NCCN 2025 Breast Cancer Congress with Updates from the 2024 San Antonio Breast Cancer Symposium

National Comprehensive Cancer Network, Inc.

15-Mar-2025 to 14-Mar-2026

 

National Comprehensive Cancer Network (NCCN) plans to conduct a one-day live-in-person educational activity.NCCN will offer the eight (8) sessions from this activity as archived endured webcasts 

Learn More
E-LEARNING

Web enduring 2025-2026 Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care

National Comprehensive Cancer Network, Inc.

01-Aug-2025 to 29-Jun-2027

 

NCCN will offer nine (9) live multidisciplinary case-based webinars focusing on the care of patients with various types of cancer 

Learn More
E-LEARNING

Behind the Guidelines: Insights into the Standard of Care in Oncology 2024

National Comprehensive Cancer Network, Inc.

10-Jan-2024 to 31-Dec-2025

 

This activity consists of twelve NCCN Guidelines Insights articles.  10 in print, 2 electronically 

Learn More
E-LEARNING

Web Antibody Drug Conjugates and Adverse Events: Improving Identification and Management Among Oncology Nurses Serving Rural and Underserved Communities

Talem Health, LLC

02-Jun-2025 to 02-Jun-2026

 

An online, on-demand enduring CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com; marketed to the target audience nationally.

Learn More
E-LEARNING

Web Advancing Precision Medicine in Breast Cancer: Targeted Therapies and the Role of Managed Care Pharmacy

Academy of Managed Care Pharmacy

14-Aug-2025 to 31-Dec-2026

 

1-hour recording with expert presentation and Q&A

Learn More
E-LEARNING

We Can Make a Difference: Metastatic Breast Cancer Updates

Texas Pharmacy Association

07-Feb-2025 to 06-Feb-2027

 

1-hour recorded Zoom webinar, with expert oncology pharmacist

Learn More
E-LEARNING

Oral Therapy Adherence: PARP Inhibitors, TKIs, and PIK3/AKT/mTOR Inhibitors

Practicing Clinicians Exchange, LLC

16-Jun-2025 to 15-Dec-2025

 

30 On-demand webcast AAPA/ANCC/ACPE-certified microlearning educational video module w/slidedeck

Learn More
E-LEARNING

Oral Therapy Adherence in Breast Cancer: SERDs, SERMs, and CDK4/6 Inhibitors

Practicing Clinicians Exchange, LLC

16-Jun-2025 to 15-Dec-2025

 

30 On-demand webcast-AAPA/ANCC/ACPE-certified microlearning educational video module w/slidedeck

Learn More
E-LEARNING

Addressing Challenges With Adherence and Persistence to Oral Anticancer Therapies in Patients With Breast Cancer

Practicing Clinicians Exchange, LLC

19-May-2025 to 18-Nov-2025

 

Downloadable Slidset from :90 live/virtual AAPA/ANCC/ACPE- Certified Intensive Training

Learn More
E-LEARNING

Global Perspectives and Clinical Resources to Guide Treatment Decisions and Management of Adverse Events With BTK Inhibitor Therapy in CLL

Clinical Care Options, LLC

25-Oct-2024 to 6-Jan-2026

 

1 CME-Certified Text Module

2 Interactive Decision Support Tools

1 Slide Player

Learn More
E-LEARNING

NCCN 2025 Annual Congress: Hematologic Malignancies™

National Comprehensive Cancer Network, Inc.

10-Oct-2025 to 11-Oct-2025

 

NCCN plans to conduct a one and one-half-day educational activity consisting of live in-person and virtual sessions with moderator-facilitated Q&A sessions on 

October 10-11, 2025, at the Hilton San Diego Bayfront, San Diego, CA

Learn More
E-LEARNING

Chronic Lymphocytic Leukemia: Evaluating Targeted Therapeutic Strategies and Optimizing Outcomes Throughout the Cancer-Care Continuum

HMP Education, LLC

25-Aug-2025 to 25-Feb-2026

 

To extend program reach to individuals unable to participate in the live event, HMP Education developed an enduring on-demand archive of the live session featuring downloadable slides.

Learn More
E-LEARNING

(2025 Great Debates in Solid Tumors) Target Over Tissue: The Rise of Tumor-Agnostic Cancer Therapies

HMP Education, LLC

10-Oct-2025 to 10-Apr-2026

 

An enduring on-demand archive of the live session

Learn More
E-LEARNING

Estrogen Receptor Mutations in HR+ Advanced Breast Cancer: Next-Generation Practice Recommendations on Mutation Screening to Guide Therapeutic Decisions

Clinical Care Options, LLC  

13-Nov-2024 to 30-Dec-2025

 

Online Activities:

•      An on-demand CME/ABIM MOC–certified webcast

•       Downloadable PowerPoint slidesets on the CCO website

•       Podcast featuring panel discussion from the live symposium

Learn More
E-LEARNING

Estrogen Receptor Mutations in HR+ Advanced Breast Cancer: Next-Generation Practice Recommendations on Mutation Screening to Guide Therapeutic Decisions

Clinical Care Options, LLC  

29-Feb-2024 to 29-Aug-2025

 

CME-certified initiative informed by a “Collaborative Learning Experience Study” designed to educate healthcare professionals on the clinical integration of TROP-2–targeted antibody–drug conjugates (ADCs) in non-small-cell lung cancer treatment.

Learn More
E-LEARNING

(NAVREF 2024 Annual Conference) Prostate Cancer Care in the Veterans Administration (VA) Health System: Adapting and Integrating Evolving Innovation in the Treatment of De Novo mHSPC

HMP Education, LLC

16-Oct-2024 to 16-Oct-2025

 

To extend the reach to learners who are unable to attend the 2024 NAVREF Satellite Symposium, HMP Education will capture and archive the recorded session proceedings for a chapterized on-demand CME/CE-certified web viewing.

Learn More
E-LEARNING

Improving Outcomes for Advanced/Unresectable Hepatocellular Carcinoma: Immune Checkpoint Inhibitor-Based Strategies in First-Line Therapy

HMP Education, LLC

19-Nov-2024 to 19-Nov-2025

 

Enduring web archive of the live session 

Learn More
E-LEARNING

Targeting HER2 Overexpression in Gastroesophageal and Colorectal Cancers: Novel and Emerging Options

HMP Education, LLC

19-Nov-2024 to 19-Nov-2025

 

To extend program reach to learners unable to participate in the live events, HMP Education developed an enduring on-demand archive of the live curriculum

Learn More
E-LEARNING

Hot Topics in Bladder and Prostate Cancer: Latest Treatments and Case-Based Learnings

HMP Education, LLC

06-Jan-2025 to 06-Jan-2026

 

HMP Education produced a CME/CE-certified enduring on-demand archive based on the live session proceedings

Learn More
E-LEARNING

Optimizing Therapy for Patients with Chronic Lymphocytic Leukemia: First Line Decision-Making and Beyond

HMP Education, LLC

20-Nov-2024 to 19-Nov-2025

 

To extend program reach to learners unable to participate in the live events, HMP Education developed an enduring on-demand archive of the live curriculum.

Learn More
E-LEARNING

CLL Landscape: Research and Clinical Advances

HMP Education, LLC

10-Mar-2025 to 10-Mar-2026

 

This initiative was designed to address the latest advancements and practical insights in CLL through dynamic discussions with leading experts and peers.

Learn More
E-LEARNING

Lymphoma Landscape: Research and Clinical Advances

HMP Education, LLC

10-Mar-2025 to 10-Mar-2026

 

This initiative was designed to address the latest advancements and practical insights in lymphoma, drawn from recent global research and developments through dynamic discussions with leading experts and peers.

Learn More
E-LEARNING

Targeted Approaches for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

HMP Education, LLC

29-Aug-2024 to 29-Aug-2025

 

Enduring on-demand web archive of the session held at the 2024 GDU in Hematologic Malignancies event series.

Learn More
E-LEARNING

Web HR+/HER2- Metastatic Breast Cancer: Addressing Unmet Needs and Endocrine Therapy Resistance in Frontline Treatment

HMP Education, LLC

02-Dec-2024 to 02-Dec-2025

 

Chapterized Enduring On-Demand Archive of the live session

Learn More
E-LEARNING

(2024 GDU Lung) Targeting HER2-Mutant NSCLC: A Focus on Biomarker Testing and Targeted Therapies

HMP Education, LLC

05-Nov-2024 to 05-Nov-2025

 

To extend program reach to individuals unable to participate in the live events, HMP Education will develop an enduring on-demand live session archive.

Learn More
E-LEARNING

Web Enduring Best of SABCS On-Demand

The University of Texas Health Science Center at San Antonio

01-Mar-2025 to 01-Nov-2025

 

The on demand format offers d peer-to-peer discussion. The programs also include clinical case scenarios for interactivity with the audience, providing a valuable educational resource for the practicing clinician

Learn More
E-LEARNING

Optimizing the Use of BTK Inhibitors in the Treatment of Chronic Lymphocytic Leukemia (CLL): Informed Managed Care Decision Making in an Evolving Landscape

National Association of Managed Care Physicians, Inc.

01-Nov-2023 to 01-Nov-2025

 

CLL Enduring Webcasts

Learn More
E-LEARNING

Informed Managed Care Decision-Making in the Management of Chronic Lymphocytic Leukemia (CLL): Optimizing Clinical and Economic Outcomes with BTK Inhibitors

National Association of Managed Care Physicians, Inc.

01-Aug-2024 to 01-Aug-2025

 

Enduring Webcast

Learn More
E-LEARNING

Web Best Practices in the Treatment and Management of HER2-Positive Advanced Breast Cancer: Expert Managed Care Strategies for Improved Clinical and Economic Outcomes

National Association of Managed Care Physicians, Inc.

01-Aug-2024 to 01-Aug-2025

 

Enduring Webcast

Learn More
E-LEARNING

Innovative Approaches in the Treatment and Management of Mantle Cell Lymphoma (MCL): A Closer Look at the Evolving Role of BTK Inhibitors

National Association of Managed Care Physicians, Inc.

01-Oct-2024 to 01-Oct-2026

 

Enduring Webcast

Learn More
E-LEARNING

Best Practices in the Treatment and Management of Chronic Lymphocytic Leukemia (CLL): Improving Clinical and Economic Outcomes with BTK Inhibitors and Their Combinations

National Association of Managed Care Physicians, Inc.

01-Aug-2025 to 01-Aug-2026

 

Enduring Webcast

Learn More
E-LEARNING

Keeping Pace with Rapid Advancements in the Management of Mantle Cell Lymphoma (MCL): Managed Care Insights on Evolving Role of BTK Inhibitors

National Association of Managed Care Physicians, Inc.

01-Aug-2025 to 01-Aug-2026

 

Enduring Webcast

Learn More
E-LEARNING

web enduring Best Practices in the Treatment and Management of Metastatic HR+/HER2- Breast Cancer: Managed Care Considerations on the Evolving Role of Antibody Drug Conjugates

National Association of Managed Care Physicians, Inc.

01-Aug-2025 to 01-Aug-2026

 

Enduring Webcast

Learn More
E-LEARNING

Web enduring Evolving Considerations in the Treatment and Management of HER2-Negative Early Breast Cancer: Optimizing Targeted Therapy for Improved Patient Outcomes

National Association of Managed Care Physicians, Inc.

01-Mar-2025 to 01-Mar-2026

 

Enduring Webcast

Learn More
E-LEARNING

Web enduring Best Practices in the Treatment and Management of Ovarian Cancer: Expert Managed Care Strategies on the Evolving Role of PARP Inhibitors

National Association of Managed Care Physicians, Inc.

01-Mar-2025 to 01-Mar-2026

 

Enduring Webcast

Learn More
E-LEARNING

Evolving Considerations in the Treatment and Management of Chronic Lymphocytic Leukemia (CLL): Managed Care Insights on Evolving Role of BTK Inhibitors

National Association of Managed Care Physicians, Inc.

01-Mar-2025 to 01-Mar-2026

 

Enduring Webcast

Learn More
E-LEARNING

Web enduring Innovative Approaches in the Treatment and Management of HER2-Positive and HER2-Low Breast Cancer: Managed Care Insights in an Evolving Paradigm

National Association of Managed Care Physicians, Inc.

01-Mar-2025 to 01-Mar-2026

 

Enduring Webcast

Learn More
E-LEARNING

Keeping Pace with the Rapid Advancements in the Treatment and Management of Chronic Lymphocytic Leukemia (CLL): Expert Managed Care Strategies on the Role of BTK Inhibitors and Their Combinations

National Association of Managed Care Physicians, Inc.

16-Jul-2025 to 23-Jul-2025

 

Live Web activiy

Learn More
E-LEARNING

Web Questions From the Community: Examining the Application of Recent Research AdvancesInto the Current Management of PatientsWith HR+/HER2- Breast Cancer

Purdue University

21-Feb-2025 to 21-Feb-2026

 

A 45-minute enduring activity designed to prepare clinicians to identify molecular alternations, sequence novel therapies,and manage treatment-associated toxicities to improve long-term outcomes for patients with HR+/HER2- advanced or metastatic BC

Learn More
E-LEARNING

Web enduring The Human Side of Breast Cancer: Using Novel Data and Patient Voices to Optimize Patient-Centered Care in HER2-Positive Breast Cancer Brain Metastases

Efficient LLC

23-Jul-2025 to 23-Jul-2026

 

60-minute multimedia activity enduring expert roundtable

Learn More
E-LEARNING

An Evolving Standard of Care in Chronic Lymphocytic Leukemia: Patient Perspectives and Clinical Insights on Novel Therapeutic Strategies Across the Disease Continuum

Efficient LLC

23-Jul-2025 to 23-Jul-2026

 

60-minute multimedia activity expert roundtable

Learn More
E-LEARNING

The Emergence of a New Subtype: HER2-Low Breast Cancer

PRIME Education, LLC

02-Aug-2024 to 01-Aug-2025

 

(One) 0.5-hour Enduring Webcast #2

Learn More
E-LEARNING

Antibody-Drug Conjugates in Breast Cancer

PRIME Education, LLC

23-Aug-2024 to 22-Aug-2025

 

(One) 1.0-hour Enduring Webcast #3 w/ whiteboard animation video

Learn More
E-LEARNING

Web Optimizing Use of PARP Inhibitors in Early-Stage and Metastatic Breast Cancer Patients With DNA Damage Repair Pathway Mutations

PRIME Education, LLC

13-Nov-2024 to 12-Nov-2025

 

1.0-hour Clinical Connections Webcast

Learn More
E-LEARNING

Web Improving Outcomes for Patients With HR+/HER2- Advanced Breast Cancer

PRIME Education, LLC

22-May-2025 to 21-May-2026

 

1.0-hour Enduring Webcast with Downloadable HR+/HER2- Advanced Breast Cancer Pocket Guide

Learn More
E-LEARNING

Web enduring Integrating Novel and Emerging ADCs Into Advanced/Metastatic HR+/HER2- Breast Cancer Care

PRIME Education, LLC

11-Jul-2025 to 10-Jul-2026

 

1.0-hour Multi-Accredited Enduring Webcast

Learn More
E-LEARNING

Web Meeting the Moment: Improving Care for Patients With HER2-Low Breast Cancer

PRIME Education, LLC

09-May-2025 to 08-May-2026

 

One (1) 1.0-hour Multi-Accredited On-Demand Video

Learn More
E-LEARNING

Not as Easy as ADC: Selecting and Sequencing Antibody-Drug Conjugates in Advanced Breast Cancer

PRIME Education, LLC

31-Jul-2025 to 01-Aug-2026

 

Webinar #4 (1.0-hour) Not as Easy as ADC: Selecting and Sequencing Antibody-Drug Conjugates in Advanced Breast Cancer

Learn More
E-LEARNING

Unlocking the Power of Novel Therapies in HER2+ Breast Cancer Treatment

PRIME Education, LLC

19-Aug-2025 to 20-Aug-2026

 

Webinar #5 (1.5-hours) Unlocking the Power of Novel Therapies in HER2+ Breast Cancer Treatment

Learn More
E-LEARNING

Addressing Disparities in Breast Cancer: Special Considerations for Marginalized Populations

PRIME Education, LLC

11-Sep-2025 to 12-Sep-2026

 

Webinar #6 (1.0-hour) Addressing Disparities in Breast Cancer: Special Considerations for Marginalized Populations – featuring real-world patient perspectives and a Clinician Spotlight

Learn More
E-LEARNING

Breast Cancer Case Competition: Test Your Knowledge on Integrating Novel Therapies Into Practice

PRIME Education, LLC

30-Sep-2025 to 01-Oct-2026

 

Webinar #7 (1.0-hour) Breast Cancer Case Competition: Test Your Knowledge on Integrating Novel Therapies into Practice  – featuring real-world patient perspectives and a Clinician Spotlight

Learn More
E-LEARNING

Individualizing Early Breast Cancer Care Based on Risk Assessment and Patient-Specific Factors

PRIME Education, LLC

28-May-2025 to 27-May-2026

 

Webcast 1 (1.0-hour) Individualizing Early Breast Cancer Care Based on Risk Assessment and Patient-Specific Factors – featuring a Clinician Spotlight

Learn More
E-LEARNING

Tailoring Early Breast Cancer Management Using the Latest Clinical Evidence

PRIME Education, LLC

28-May-2025 to 27-May-2026

 

0.25-hour Clinical Case Challenge

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

11-Jul-2025 to 10-Jul-2026

 

0.25-hour Clinical Case Challenge

Learn More
E-LEARNING

Novel and Emerging Treatment Strategies in Triple-Negative Breast Cancer: Antibody-Drug Conjugates, Immunotherapy, and Targeted Therapies

PRIME Education, LLC

11-Jul-2025 to 10-Jul-2026

 

Webinar #2 (1.5-hours) Novel and Emerging Treatment Strategies in Triple Negative Breast Cancer: Antibody-Drug Conjugates, Immunotherapy, and Targeted Therapies – featuring a Clinician Spotlight

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

28-Jul-2025 to 27-Jul-2026

 

Webcast #3 (1.5-hours) Navigating Endocrine Resistance in HR+/HER2- Breast Cancer: Novel SERDS, SERMS, and Targeted Therapies

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

22-Aug-2025 to 21-Aug-2026

 

0.50-hour Clinical Case Challenge

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

22-Aug-2025 to 21-Aug-2026

 

Webcast #4 (1.0-hour) Not as Easy as ADC: Selecting and Sequencing Antibody-Drug Conjugates in Advanced Breast Cancer

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

12-Sep-2025 to 11-Sep-2026

 

0.25-hour Clinical Case Challenge

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

12-Sep-2025 to 11-Sep-2026

 

Webcast #5 (1.5-hours) Unlocking the Power of Novel Therapies in HER2+ Breast Cancer Treatment

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

03-Oct-2025 to 02-Oct-2026

 

Webcast #6 (1.0-hour) Addressing Disparities in Breast Cancer: Special Considerations for Marginalized Populations – featuring real-world patient perspectives and a Clinician Spotlight

Learn More
E-LEARNING

Leveraging Cutting-Edge Clinical Evidence and Real-World Insights to Advance Personalized Breast Cancer Care: 3rd Annual Breast Cancer Hot Topics Series

PRIME Education, LLC

24-Oct-2025 to 23-Oct-2026

 

Webcast #7 (1.0-hour) Breast Cancer Case Competition: Test Your Knowledge on Integrating Novel Therapies into Practice  – featuring real-world patient perspectives and a Clinician Spotlight

Learn More
E-LEARNING

Web enduring Precision Medicine in NSCLC: Optimizing Biomarker Testing for Personalized Treatment Selection

PRIME Education, LLC

01-Apr-2025 to 31-Mar-2026

 

Webcast #1 (1.0-hour): Precision Medicine in NSCLC: Optimizing Biomarker Testing for Personalized Treatment Selection (features 'Clinician Spotlight' from PRIME QI project)

Learn More
E-LEARNING

Web enduring From Guidelines to Practice: Exploring Immunotherapy in Limited-Stage Small Cell Lung Cancer

PRIME Education, LLC

30-Dec-2024 to 30-Jan-2026

 

0.25-hour Multi-Accredited Booster Quiz

Learn More
E-LEARNING

Web Applying the Latest Evidence to Overcome Endocrine Resistance in HR+/HER2- Breast Cancer

PRIME Education, LLC

28-Jun-2024 to 03-Oct-2025

 

0.25-Hour Booster Quiz

Learn More
E-LEARNING

Web enduring Management of Brain Metastases in Patients With HER2+ Advanced Breast Cancer

PRIME Education, LLC

30-Dec-2024 to 29-Dec-2025

 

Clinical Case Challenge 1 (0.25-hour)

Learn More
E-LEARNING

Web enduring Advancing Risk-Based, Personalized Care for Veterans With mCRPC

PRIME Education, LLC

19-Nov-2024 to 18-Nov-2025

 

1.0-hour Multi-Accredited On-Demand Video

Learn More
E-LEARNING

Exploring the Evolving Role of HER2 for the Treatment of Gynecologic Cancers

PRIME Education, LLC

09-May-2025 to 08-May-2026

 

One (1) 0.5-hour Multi-Accredited, On-Demand Webcast 3-Part Series (1 of 3)

Learn More
E-LEARNING

Latest Evidence for HER2-Directed Therapies in Hepatobiliary Cancers

PRIME Education, LLC

30-May-2025 to 29-May-2026

 

One (1) 0.5-hour Multi-Accredited, On-Demand Webcast 3-Part Series (2 of 3)

Learn More
E-LEARNING

Emerging Clinical Data for Targeting HER2 in Bladder Cancer

PRIME Education, LLC

13-Jun-2025 to 12-May-2026

 

One (1) 0.5-hour Multi-Accredited, On-Demand Webcast 3-Part Series (3 of 3)

Learn More
E-LEARNING

Web enduring Reimagining Lung Cancer Treatment: A Journey Through New and Emerging Therapeutics Related to the Care of Patients with Small Cell and Non-Small Cell Lung Cancer

Efficient LLC

23-Jun-2025 to 23-Jun-2026

 

9-part microlearning series (4-7 minutes each; 75 mins total). Each episode to highlight critical, recent therapeutic advances across indications and disease subtypes in SCLC and NSCLC

Learn More
E-LEARNING

Live ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer

USH Axis Holdings Inc.

29-Jul-2025 to 29-Jul-2026

 

In this Virtual Case Clinic, explore three patient case examples with Dr. Mahtani as she demonstrates the application of the latest clinical evidence in HER2-positive, HER2-low, and HER2-ultralow metastatic breast cancer.

Learn More
E-LEARNING

Web enduring Improving HR+/HER2- Breast Cancer Outcomes with TROP2 Antibody-Drug Conjugates

USH Axis Holdings Inc.

18-Apr-2025 to 18-Apr-2026

 

online enduring Chairman's Perspective

Learn More
E-LEARNING

Think Tank Live: Collaborative Insights to Solve the Puzzle of Bladder Cancer

Global Learning Collaborative, Inc.

14-Mar-2025 to 14-Mar-2026

 

This online educational activity reviews molecular profiling, clinical trial data, therapy sequencing, and AE management to support evidence-based, personalized treatment strategies and improve outcomes in bladder cancer care.

Learn More
E-LEARNING

Web enduring Redefining Treatment Across the Spectrum of HR+ HER2-Expressing Metastatic Breast Cancer

USH Axis Holdings Inc.

26-Sep-2025 to 26-Sep-2026

 

enduring program from grand rounds series

Learn More
E-LEARNING

Web enduring HER2-Expressing MBC In Depth: The Latest Advances in Targeted Therapies and Brain Metastases Management

Global Learning Collaborative, Inc.

06-Feb-2025 to 06-Feb-2026

 

MinuteCE

Learn More
E-LEARNING

Web enduring Improving Equity in Endometrial Cancer Care and Treatment: Accelerating Change to Improve Patient Outcomes in Rural and Underserved Communities

Talem Health, LLC

15-Dec-2024 to 15-Dec-2025

 

An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com and marketed to the target audience nationally

Learn More
E-LEARNING

Web enduring Evolving Treatment Paradigms in HR+/HER2- Early Breast Cancer: Advancing Equitable Care in Rural and Underserved Communities

Talem Health, LLC

15-Dec-2024 to 15-Dec-2025

 

An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com and marketed to the target audience nationally

Learn More
E-LEARNING

Web enduring Targeting the PI3K/AKT/PTEN Pathway for Treatment of Breast Cancer: Innovative Solutions for Equitable Care

Talem Health, LLC

15-Dec-2024 to 15-Dec-2025

 

An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com and marketed to the target audience nationally

Learn More
E-LEARNING

Update on Surveillance and Management of HCC for Primary Care Clinicians: A Guide for Improving Outcomes in Rural and Underserved Communities

Talem Health, LLC

28-Feb-2025 to 28-Feb-2026

 

Online enduring activity: An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com and marketed to the target audience nationally. (1.0 AMA/ANCC credit)

Learn More
E-LEARNING

Web Enduring Official Best of San Antonio Breast Cancer Symposium 2024 Video Highlights

Encore Medical Education, LLC

11-Dec-2024 to 01-Dec-2025

 

This educational program includes original presentation slides accompanied by commentary from key opinion leaders (KOLs) in a micro-learning video format available for viewing within 12hours of the original presentation

Learn More
E-LEARNING

Enduring Materials: Precision Medicine in Practice Primer Recordings and Evaluation

Beckman Research Institute of City of Hope

01-Aug-2025 to 30-Jul-2026

 

upload, dissemination and outcomes tracking of 10 recorded modules addressing key elements of cancer genomics and precision medicine in practice

Learn More
E-LEARNING

Expert Perspectives: The Role of Immunotherapy in Advancing the Treatment of HCC and BTC

The France Foundation

24-Sep-2024 to 03-Sep-2025

 

Tumor-board case based online learning activity

Learn More
E-LEARNING

Addressing HER2 Alterations in Advanced NSCLC With Antibody-Drug Conjugate Therapy: Updates for The Community Oncologist

Med Learning Group, LLC

21-Nov-2024 to 21-Nov-2025

 

1-hr enduring activity of the live TeleECHOs of the same grant

Learn More
E-LEARNING

Are You Up to Date in the Management of HER2-Positive Solid Tumors? Focusing on Gastric and GEJ Cancer From Evaluation to Clinical Efficacy and Adverse Event Monitoring

Med Learning Group, LLC

12-Dec-2024 to 12-Dec-2025

 

Interactive enduring Grand Rounds program focusing on advanced HER2-expressing GC or GEJ cancers providing critical review of clinical trial findings and practical guidance on multidisciplinary monitoring.

Learn More
E-LEARNING

Are You Up to Date on the Latest Data on HER2-Targeted Antibody-Drug Conjugates for HER2-Expressing Solid Tumors?

Med Learning Group, LLC

02-Jan-2025 to 02-Jan-2026

 

A 1 Hour endured presentation of the Live Grand Rounds associated with this grant. 

Learn More
E-LEARNING

web Case by Case: Optimizing a Multidisciplinary Approach for Front-Line Maintenance Therapy in Advanced Ovarian Cancer

Med Learning Group, LLC

21-May-2025 to 21-May-2026

 

The activity is comprised of 3 interactive, video-based modules that escalate in complexity. Each module includes a brief clinical primer, followed by case presentation and discussion. 

Learn More
E-LEARNING

Chronic Lymphocytic Leukemia: An Evolving Treatment Landscape

Med Learning Group, LLC

06-Dec-2024 to 06-Dec-2025

 

1-hr enduring activity of TeleECHO session from this grant

Learn More
E-LEARNING

Live Comprehensive Care with HER2 ADCs Across Solid Tumors: Strategies to Enhance Efficacy and Minimize Toxicity

Med Learning Group, LLC

30-Jun-2025 to 30-Jun-2026

 

2 SmartCast Micro-learning podcasts, one on adverse event monitoring and management and another on integrating with pathology across HER2+ malignancies

Learn More
E-LEARNING

Web Comprehensive Care with HER2 ADCs Across Solid Tumors: Strategies to Enhance Efficacy and Minimize Toxicity

Med Learning Group, LLC

15-Jul-2025 to 15-Jul-2026

 

A smart reach reply enduring version of the ASCO virtual symposium presented on 5/30

Learn More
E-LEARNING

Web Managing Ocular Toxicity Associated with TROP2-Directed ADCs: Multidisciplinary Solutions

Med Learning Group, LLC

17-Jul-2025 to 17-Jul-2026

 

1-hr enduring program aiming to increase treatment team's awareness and knowledge of prophylactic management, ID/treatment strategies for ocular adverse events associated with TROP2-directed ADCs.

Learn More
E-LEARNING

web enduring Optimizing HER2 Testing for Advanced Breast Cancer: Guiding Treatment with HER2-Targeted Antibody-Drug Conjugates

Med Learning Group, LLC

20-Dec-2024 to 20-Dec-2025

 

Enduring focused on HER2-directed ADCs for HER2+/HER2-low advanced/metastatic BC, practical guidance to incorporate testing & best practices, clinical guidelines, trial findings, and monitoring & management of key treatment-related adverse events

Learn More
E-LEARNING

Web Overcoming Challenges for HER2-Low Testing in Metastatic Breast Cancer: A Multidisciplinary Effort

Med Learning Group, LLC

30-May-2025 to 30-May-2026

 

1-Hr Enduring Case-Based Educational program designed for Oncologists and Pathologists focused on HER2 testing in metastatic breast cancer.

Learn More
E-LEARNING

Clinical Conversations Online Replay

Med Learning Group, LLC

30-May-2025 to 30-May-2026

 

This enduring, case-based educational program is designed for oncologists and pathologists. 

Learn More
E-LEARNING

Live Online Enduring Program

Med Learning Group, LLC

29-Nov-2024 to 29-Nov-2025

 

Online Enduring Program of recorded Grand Round available for 1 year.

Learn More
E-LEARNING

Web enduring Recognizing the Role of TROP2 in NSCLC Management: Biologic Rationale, Clinical Data, and Community Oncologists as Champions of Multidisciplinary Care

Med Learning Group, LLC

29-Nov-2024 to 29-Nov-2025

 

1-hr enduring activity of live Grand Rounds under this grant

Learn More
E-LEARNING

Web enduring Smart Reach Replay Enduring

Med Learning Group, LLC

30-Oct-2024 to 30-Oct-2025

 

This interactive program combines didactic instruction with case-based discussions and illustrative animations.

Learn More
E-LEARNING

Session 2: Transforming CLL Management – Leveraging Emerging Data

Partners for Advancing Clinical Education

28-Jan-2025 to 28-Jul-2025

 

Get up to speed with key findings from the 2024 ASH® Annual Meeting. These two expert-led sessions provide critical updates on MCL and CLL

Learn More
E-LEARNING

Session 1: Advancing MCL Care – From Clinical Insights to Practical Applications

Partners for Advancing Clinical Education

07-Feb-2025 to 07-Aug-2025

 

Get up to speed with key findings from the 2024 ASH® Annual Meeting. These two expert-led sessions provide critical updates on MCL and CLL

Learn More
E-LEARNING

Patient Priorities for CLL Care

UMA Education Inc. dba Global Education Group

03-Feb-2025 to 06-Sep-2025

 

As targeted therapies have become the standard of care in chronic lymphocytic leukemia (CLL), it is increasingly important to refine therapy selection based on risk stratification.

Learn More
E-LEARNING

Guideline Recommendations for the Front-line Setting

UMA Education Inc. dba Global Education Group

03-Feb-2025 to 06-Sep-2025

 

As targeted therapies have become the standard of care in chronic lymphocytic leukemia (CLL), it is increasingly important to refine therapy selection based on risk stratification.

Learn More
E-LEARNING

Guideline Recommendations for the Relapsed/Refractory Setting

UMA Education Inc. dba Global Education Group

03-Feb-2025 to 06-Sep-2025

 

As targeted therapies have become the standard of care in chronic lymphocytic leukemia (CLL), it is increasingly important to refine therapy selection based on risk stratification.

Learn More
E-LEARNING

Module 1: Cytogenetic Testing for Patients with CLL/SLL

UMA Education Inc. dba Global Education Group

03-Feb-2025 to 06-Sep-2025

 

Hear from expert clinicians, Dr. Danielle Brander and Dr. Nilanjan Ghosh, as they explore current data and the patient and care-team factors that influence selection of therapy for CLL in the community setting. 

Learn More
E-LEARNING

Immunotherapy for Small-Cell Lung Cancer: Addressing Treatment Challenges

Plexus Communications LLC

15-Nov-2024 to 15-Nov-2025

 

This educational program aims to equip the healthcare team with the latest advancements and key insights into the treatment of small-cell lung cancer (SCLC).

Learn More
E-LEARNING

Web enduring Improving Patient Outcomes via Antibody-Drug Conjugates in Non-Small Cell Lung Cancer

Plexus Communications LLC

24-Jan-2025 to 24-Jan-2026

 

This activity focuses on the latest developments in antibody-drug conjugates (ADCs) for NSCLC and their expanding role in patient care.

Learn More
E-LEARNING

Novel Strategies in Mantle Cell Lymphoma: A Focus on BTK Inhibitors in the Front Line

Plexus Communications LLC

24-Jan-2025 to 24-Jan-2026

 

This activity focuses on the latest developments in antibody-drug conjugates (ADCs) for NSCLC and their expanding role in patient care.

Learn More
E-LEARNING

Optimizing Mantle Cell Lymphoma Management: Innovative Strategies with BTK Inhibitors in Front-Line Therapy

Plexus Communications LLC

17-Jul-2025 to 17-Jul-2026

 

1 hour pre-recorded enduring activity

Learn More
E-LEARNING

Expanding Targets in NSCLC: Updates on HER2- and TROP-2-directed Therapies

Haymarket Medical Education

31-Mar-2025 to 31-Mar-2026

 

•60-minute (1.0 credit hour) infographic webcast

Learn More
E-LEARNING

Web enduring PARP Inhibitors for Metastatic Prostate Cancer in the VHA Health System: Integrating New Agents into Practice

Plexus Communications LLC

14-Feb-2025 to 14-Feb-2026

 

This program equips clinicians with the knowledge to optimize care for patients with metastatic prostate cancer (mPC) by integrating PARP inhibitors into practice.

Learn More
E-LEARNING

Optimizing Personalized Care of Patients with CLL or MCL Using BTK Inhibitors in the Frontline and Relapsed/Refractory Settings

Plexus Communications LLC

06-Jan-2025 to 06-Jan-2026

 

This course helps clinicians optimize CLL/MCL treatment with BTKi agents in frontline and R/R settings, focusing on personalized therapy planning, veteran-specific predispositions, comorbidities, and resistance patterns.

Learn More
E-LEARNING

Web enduring Targeting EGFR Alterations at Exons 19 and 21 in Veterans with Non-Small Cell Lung Cancer: Bringing Therapeutic Advances into the Clinic

Plexus Communications LLC

28-Feb-2025 to 08-Feb-2026

This program equips clinicians with the knowledge to optimize care for patients with NSCLC and EGFR exon 19 and 21 alterations. Participants will learn about current molecular testing strategies and how these inform treatment decisions.

Learn More
E-LEARNING

Web Hybrid Community/VHA Oncology Forums: EGFR Exons 19 and 21 Alterations in Non-Small Cell Lung Cancer: Recent Therapeutic Advances and Implications for Care

Plexus Communications LLC

22-Jan-2025 to 22-Jan-2026

 

This program offers comprehensive education for oncology and lung cancer MDC teams on managing NSCLC with EGFR exon 19 and 21 alterations.

Learn More
E-LEARNING

Web TROP2 ADCs in Breast Cancer: Updates on the Latest Clinical Trial Data and AE Management

Paradigm Medical Communications, LLC

06-Jun-2025 to 06-Jun-2026

 

1-hour on-demand news broadcast, with whiteboard animation

Learn More
E-LEARNING

Web Targeting TROP2 in Advanced NSCLC: What Do We Know From Recent Clinical Trials?

PeerVoice America Limited

31-Jul-2025 to 30-Jul-2026

 

In this activity, based on a recent virtual live event, lung cancer experts explore the evidence for novel TROP2-directed therapies for the management of advanced NSCLC.

Learn More
E-LEARNING

Live web Hybrid Community/VHA Oncology Forums: Improving Patient Outcomes via Antibody-Drug Conjugates in Non-Small Cell Lung Cancer

Plexus Communications LLC

05-Dec-2024 to 19-Nov-2025

 

1 hour live hospital-based meetings in hem/onc departments nationwide

Learn More
E-LEARNING

Hybrid VHA Oncology Clinical Forums: Optimizing Mantle Cell Lymphoma Management in the VHA: Innovative Strategies with BTK Inhibitors in Front-Line Therapy

Plexus Communications LLC

24-Mar-2025 to 28-Nov-2025

 

1 hour live hospital-based meetings in hem/onc departments nationwide

Learn More
E-LEARNING

Web enduring Inside the Issue: Managing Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

16-Sep-2025 to 16-Sep-2025

 

1-hour archived AUDIO (1 CME/MOC); 2 clinical investigators with an expertise and/or specialized interest in the management ocular toxicities associated with cancer therapy to serve as the faculty - moderated by Dr Neil Love

Learn More
E-LEARNING

Inside the Issue: Managing Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

12-Sep-2025 to 12-Sep-2025

 

1-hour archived VIDEO (1 CME/MOC); 2 clinical investigators with an expertise and/or specialized interest in the management ocular toxicities associated with cancer therapy to serve as the faculty - moderated by Dr Neil Love

Learn More
E-LEARNING

Oncology Today with Dr Neil Love: Optimal Management of Brain Metastases in Patients with HER2-Positive Breast Cancer

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

26-Aug-2025 to 26-Aug-2026

 

Audio and Video interview program reviewing the management of patients with HER2-positive metastatic breast cancer (mBC) and brain metastases.

Learn More
E-LEARNING

Web Oncology Today with Dr Neil Love: Optimal Management of Brain Metastases in Patients with HER2-Positive Breast Cancer

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

26-Aug-2025 to 26-Aug-2026

 

Audio and Video interview program reviewing the management of patients with HER2-positive metastatic breast cancer (mBC) and brain metastases.

Learn More
E-LEARNING

Web Practical Perspectives: Experts Review Actual Cases of Patients with Advanced Gastroesophageal Cancers

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

18-Jun-2025 to 18-Jun-2026

 

1-hour audio enduring program

Learn More
E-LEARNING

Practical Perspectives: Experts Review Actual Cases of Patients with Advanced Gastroesophageal Cancers

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

18-Nov-2025 to 18-Nov-2025

 

1-hour live webinar a webinar to be held on November 18, 2025, moderated by Dr Neil Love.

Learn More
E-LEARNING

SIO Meet the Data Podcast Series

Society of Interventional Oncology

13-Oct-2025 to 16-Oct-2026

 

This podcast-series with multidisciplinary faculty will cover topics such as a comparison of the LEAP-012 Study vs. EMERALD-1 Study and Local Therapy vs. Combination Therapy.

Learn More
E-LEARNING

SIO 2025 Annual Meeting

Society of Interventional Oncology

01-April-2025 to 03-Feb-2026

 

SIO 2025 will offer an innovative education program including didactic sessions, panel discussions, tumor boards, case-based reviews and lectures to meet the needs of attendees.

Learn More
E-LEARNING

Tweetorial Series

American Society for Clinical Pathology

22-Aug-2024 to 30-Aug-2025

 

Tweetorials (10 -15 threaded tweets) will reinforce concepts in pan-tumor HER2 testing and potential clinical implications around treatment planning.

Learn More
E-LEARNING

Web Updated Germline Testing Guidelines

Integrity CE LLC

15-Apr-2025 to 14-Apr-2026

 

Bi-directional social media activity that applies a thought-provoking call to action accompanied by a succinct summary image and a video of faculty discussing topic

Learn More
E-LEARNING

CME/NCPD-approved Virtual Tumor Board

i3 Health LLC

26-Jun-2025 to 25-Jun-2026

 

This activity will provide a collaborative platform for expert oncology, pathology, and nursing faculty to discuss comprehensive management strategies for prostate cancer, aiming to improve clinician competence and patient outcomes.

Learn More
E-LEARNING

Journey Through the Breast Cancer Clinic: A Spectrum of HER2 Expression to Guide Treatment Decisions

Partners for Advancing Clinical Education

15-Sep-2024 to 15-Sep-2025

 

On-demand video

Learn More
E-LEARNING

Web Navigating Treatment Selection for Newly Diagnosed and Relapsed/Refractory BTC in the Era of Personalized Oncology Care

Partners for Advancing Clinical Education

13-Nov-2024 to 13-Nov-2025

 

The proposed 60-minute on-demand CME activity will be led by two GI oncology specialists.

Learn More
E-LEARNING

Live Implementing Immuno-Oncology in Gynecologic Cancer Care for Veterans: Expert Insights on Personalized Treatment

PVI, PeerView Institute for Medical Education, Inc.

22-Aug-2025  to 22-Aug-2025

 

Join PeerView and the NAVREF for this live virtual symposium for expert insights on biomarker testing, integrating personalized treatment plans, and communicating with Veterans about their care.

Learn More
E-LEARNING

Rethinking and Refining Endometrial Cancer Care in the Modern Age of Precision Medicine: How to Translate Clinical Evidence into Meaningful Improvements for Patients

PVI, PeerView Institute for Medical Education, Inc.

02-Aug-2024  to 01-Aug-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Exceeding Expectations in CLL: Workshops on Targeted Standards, Sequential Options, and Emerging Therapeutics for Team-Based Care

Medical Learning Institute Inc

04-Sep-2024 to 03-Oct-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Personalized Care and Tailored Treatment Plans for Gynecologic Cancers Practical Nurse Guidance on Utilizing Modern Therapeutic Approaches

PVI, PeerView Institute for Medical Education, Inc.

31-Dec-2024  to 30-Dec-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Live Web Personalized Care and Tailored Treatment Plans for Gynecologic Cancers: Practical Nurse Guidance on Utilizing Modern Therapeutic Approaches

PVI, PeerView Institute for Medical Education, Inc.

19-Jan-2025  to 30-Dec-2025

 

In this activity, developed with NOCC and FWC, oncology nurse experts provide insights on managing gynecologic cancers, including diagnostic testing, treatment support, adverse event management, patient education, and actionable care strategies.

Learn More
E-LEARNING

Crafting Custom Care in CLL: Guidance on Upfront and Sequential Treatment Decisions With Targeted and Immune-Based Platforms

PVI, PeerView Institute for Medical Education, Inc.

06-Dec-2024  to 05-Jan-2026

 

In collaboration with the CLL Society, PeerView’s Candid Conversations & Clinical Consults event at the ASH Annual meeting provided expert-led discussions and practical case-based guidance to help learners address common clinical challenges in CLL.

Learn More
E-LEARNING

Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC

PVI, PeerView Institute for Medical Education, Inc.

08-Sep-2024 to 07-Oct-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Web Elevating Care in Resectable Stage I-III NSCLC: Targeted Therapy and Immunotherapy at the Forefront of Multimodal Treatment Strategies

PVI, PeerView Institute for Medical Education, Inc.

09-Sep-2024 to 08-Oct-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Web The Innovation Intersection in B-Cell Cancers: Navigating Choices With Modern Targeted Strategies, Cellular Therapy, and HCT

PVI, PeerView Institute for Medical Education, Inc.

13-Feb-2025 to 12-Mar-2026

 

On-demand activity, based on a 2025 Tandem Meetings symposium, explores advances in CLL and MCL. Experts discuss how targeted and immunotherapies have reshaped B-cell cancer management and impacted HCT use.

Learn More
E-LEARNING

Optimizing PARP Inhibitor Therapy in Veterans With Prostate Cancer: A Practical Guide for VA Pharmacists

PVI, PeerView Institute for Medical Education, Inc.

11-Nov-2024 to 10-Dec-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Web endurig Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways

PVI, PeerView Institute for Medical Education, Inc.

10-Oct-2024 to 09-Nov-2025

 

0.75 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Off-the-Shelf and On the Mark in NHL: Strategic Approaches With Bispecific Antibodies and ADCs for Enhanced DLBCL and FL Care

PVI, PeerView Institute for Medical Education, Inc.

31-Jul-2025 to 30-Jul-2026

 

In this on-demand enduring activity, faculty will explore real-world strategies for selecting, sequencing, and safely delivering modern and emerging off-the-shelf immunotherapies through engaging MasterClass lectures and practical case discussions.

Learn More
E-LEARNING

Web Enduring Reinforcing Precision Tactics in Genomically Altered Resectable NSCLC: Collaborative Workflows and Personalized Solutions for Integration of Adjuvant EGFR- and ALK-Targeted Therapies

PVI, PeerView Institute for Medical Education, Inc.

10-Oct-2024 to 09-Nov-2025

 

0.75 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

Web A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical Impact

PVI, PeerView Institute for Medical Education, Inc.

28-Jan-2025 to 27-Jan-2026

 

PeerView on-demand activity delivering evidence on ADCs and novel therapies for HER2-positive, HER2-low, or HER2-ultralow breast cancer and guiding their integration into personalized treatment plans.

Learn More
E-LEARNING

Maximizing Therapeutic Innovations in Bladder Cancer: Expert Strategies for Comprehensive Care Across Disease Stages

PVI, PeerView Institute for Medical Education, Inc.

15-Feb-2025 to 14-Mar-2026

 

Join this CME/MOC/AAPA/IPCE-certified activity, held with BCAN alongside the 2025 ASCO® GU Cancers Symposium. Gain expert insights on selecting treatments, personalizing care, and integrating modern immunotherapy and targeted therapies.

Learn More
E-LEARNING

Fortifying the Framework for HER2+ GI Cancers: Precision Treatment Planning With Molecularly Targeted Therapies in GC/GEJC, CRC, and BTC

PVI, PeerView Institute for Medical Education, Inc.

24-Jan-2025 to 24-Jan-2025

 

This MasterClass & Practicum at ASCO GI 2025 offers GI care teams concise lectures with comprehensive guidance on evidence-based integration and practical use of validated targeted therapies for HER2+ GI malignancies.

Learn More
E-LEARNING

Web enduring “Experts vs AI” ADC Challenge—Lung Cancer Edition: Interpreting the Evidence, Exploring Practicalities

PVI, PeerView Institute for Medical Education, Inc.

21-Feb-2025 to 20-Mar-2026

 

n this interactive session, based on a live event and featuring ongoing audience engagement, the faculty panel present challenging questions and case scenarios to AI, then analyze and discuss the accuracy of its responses.

Learn More
E-LEARNING

Web enduring A New Era in Treating Advanced Ovarian Cancer: Practical Tips for Maximizing the Use of PARP Inhibitors, Immunotherapy, and ADCs

PVI, PeerView Institute for Medical Education, Inc.

15-Mar-2025 to 14-Apr-2026

 

This activity, recorded at SGO 2025 in collaboration with the Foundation for Women’s Cancer, offers expert insights on optimizing PARP inhibitors, immunotherapy, ADCs, and emerging targeted regimens.

Learn More
E-LEARNING

Precision Medicine Crafts a New Story for Metastatic Prostate Cancer: The Next Act of Therapeutic Intensification With AKT Inhibition and Beyond

PVI, PeerView Institute for Medical Education, Inc.

14-Feb-2025 to 13-Mar-2026

 

This on-demand activity, based on a live ASCO GU 2025 symposium, explores AKT inhibition’s role in targeting the PI3K/AKT/PTEN pathway and advancing personalized care in advanced prostate cancer.

Learn More
E-LEARNING

Accelerating Innovation in Biliary Tract Cancer: Restructuring Treatment Models With Immunotherapy & Targeted Platforms in Advanced Disease

PVI, PeerView Institute for Medical Education, Inc.

24-Jan-2025 to 23-Feb-2026

 

In collaboration with the Cholangiocarcinoma Foundation, this live event at the 2025 ASCO GI Cancers Symposium will offer expert guidance on treatment decisions, therapy selection, and personalized care with immunotherapy and targeted platforms.

Learn More
E-LEARNING

The Second Coming of Finite Therapy in CLL: Making Informed Treatment Decisions With Newer, Time-Limited BTKi Combinations

PVI, PeerView Institute for Medical Education, Inc.

23-Jun-2025 to 22-Jul-2026

 

Experts provide insights on the latest evidence with finite BTKi-BCL2i combinations and guidance on how to integrate these regimens into personalized upfront care.

Learn More
E-LEARNING

Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations

PVI, PeerView Institute for Medical Education, Inc.

23-Jun-2025 to 22-Jul-2026

 

Experts share frontline BTKi evidence and apply it through real-world cases, debating CIT, BTKi regimens, and ASCT strategies.

Learn More
E-LEARNING

Putting Precision Into Practice for Bladder Cancer Treatment: Insights for Individualized Care Across the Disease Continuum

PVI, PeerView Institute for Medical Education, Inc.

28-Apr-2025 to 27-May-2026

 

In this activity, expert faculty provide guidance on bringing scientific advances to patients with bladder cancer as they review the latest clinical data, guideline recommendations, and real-world applications of modern bladder cancer therapies.

Learn More
E-LEARNING

Refining the First Strike Against EGFR-Mutated Advanced NSCLC

PVI, PeerView Institute for Medical Education, Inc.

22-Nov-2024 to 21-Dec-2025

 

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More
E-LEARNING

ALL-in on Bispecific Innovation: Guidance on the Present and Future of Off-the-Shelf Immunotherapy in Acute Lymphoblastic Leukemia

PVI, PeerView Institute for Medical Education, Inc.

05-Jun-2025 to 04-Jul-2026

 

This activity provides perspectives on bispecific antibody standards in adult and pediatric ALL care while preparing for future innovation with novel TCE strategies.

Learn More
E-LEARNING

From Innovation to Implementation: Unlocking the Full Potential of Antibody-Drug Conjugates in Solid Tumors

PVI, PeerView Institute for Medical Education, Inc.

28-Apr-2025 to 27-May-2026

 

This activity covers the latest trial data on diverse ADC modalities in breast, lung, GI, GU, and other cancers.

Learn More
E-LEARNING

Web Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

PVI, PeerView Institute for Medical Education, Inc.

27-Jan-2025 to 26-Jan-2026

 

PeerView on-demand activity providing the latest evidence and guidelines on consolidation immunotherapy in LS-SCLC.

Learn More
E-LEARNING

Web enduring Mastering the Integration of Immunotherapy in Resectable NSCLC: Practical Considerations for Real-World Practice

PVI, PeerView Institute for Medical Education, Inc.

26-Jan-2025 to 25-Feb-2026

 

In this on-demand activity from the 2025 STS Annual Meeting, experts share insights on stage I-III rNSCLC via tumor board-style cases, guiding learners in identifying immunotherapy candidates, selecting optimal approaches, and supporting patients.

Learn More
E-LEARNING

Web Targeting Higher Standards in Resectable NSCLC: The Surgery-Oncology Coalition for Tailoring Care in EGFR & ALK TKI Therapy

PVI, PeerView Institute for Medical Education, Inc.

25-Jan-2025 to 24-Jan-2026

 

In this PeerView activity from the 2025 STS Annual Meeting, NSCLC experts discuss the latest evidence and guidelines on EGFR- & ALK-targeted therapies as adjuvant and neoadjuvant treatments for EGFR- & ALK-mutated NSCLC.

Learn More
E-LEARNING

Hope on the Horizon in Gastric Cancer: Breakthroughs in Personalized Care With Immunotherapy and Targeted Strategies

PVI, PeerView Institute for Medical Education, Inc.

01-Jun-2025 to 30-Jun-2026

 

Developed with Hope For Stomach Cancer, this ASCO 2025 recorded event shares patient perspectives and offers resources to support shared decision-making in stomach cancer care.

Learn More
E-LEARNING

Web Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies

PVI, PeerView Institute for Medical Education, Inc.

01-Jun-2025 to 30-Jun-2026

 

This educational activity with LUNGevity and the Oncology Brothers, recorded during ASCO 2025, offers insights on NSCLC biomarkers and targeted therapy strategies from early to advanced stages.

Learn More
E-LEARNING

Web Mission Possible in Prostate Cancer: Leveraging Genomics, Modern Therapeutics, and Individualized Patient Care

PVI, PeerView Institute for Medical Education, Inc.

01-Jun-2025 to 30-Jun-2026

 

In this educational activity from PeerView Live and ZERO Prostate Cancer recorded at ASCO 2025, a panel of experts will link the evidence.

Learn More
E-LEARNING

Purpose in Practice for HCC: Delivering Effective Care With Modern Systemic Platforms Across Disease Settings

PVI, PeerView Institute for Medical Education, Inc.

01-Jun-2025 to 30-Jun-2026

 

In collaboration with Blue Faery, this educational activity, recorded during the 2025 ASCO Annual Meeting, is designed to help clinicians deliver more effective care for HCC across the disease spectrum.

Learn More
E-LEARNING

Committing to Advances for CLL Care: Conversations on Modern Standards of Care and Next-Gen Innovation

PVI, PeerView Institute for Medical Education, Inc.

05-Sep-2025 to 04-Oct-2026

 

Join experts as they discuss the latest evidence and guidelines supporting targeted therapy platforms and immune-based strategies.

Learn More
E-LEARNING

Web Integrating Immunotherapy in Resectable NSCLC: How to Move From Complexity Toward Clarity

PVI, PeerView Institute for Medical Education, Inc.

14-May-2025 to 13-Jun-2026

 

Experts explore neoadjuvant, adjuvant, and perioperative immunotherapy advances and address key questions in this enduring activity based on a live thoracic oncology event.

Learn More
E-LEARNING

Web Harnessing Precision With EGFR-Targeted Therapy in Resectable NSCLC

PVI, PeerView Institute for Medical Education, Inc.

15-May-2025 to 14-Jun-2026

 

In this activity, based on a live event, experts share key evidence and case guidance on biomarker testing and targeted therapies for resectable NSCLC.

Learn More
E-LEARNING

The Clock Strikes Innovation in CLL: Upfront Care With Newer, Time-Limited BTKi Combinations

PVI, PeerView Institute for Medical Education, Inc.

14-Sep-2025 to 13-Oct-2026

 

Expert discussion on the advances in CLL frontline treatment recorded at the 2025 International Workshop on CLL.

Learn More
E-LEARNING

Web Implementing Immuno-Oncology in Gynecologic Cancer Care for Veterans: Expert Insights on Personalized Treatment

PVI, PeerView Institute for Medical Education, Inc.

23-Aug-2025  to 22-Sep-2026

 

An on-demand activity based on a live virtual symposium from PeerView and NAVREF, offering expert insights on biomarker testing, integrating personalized treatment plans, and communicating with Veterans about their care.

Learn More
E-LEARNING

Expert discussion on the advances in CLL frontline treatment recorded at the 2025 International Workshop on CLL.

PVI, PeerView Institute for Medical Education, Inc.

08-Sep-2025 to 07-Sep-2026

 

An on-demand self-study activity offering guidance on optimal healthcare team collaboration and clinical decision-making for patients with DLBCL.

Learn More
E-LEARNING

Achieving Excellence in Gastric/GEJ Cancer Care: Multidisciplinary Guidance on Immunotherapy Platforms in Resectable Disease

PVI, PeerView Institute for Medical Education, Inc.

17-Jun-2025  to 16-Jul-2026

 

This activity provides expert insights on immunotherapy advances and strategies for integrating them into personalized care for resectable GC/GEJC.

Learn More
E-LEARNING

Web Building a Precision-Centric Community for Patients with EGFRm NSCLC: Adopting Success Strategies with Targeted Standards, Potent Combinations, and Emerging Agents

PVI, PeerView Institute for Medical Education, Inc.

30-Oct-2025 to 29-Oct-2026

 

Stay up to date on the latest advances in EGFRm NSCLC with this CME/MOC/NCPD/AAPA-certified enduring activity.

Learn More
E-LEARNING

Immune to the Impossible in Hepatobiliary Malignancies: Expert Insights on Breakthrough Innovations for Immunotherapy Platforms in Advanced-Stage Disease

PVI, PeerView Institute for Medical Education, Inc.

29-Aug-2025  to 28-Aug-2026

 

On-demand activity featuring expert-led analyses of emerging immunotherapies paired with real-world clinical guidance through case-based discussions.

Learn More
E-LEARNING

Web enduring Critical Conversations for Surgeons & Oncologists in Resectable Gastric/GEJ Cancer

PVI, PeerView Institute for Medical Education, Inc.

14-Oct-2025 to 13-Oct-2026

 

In this activity, based on a PeerView Live Critical Conversations event at the 2025 AATS ITSOS, experts review evidence on immunotherapy in resectable GC/GEJC, share real-world cases, and highlight strategies for collaboration and best practices.

Learn More
E-LEARNING

Web ME Highlights: The Principles of Care in Advanced NSCLC: An Advanced Practitioners' Guide to Antibody Drug Conjugates

Answers in CME Inc.

09-Dec-2024  to 08-Dec-2025

 

Key takeaways, session highlights, complete recordings, and downloadable slides from the JADPRO live session

Learn More
E-LEARNING

Web enduring ME Highlights: TROP2-Directed ADCs in the Treatment of Advanced NSCLC: Answering Key Questions to Establish Evidence-Based Practices

Answers in CME Inc.

26-Dec-2024  to 25-Dec-2025

 

Summarize the most salient information from the Virtual Live, in a text- and slide-based format, divided into 5 sessions.

Learn More
E-LEARNING

Translating the Latest Evidence on First-Line Treatment for EGFR-Mutated NSCLC Into Practice: An Update for Community Clinicians

Answers in CME Inc.

26-Sep-2025 to 25-Sep-2026

 

Fast-paced, interactive web-based program including expert speaker feedback, current evidence, and best practices

Learn More
E-LEARNING

Keeping Pace With TROP2-Directed ADCs in HR-Positive, HER2-Negative/Low Advanced Breast Cancer

Answers in CME Inc.

19-Dec-2024  to 18-Dec-2025

 

Fast-paced, interactive, microburst sessions with expert faculty commentary.

Learn More
E-LEARNING

Web enduring Expanding Pathways of Care for HER2-Positive Metastatic NSCLC: Beyond Mutation to Overexpression

Answers in CME Inc.

19-Dec-2024  to 18-Dec-2025

 

An expert in NSCLC discusses testing for overexpression of HER2 in patients with metastatic NSCLC, as well as clinical skills related to treatment selection/management for HER2-overexpressing NSCLC

Learn More
E-LEARNING

Web enduring ME Highlights: Decoding HER2 Low and Ultralow in Breast Cancer: The Path to Precision Care With Antibody-Drug Conjugates

Answers in CME Inc.

06-May-2025  to 05-May-2026

 

Enduring initiative with content highlighting the most salient points from all 3 Virtual Live Micro Series events

Learn More
E-LEARNING

Web enduring ME Highlights: Staying Abreast of Shifting Paradigms in Advanced HR+, HER2- Breast Cancer: Updates on Novel Oral SERDs

Answers in CME Inc.

21-Jul-2025 to 20-Jul-2026

 

Summarize the most salient information from the Virtual Live, in a text- and slide-based format, divided into 5 sessions.

Learn More
E-LEARNING

Web enduring Keeping Pace with TROP2-Directed ADCs: Their Evolving Role in Advanced, Pretreated EGFR-Mutated NSCLC

Answers in CME Inc.

30-Jun-2025  to 29-Jun-2026

 

Fast-paced, interactive, microburst sessions with expert faculty commentary.

Learn More
E-LEARNING

From Theory to Practice: Integrating TROP2 ADCs in HR+/HER2- Breast Cancer

Answers in CME Inc.

13-Nov-2026  to 12-Nov-2027

 

Interactive case scenarios, followed by faculty-led explanation and discussion.

Learn More
E-LEARNING

Web enduring Ocular Safety in Breast Cancer Care: What Eye Clinicians Need to Know About Novel Oral Endocrine Therapies

Answers in CME Inc.

15-Oct-2025 to 14-Oct-2026

 

Interactive e-learning featuring clinical perspectives and discussion from 2 leading experts.

Learn More
E-LEARNING

Web ME Highlights: What’s Now and What’s Next for ADCs in NSCLC? Integrating HER2- and TROP2-Targeted Therapies Into the Evolving Treatment Landscape

Answers in CME Inc.

29-Dec-2025 to 28-Dec-2026

 

Key takeaways, session highlights, complete recordings, and downloadable slides from the IASLC NA live session

Learn More
E-LEARNING

Web Translating Trials to Treatment: Practical Strategies for Immunotherapy Integration in Limited Stage- and Extensive Stage-SCLC

Answers in CME Inc.

31-Dec-2025 to 30-Dec-2026

 

Fast-paced, interactive, microburst sessions with expert faculty commentary.

Learn More
E-LEARNING

Web enduring ME Highlights: Rapid Roundup 2025 in NSCLC: Keeping Up with ADC Therapies Driving Precision Lung Cancer Care

Answers in CME Inc.

16-Dec-2025 to 15-Dec-2026

 

Summarize the most salient information from the Virtual Live, in a text- and slide-based format, divided into 5 sessions.

Learn More
E-LEARNING

ME Replay: ADC-elerating Progress: Targeting TROP2 in Triple-Negative Breast Cancer to Improve Front-Line Care

Answers in CME Inc.

26-Jan-2026 to 13-Feb-2026

 

Full session recording from the 60-minute Virtual Live event

Learn More
E-LEARNING

Web enduring Bridging Clinic and OR: A Dialogue on the Emerging Role of Neoadjuvant HER2-Directed ADCs in HER2+ Breast Cancer

Answers in CME Inc.

26-Jan-2026 to 25-Jan-2027

 

Interactive e-learning featuring clinical perspectives and discussion from 2 leading experts.

Learn More
E-LEARNING

Evolving Care in B-ALL: From Questions to Answers on The Role of CD19 Bispecific T-Cell Engagers

Answers in CME Inc.

04-Mar-2026 to 03-Mar-2027

 

Fast-paced, interactive web-based program including expert speaker feedback, current evidence, and best practices

Learn More
E-LEARNING

Web Germline Testing in Cancer Patients: Molecular Diagnostic Considerations and Clinical Implications

Association for Molecular Pathology

30-Jan-2025 to 31-Dec-2026

 

This webinar addresses when genetic testing is indicated in cancer patients, laboratory considerations for genetic testing, identifying germline variants in tumor sequencing data, and how to treat when detecting germline pathogenic variants.

Learn More
E-LEARNING

On-Demand Recording of the ASCP Panel Discussion

American Society for Clinical Pathology

09-Jan-2026 to 11-Jan-2027

 

To further extend the reach of the Annual Meeting session, ASCP will develop one CME/CMLE-accredited on-demand recording from the Annual Meeting Session.

Learn More
E-LEARNING

Inside the Lab Podcast

American Society for Clinical Pathology

09-Jan-2026 to 11-Jan-2027

 

45-minute CME/CMLE-accredited podcast, titled “Advances in NSCLC Biomarker Testing.”

Learn More
E-LEARNING

Case-Based Microlearning Series

American Society for Clinical Pathology

03-Feb-2025 to 11-Jan-2027

 

An interactive, online CME/CMLE credit-bearing microlearning series consisting of 1 hour of case-based education on biomarker testing and treatment for NSCLC segmented into 4 easily consumable 15-minute segments.

Learn More
E-LEARNING

Web Pick the Best Path: Optimizing PI3KCA Mutation-Targeted HR+/HER2- PIK3CA-Mutated Therapy and Hyperglycemia Management

Annenberg Center for Health Sciences at Eisenhower

01-Jan-2026 to 31-Jan-2027

 

45-minute with 2 experts presenting and discussing; recording

Learn More
E-LEARNING

Downloadable Resource Guide

American Society for Clinical Pathology

24-Oct-2025 to 11-Jan-2027

 

A non-accredited Resource Guide to empower pathologists and laboratory professionals on ways to operationalize testing pathways that will lead to timely, effective, efficient, and equitable testing for patients diagnosed at their institutions.

Learn More
E-LEARNING

TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Significance of the Construct

PeerVoice America Limited

25-Jan-2024 to 24-Jan-2026

 

20 minute web enduring activity with experts discussing TROP2-directed antibody-drug conjugates (ADCs) for breast cancer.

Learn More
E-LEARNING

Web When They Need More Than Trastuzumab: Deciding on What’s Next for Patients With HER2+ Gastric Cancer

PeerVoice America Limited

11-Sep-2024 to 10-Sep-2026

 

5 Micro Episodes (5 mins each) with an expert's presentation

Learn More
E-LEARNING

Pathological Assessment of HER2 Status in Gastric and Gastroesophageal Cancers: Important Steps That Can Impact Outcomes

PeerVoice America Limited

27-Sep-2024 to 26-Sep-2026

 

5 Micro Episodes (5 min each) with an Experts presentation

Learn More
E-LEARNING

Web enduring Practical Protocols for Preventing and Managing Antibody-Drug Conjugate-Associated Nausea and Vomiting

PeerVoice America Limited

30-Sep-2024 to 29-Sep-2026

 

In this video CE activity, Karin Jordan, MD, PhD, explores strategies for preventing and managing antibody-drug conjugate-associated nausea and vomiting

Learn More
E-LEARNING

Applying Foresight to Optimise Emesis Control in Patients Receiving Antibody-Drug Conjugates

PeerVoice America Limited

31-Oct-2024 to 30-Oct-2026

 

In this two-part video CE activity, Karin Jordan, MD, PhD, and Erika Hamilton, MD, discuss strategies for controlling emesis in patients who are receiving antibody-drug conjugates.

Learn More
E-LEARNING

Testing Impacts Treatment: Applying Best Practices in HER2 Assessment in Solid Tumours

PeerVoice America Limited

08-Nov-2024 to 07-Nov-2026

 

An expert discusses HER2 assessment and therapeutic management in solid tumours.

Learn More
E-LEARNING

Live Enhancing Multidisciplinary Strategies for the Management of Ocular Toxicities From Novel Oncology Therapies

PRIME Education, LLC

29-Sep-2025 to 11-Feb-2026

 

Five (5) 1.0-hour Multi-Accredited Clinical Connections Regional Forums

Learn More
E-LEARNING

Web enduring Advanced NSCLC: Empowering Nurses to Improve Patient Care in Rural and Underserved Communities

Talem Health, LLC

02-Jun-2025 to 02-Jun-2026

 

An online, on-demand enduring CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com; marketed to the target audience nationally.

Learn More
E-LEARNING

Gastric Cancer ECHO – Linking Experts and Community Oncologists To Improve the Management of Gastric/GEJ Cancer in Rural and Underserved Communities

Talem Health, LLC

30-Sep-2025 to 30-Sep-2026

 

Community oncologists will connect with a multidisciplinary team of experts at a 'hub' site. Each monthly ECHO session will include a brief didactic presentation by expert faculty followed by participant-led case presentation and group discussion.

Learn More
E-LEARNING

Web Interdisciplinary Strategies for BRCA-Mutated EBC: Testing, Targeting, and Team-Based Care

USH Axis Holdings Inc.

15-Jan-2026 to 15-Jan-2027

 

1-hour Grand Rounds replay on molecular testing, evidence-based therapy, and team-based care for high-risk early-stage breast cancer with germline BRCA mutations. Covers BRCA testing, disparities, and case-based adjuvant strategies.

Learn More
E-LEARNING

Web ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer

USH Axis Holdings Inc.

29-July-2025 to 29-July-2026

 

Explore 3 cases with Dr. Mahtani showcasing how current evidence guides the use of antibody-drug conjugates in HER2-positive, HER2-low, and ultralow metastatic breast cancer to support optimal, evidence-based treatment selection.

Learn More
E-LEARNING

Web Video Webinar: HER2 Overexpression/Mutation as an Actionable Target in NSCLC

USF Health Professions Conferencing Corporation (HPCC)

11-July-2025 to 11-July-2026

 

1.0-hour, CE-certified, enduring video webinar of the live tumor board

Learn More
E-LEARNING

Web Roundtable: ADCs Targeting HER2 in NSCLC

USF Health Professions Conferencing Corporation (HPCC)

02-May-2025 to 02-May-2026

 

0.50-hour, CE-certified, on-demand expert roundtable webinar

Learn More
E-LEARNING

Oncology Congress: Navigating the Expanding Treatment Landscape in NSCLC: Addressing Key Targets to Improve Access and Outcomes in Rural and Underserved Communities

Talem Health, LLC

15-Jan-2026 to 15-Jan-2027

 

Online enduring activity: An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com; marketed to the target audience nationally. (1.0 AMA/ANCC credit)

Learn More
E-LEARNING

Web Oncology Congress – Navigating Advances in Early Breast Cancer: Improving Access in Rural and Underserved Settings

Talem Health, LLC

15-Jan-2026 to 15-Jan-2027

 

Online enduring activity: An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com; marketed to the target audience nationally. (1.0 AMA/ANCC credit)

Learn More
E-LEARNING

Sorting the Sequence in Multiple Myeloma: Making Personalized Choices With BCMA and non-BCMA Immunotherapies in Relapsed/Refractory Disease

PVI, PeerView Institute for Medical Education, Inc.

19-March-2026 to 18-April-2027

 

In this PeerView activity based on a live symposium at the 2026 Tandem Meetings of ASTCT and CIBMTR, myeloma experts use a series of interactive case-based workshops to model team-based care solutions for optimizing the RRMM treatment sequence.

Learn More
E-LEARNING

Synchronizing Success in Resectable Gastric/GEJ Cancer: Merging Expertise to Effectively Deliver Immunotherapy Platforms in the Surgical Setting

PVI, PeerView Institute for Medical Education, Inc.

29-Jan-2026 to 28-Feb-2027

 

Join this PeerView activity to gain the latest data and expert-approved strategies for delivering chemoimmunotherapy platforms in the surgical setting. This activity was recorded during a live event at the 2026 STS Annual Meeting.

Learn More
E-LEARNING

Web From Evidence to Impact: Harnessing PI3K/AKT/mTOR Pathway Inhibitors to Improve Outcomes in HR+/HER2– mBC

PVI, PeerView Institute for Medical Education, Inc.

23-March-2026 to 22-March-2027

 

Interactive PeerView inQuiry activity using question-driven self-assessment and expert discussion to strengthen clinicians’ understanding of PI3K/AKT/mTOR pathway alterations in HR+/HER2– metastatic breast cancer.

Learn More
E-LEARNING

Streamlining Multidirectional Care in HCC: Applying Groundbreaking Evidence on Systemic Treatment Approaches Across the Disease Spectrum

PVI, PeerView Institute for Medical Education, Inc.

09-Jan-2026 to 08-Feb-2027

 

Join PeerView Live and Blue Faery: The Adrienne Wilson Liver Cancer Association for this activity recorded at ASCO GI 2026 to gain insights and practical strategies for treating HCC.

Learn More
E-LEARNING

Web Innovative Approaches in Prostate Cancer: Bridging Genomics and Patient-Centric Treatment

PVI, PeerView Institute for Medical Education, Inc.

03-Dec-2025 to 02-Jan-2027

 

This activity from PeerView and ZERO Prostate Cancer, recorded during the SUO annual meeting, provides learners with the tools they need to ensure that their patients are benefiting from state-of-the-art prostate cancer therapeutics.

Learn More
E-LEARNING

Navigating Frontline CLL Care With Modern BTKi and BCL2i Strategies: Rising to the Global Challenge

PVI, PeerView Institute for Medical Education, Inc.

06-Nov-2025 to 25-Jan-2027

 

A clinician-directed assessment-based microlearning intervention targeting academic and community hematology-oncology professionals globally

Learn More
E-LEARNING

Web Harnessing the Power of ADCs in Gynecologic Cancers: Expert Insights for Practice Integration

PVI, PeerView Institute for Medical Education, Inc.

21-Nov-2025 to 20-Nov-2026

 

In this activity, experts review the latest evidence on approved and emerging ADCs presented at the 2025 ESMO Congress and the IGCS Annual Global Meeting and provide strategies for bringing these agents to clinical practice.

Learn More
E-LEARNING

Web Pathway to Precision in Ovarian Cancer: A Pathology-Informed Guide to Translating Biomarker Testing Results Into Actionable Treatment With ADCs

PVI, PeerView Institute for Medical Education, Inc.

23-Feb-2026 to 22-Feb-2027

 

This on-demand activity will focus on biomarker interpretation and the integration of relevant findings into personalized treatment plans.

Learn More
E-LEARNING

Dialing Up Precision in HR+, HER2- MBC With New Endocrine Agents, Targeted Therapies, and Combinations

PVI, PeerView Institute for Medical Education, Inc.

16-Dec-2025 to 15-Jan-2027

 

Join top experts in this SABCS 2025 PeerView/LBBC recorded activity for a cutting-edge, case-based look at applying precision evidence and key patient factors to guide nuanced breast cancer treatment decisions.

Learn More
E-LEARNING

Forging New Paths With Earlier Use of ADCs in Breast Cancer: From Clinical Breakthroughs to Improved Outcomes

PVI, PeerView Institute for Medical Education, Inc.

17-Dec-2025 to 16-Jan-2027

 

In this SABCS 2025 PeerView/GRASP recorded activity, explore evolving ADC science and real-world cases as experts translate emerging evidence into practical, individualized breast cancer care in a fast-moving field.

Learn More
E-LEARNING

Mapping Therapeutic Directions in DLBCL: Team Strategies for Prognostic Assessment & Implications for Targeted Therapy and Other Innovative Options

PVI, PeerView Institute for Medical Education, Inc.

08-Sep-2025 to 07-Sep-2026

 

An on-demand self-study activity offering guidance on optimal healthcare team collaboration and clinical decision-making for patients with DLBCL.

Learn More
E-LEARNING

Off the Shelf and in the Clinic for NHL: Leveraging Bispecific Antibody Strategies in DLBCL, FL, and Beyond

PVI, PeerView Institute for Medical Education, Inc.

05-Dec-2025 to 04-Jan-2027

 

In collaboration with the HealthTree Foundation for NHL, this expert-led, case-based activity—recorded during ASH 2025—is designed to model team-based care solutions for integrating bispecifics into clinical practice.

Learn More
E-LEARNING

Pathways to Personalized Remission in CLL: Leveraging Targeted Standards and Next-Gen Advances for Upfront and Sequential Care

PVI, PeerView Institute for Medical Education, Inc.

05-Dec-2025 to 04-Jan-2027

 

In collaboration with CLL Society, this expert-led activity recorded during ASH 2025, covers modern CLL pathways to remission through a series of interactive, case-based workshops focused on real-world challenges in CLL care.

Learn More
E-LEARNING

Moving Forward in B-ALL: Insights on Modern and Emerging Standards With Off-the-Shelf Bispecific Antibodies

PVI, PeerView Institute for Medical Education, Inc.

05-Dec-2025 to 04-Jan-2027

 

In collaboration with HealthTree Foundation for ALL, this expert-led activity recorded during ASH 2025, provides perspectives on modern clinical standards in modern ALL care

Learn More
E-LEARNING

Web Implementing Immuno-Oncology in Gynecologic Cancer Care for Veterans: Expert Insights on Personalized Treatment

PVI, PeerView Institute for Medical Education, Inc.

23-Aug-2025 to 22-Sep-2026

 

An on-demand activity based on a live virtual symposium from PeerView and NAVREF, offering expert insights on biomarker testing, integrating personalized treatment plans, and communicating with Veterans about their care.

Learn More
E-LEARNING

Redrawing Frontlines in MCL: The Upfront Expansion of BTKi Options & Modern Clinical Decision-Making in Newly Diagnosed Disease

PVI, PeerView Institute for Medical Education, Inc.

05-Dec-2025 to 04-Jan-2027

 

In collaboration with the HealthTree Foundation for MCL, this expert-led activity recorded during ASH 2025, demonstrates how the latest evidence on 1L BTKi platforms is impacting decision-making for different MCL presentations and patient cohorts.

Learn More
E-LEARNING

Turning the Tide in Gastric Cancer Management: Integrating Modern Systemic Therapies Across the Disease Continuum for Community-Based Clinicians

PVI, PeerView Institute for Medical Education, Inc.

22-Dec-2025 to 21-Dec-2026

 

This enduring activity features expert dialogue and case-based insights on biomarkers, molecular profiling, and updated immunotherapy and targeted options to guide personalized treatment selection and sequencing for gastric/GEJ cancer.

Learn More
E-LEARNING

Purpose in Practice for HCC: Delivering Effective Care With Modern Systemic Platforms Across Disease Settings

PVI, PeerView Institute for Medical Education, Inc.

01-June-2025 to 30-June-2026

 

In collaboration with Blue Faery, this educational activity, recorded during the 2025 ASCO Annual Meeting, is designed to help clinicians deliver more effective care for HCC across the disease spectrum.

Learn More
E-LEARNING

Precision Medicine Crafts a New Story for Metastatic Prostate Cancer: The Next Act of Therapeutic Intensification With AKT Inhibition and Beyond

PVI, PeerView Institute for Medical Education, Inc.

14-Feb-2025 to 13-Mar-2026

 

This on-demand activity, based on a live ASCO GU 2025 symposium, explores AKT inhibition’s role in targeting the PI3K/AKT/PTEN pathway and advancing personalized care in advanced prostate cancer.

Learn More
E-LEARNING

Web enduring A New Era in Treating Advanced Ovarian Cancer: Practical Tips for Maximizing the Use of PARP Inhibitors, Immunotherapy, and ADCs

PVI, PeerView Institute for Medical Education, Inc.

15-Mar-2025 to 14-April-2026

 

This activity, recorded at SGO 2025 in collaboration with the Foundation for Women’s Cancer, offers expert insights on optimizing PARP inhibitors, immunotherapy, ADCs, and emerging targeted regimens.

Learn More
E-LEARNING

Web The Innovation Intersection in B-Cell Cancers: Navigating Choices With Modern Targeted Strategies, Cellular Therapy, and HCT

PVI, PeerView Institute for Medical Education, Inc.

21-Mar-2025 to 20-April-2026

 

On-demand activity, based on a 2025 Tandem Meetings symposium, explores advances in CLL and MCL. Experts discuss how targeted and immunotherapies have reshaped B-cell cancer management and impacted HCT use.

Learn More
E-LEARNING

Advancing Evidence-Based Care for Veterans With mHSPC: Pathways, Personalization, and Team-Based Strategies

PRIME Education, LLC

13-Feb-2026 to 12-Feb-2027

 

1.0-hour Multi-Accredited Enduring Webcast (includes clinical trial pocket guide)

Learn More
E-LEARNING

Latest Clinical Data for Emerging Combination Strategies in mHSPC

PRIME Education, LLC

13-Feb-2026 to 12-Feb-2027

 

One (1) 0.25-hour Multi-Accredited Booster Quiz (includes clinical trial pocket guide)

Learn More
E-LEARNING

Biomarker to Bedside: Practical Approaches to HER2 Testing and Targeted Treatment in Gynecologic Cancers

PRIME Education, LLC

13-Feb-2026 to 12-Feb-2027

 

1.0-hr Multi-Accredited Enduring Webcast with HER2 Testing Toolkit Resource

Learn More
E-LEARNING

Web Integrating Real-World Patient Insights in Metastatic Breast Cancer Care: Personalizing Treatment With Novel Agents

PRIME Education, LLC

11-DEC-2026 to 10-Dec-2026

 

1.0-hour Multi-Accredited, On-Demand Enduring Webcast with downloadable Companion Guides

Learn More
E-LEARNING

Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer

PRIME Education, LLC

04-DEC-2025 to 03-Dec-2026

 

One (1) 0.5-hour On-Demand Webcast with Point-of-Care AE Management Guide

Learn More
E-LEARNING

Web Unlocking Precision: Genetic Testing and Counseling Essentials for Breast Cancer Care

PRIME Education, LLC

05-DEC-2025 to 04-Dec-2026

 

0.5-hour Corresponding Enduring Activities in Breast Cancer Genomics #1

Learn More
E-LEARNING

Translating Clinical Data Into Practice: Genetic Testing and PARP Inhibitors in Breast Cancer Management

PRIME Education, LLC

10-DEC-2025 to 09-Dec-2026

 

1.0-hour Multi-Accredited Enduring Webcast

Learn More
E-LEARNING

Web Translating Clinical Data Into Practice: Genetic Testing and PARP Inhibitors in Breast Cancer Management

PRIME Education, LLC

10-DEC-2025 to 09-Dec-2026

 

1.0-hour Multi-Accredited Enduring Webcast

Learn More
E-LEARNING

Beyond Positive and Negative: Redefining HER2 Testing and Treatment Pathways in Metastatic Breast Cancer

PRIME Education, LLC

18-Aug-2025 to 17-Aug-2026

 

1.0-hour Multi-Accredited Enduring Webcast

Learn More
E-LEARNING

Web HER2 Beyond the Binary: Navigating HER2-Low and HER2-Ultralow Metastatic Breast Cancer

PRIME Education, LLC

24-Nov-2025 to 23-Nov-2026

 

1.0-hour Multi-Accredited Enduring Webcast GME HER2-low mBC Early Career Clinicians

Learn More
E-LEARNING

Live web New Horizons in NSCLC: The Role of ADCs in Enhancing Personalized Care in HER2-Altered Disease

Plexus Communications LLC

01-Feb-2026 to 31-Aug-2026

 

1 hour live hospital-based meetings held in hem/onc departments nationwide

Learn More
E-LEARNING

Live Targeting EGFR Alterations: Precision Approaches to Frontline Treatment of Late-Stage Non-Small Cell Lung Cancer (NSCLC)

Plexus Communications LLC

31-Oct-2025 to 18-June-2026

 

1 hour live hospital-based meetings held in hem/onc departments nationwide

Learn More
E-LEARNING

Web enduring Advancing Metastatic NSCLC Care in the VA: The Role of HER2- and TROP2-Targeted Antibody-Drug Conjugates

Plexus Communications LLC

16-Dec-2025 to 16-Sep-2026

 

1 hour on-demand video presentation with slides and graphics; Polling interactivity

Learn More
E-LEARNING

Live Hybrid Community Oncology Forums: Advances in Perioperative Immunotherapy for Resectable NSCLC

Plexus Communications LLC

09-Oct-2025 to 09-March-2026

 

1 hour live hospital-based meetings held in hem/onc departments nationwide

Learn More
E-LEARNING

Subtype-Driven Therapy in DLBCL: The Emerging Role of Frontline BTK Inhibition

Plexus Communications LLC

05-Nov-2025 to 23-April-2026

 

1 hour live hospital-based meetings held in hem/onc departments nationwide

Learn More
E-LEARNING

Live Hybrid Community Oncology Forums: New Horizons in NSCLC: The Role of ADCs in Enhancing Personalized Care in HER2-Altered Disease

Plexus Communications LLC

15-Nov-2025 to 03-April-2026

 

1 hour live hospital-based meetings held in hem/onc departments nationwide

Learn More
E-LEARNING

Web enduring Emerging Therapies in Prostate Cancer: Key Insights for Urology Nurses

Plexus Communications LLC

11-Dec-2025 to 11-Sep-2026

 

1 hour on-demand video presentation with slides and graphics; Polling interactivity

Learn More
E-LEARNING

Web Making the Most of Maintenance Therapy for Ovarian Cancer: Optimizing the Use of PARP Inhibitors

Plexus Communications LLC

22-Oct-2025 to 22-Oct-2026

 

1 hour on-demand video presentation with slides and graphics; Polling interactivity

Learn More
E-LEARNING

Live Hybrid Oncology Forums: Making the Most of Maintenance Therapy for Ovarian Cancer: Optimizing the Use of PARP Inhibitors

Plexus Communications LLC

18-July-2025 to 10-March-2026

 

1 hour live hospital-based meetings held in hem/onc departments nationwide

Learn More
E-LEARNING

Web enduring Bridging the Gaps in PARP Inhibitor Use for Metastatic Prostate Cancer in the VHA System

Plexus Communications LLC

22-Dec-2025 to 22-Dec-2026

 

1 hour on-demand video presentation with slides and graphics; Polling interactivity

Learn More
E-LEARNING

Advancing Frontline Therapy in Mantle Cell Lymphoma: The Evolving Role of BTK Inhibitors

Plexus Communications LLC

19-Dec-2025 to 19-Sep-2026

 

1 hour on-demand video presentation with slides and graphics; Polling interactivity

Learn More
E-LEARNING

Optimizing Second- and Next-Generation BTK Inhibitor Use in the Management of Chronic Lymphocytic Leukemia

Plexus Communications LLC

30-July-2025 to 30-July-2026

 

1 hour pre-recorded enduring activity

Learn More
E-LEARNING

Web Integrating PARP Inhibitors for the Treatment of Metastatic Prostate Cancer: Optimizing Personalized Care in the VHA and Community Health Care Systems

Plexus Communications LLC

27-Aug-2025 to 27-Aug-2026

 

1 hour on-demand video presentation with slides and graphics; Polling interactivity

Learn More
E-LEARNING

Web The Emerging Nuances of Extensive Stage SCLC Treatment: Individualizing Care in the Immunotherapy Era

PeerVoice America Limited

03-March-2026 to 02-March-2028

 

Micro Episodes activity equips oncologists including community oncologists, and oncology midlevel providers, nurses and pharmacists to deliver individualized care and support shared clinical decision-making in SCLC as the treatment landscape evolves.

Learn More
E-LEARNING

Web Antibody-Drug Conjugates in Breast Cancer: Keeping Abreast of the Latest Data As They Emerge From ESMO

PeerVoice America Limited

27-Oct-2025 to 26-Oct-2026

 

In this activity, experts explore recently presented data on the management of breast cancer.

Learn More
E-LEARNING

Navigating Fixed-Duration Treatments in CLL

Partners for Advancing Clinical Education

03-April-2025 to 11-Aug-2026

 

30-minute online endured patient/caregiver activity. The education will increase patient awareness and understanding of available and novel treatments in CLL, while providing strategies to align with clinicians on goals of therapy.

Learn More
E-LEARNING

Real-world Application of Targeted Therapy for CLL: Insights for the Community Oncologist

Partners for Advancing Clinical Education

11-Aug-2025 to 11-Aug-2026

 

60-minute online endured CME activity. Four on-demand pre-recorded modules designed as part of a 60-minute HCP toolkit to improve practice integration. The content for this toolkit will be heavily informed by the data uncovered in phase 1

Learn More
E-LEARNING

Decoding Treatment Paradigms in CLL: Fixed-Duration vs Treat-to-Progression

Partners for Advancing Clinical Education

28-May-2025 to 11-Aug-2026

 

60-minute online endured CME activity. Experts will provide education on fixed-duration and treat-to-progression approaches including a snapshot of the community-based practice patterns uncovered

Learn More
E-LEARNING

Web TROP2 ADCs in Breast Cancer: Updates on the Latest Clinical Trial Data and AE Management

Paradigm Medical Communications, LLC

06-June-2025 to 06-June-2026

 

1-hour on-demand news broadcast, with whiteboard animation

Learn More
E-LEARNING

Web LUGPA 2025 Enduring CME Program

Opt-in CME, LLC

18-Dec-2025 to 18-Dec-2028

 

4.25 hours enduring video activity of the entire LUGPA CME day

Learn More
E-LEARNING

Web Expert Second Opinion: Investigators Discuss the Optimal Management of HER2-Positive Gastrointestinal Cancers

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

28-Jan-2026 to 18-Jan-2027

 

Video enduring progra

Learn More
E-LEARNING

Live Expert Second Opinion: Investigators Discuss the OptimLal Management of HER2-Positive Gastrointestinal Cancers

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

28-Jan-2026 to 18-Jan-2027

 

audio enduring program

Learn More
E-LEARNING

Web Integrating New Advances into the Care of Patients with Cancer — A Multitumor Symposium in Partnership with the American Oncology Network

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

13-Dec-2025 to 13-Dec-2026

 

audio enduring program

Learn More
E-LEARNING

Integrating New Advances into the Care of Patients with Cancer — A Multitumor Symposium in Partnership with the American Oncology Network

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

13-Dec-2025 to 13-Dec-2026

 

video enduring program

Learn More
E-LEARNING

Live Data + Perspectives: Clinical Investigators Explore the Application of Recent Data Sets in Current Oncology Care — Diffuse Large B-Cell Lymphoma and Follicular Lymphoma Module

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

13-Dec-2025 to 13-Dec-2026

 

Video enduring from a Live CME Symposium Hosted in Conjunction with Florida Cancer Specialists

Learn More
E-LEARNING

Web Data + Perspectives: Clinical Investigators Explore the Application of Recent Data Sets in Current Oncology Care — Prostate Cancer Module

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

13-Dec-2025 to 13-Dec-2026

 

Audio enduring from a Live CME Symposium Hosted in Conjunction with Florida Cancer Specialists

Learn More
E-LEARNING

Data + Perspectives: Clinical Investigators Explore the Application of Recent Data Sets in Current Oncology Care — Prostate Cancer Module

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

13-Dec-2025 to 13-Dec-2026

 

Video enduring from a Live CME Symposium Hosted in Conjunction with Florida Cancer Specialists

Learn More
E-LEARNING

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care - Breast Cancer Module

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

13-Dec-2025 to 13-Dec-2026

 

Audio enduring from live symposium in partnership with Florida Cancer Specialists

Learn More
E-LEARNING

Web Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care - Breast Cancer Module

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

13-Dec-2025 to 13-Dec-2026

 

Video enduring from live symposium in partnership with Florida Cancer Specialists

Learn More
E-LEARNING

Web audio programCases from the Community: Investigators Discuss the Optimal Management of HER2-Positive Breast Cancer

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

14-Jan-2026 to 14-Jan-2027

 

audio program

Learn More
E-LEARNING

Web video Cases from the Community: Investigators Discuss the Optimal Management of HER2-Positive Breast Cancer

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

14-Jan-2026 to 14-Jan-2027

 

video program

Learn More
E-LEARNING

Web The Implications of Recent Datasets for the Current and Future Management of Non-Hodgkin Lymphoma

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

07-Oct-2025 to 07-Oct-2026

 

Audio enduring

Learn More
E-LEARNING

Live The Implications of Recent Datasets for the Current and Future Management of Non-Hodgkin Lymphoma

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

07-Oct-2025 to 07-Oct-2026

 

Video enduring

Learn More
E-LEARNING

Cases from the Community: Investigators Discuss Available Research Guiding the Selection of Therapy for Patients with Chronic Lymphocytic Leukemia

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

07-Jan-2026 to 07-Jan-2027

 

video enduring program

Learn More
E-LEARNING

Cases from the Community: Investigators Discuss Available Research Guiding the Selection of Therapy for Patients with Chronic Lymphocytic Leukemia

NL COMMUNICATIONS, INC. DBA RESEARCH TO PRACTICE

07-Jan-2026 to 07-Jan-2027

 

audio enduring program

Learn More
E-LEARNING

NCCN 2026 Breast Cancer Congress with Updates from the 2025 San Antonio Breast Cancer Symposium

National Comprehensive Cancer Network, Inc.

06-Feb-2026 to 06-Feb-2027

 

a one-day live-in-person educational activity with livestreaming, real-time polling, and moderator-facilitated Q&A sessions.

Learn More
E-LEARNING

Behind the Guidelines: Insights into the Standard of Care in Oncology 2026

National Comprehensive Cancer Network, Inc.

10-Jan-2026 to 31-Dec-2027

 

This activity consists of twelve NCCN Guidelines Insights articles

Learn More
E-LEARNING

Transforming Gastric and GEJ Cancer Care With Perioperative Immunotherapy: Latest Updates From Chicago

Medscape LLC

11-July-2025 to 11-July-2026

 

Medscape Onsite: A 30-minute On Demand video discussion between 2 gastric oncology specialists offering data dissemination from ASCO 2025, May 30- June 3, 2025, in Chicago, IL

Learn More
E-LEARNING

Web TROP2 ADCs for NSCLC: What Community Oncologists Need to Know

Med Learning Group, LLC

20-Nov-2025 to 20-Nov-2026

 

1-hr endured TeleECHO meeting for US and global community oncologists in NSCLC to better understand TROP2 in pathophysiology

Learn More
E-LEARNING

The Emerging Role of Oral SERDs in Community Care for Frontline HR+/HER2- Metastatic Breast Cancer

Med Learning Group, LLC

21-Nov-2025 to 21-Nov-2026

 

15/20 min series of 3 SmartCast podcasts with Dr. Erica Mayer & renowned experts on oral ET in HR+ & HER2-negative MBC

Learn More
E-LEARNING

Web The Emerging Role of Oral SERDs in Community Care for Frontline HR+/HER2- Metastatic Breast Cancer

Med Learning Group, LLC

07-Nov-2025 to 07-Nov-2026

 

1-hr endured presentation of the Community Oncology Connection meetings on oral ET in HR+ & HER2-negative MBC

Learn More
E-LEARNING

(Enduring) Novel Targeted Therapeutics and Essential Strategies for Optimized Outcomes in Chronic Lymphocytic Leukemia

HMP Education, LLC

18-Nov-2025 to 18-May-2026

 

To extend program reach to learners unable to participate in LL&M, HMP Education will develop an enduring on-demand archive of the session

Learn More
E-LEARNING

Web (Enduring) Advances in R/R Follicular Lymphoma: Diagnostic Approaches and Novel Therapeutic Options

HMP Education, LLC

18-Nov-2025 to 18-May-2026

 

To extend program reach to learners unable to participate in LL&M, HMP Education will develop an enduring on-demand archive of the session

Learn More
E-LEARNING

Digital Pathology and AI in Cancer Diagnostics

Florida Society of Pathologists

30-May-2025 to 30-May-2026

 

1 hr on-demand webinar

Learn More
E-LEARNING

Effective Communication and Collaboration Across the Multidisciplinary Team

Florida Society of Pathologists

25-April-2025 to 25-April-2026

 

1 hr on-demand webinar

Learn More
E-LEARNING

Application of Molecular and Genomic Biomarker Testing in Hematopathology

Florida Society of Pathologists

13-March-2025 to 13-March-2026

 

1 hr on-demand webinar

Learn More
E-LEARNING

Application of Molecular and Genomic Biomarker Testing in Solid Tumors

Florida Society of Pathologists

01-March-2025 to 01-March-2026

 

1 hr on-demand webinar

Learn More
E-LEARNING

Web Case #1 - Aligning the Patient-Provider Therapeutic Connection to Improve Clinical Outcomes in Progressive HR+/HER2- Metastatic Breast Cancer

Clinical Care Options, LLC

19-Dec-2025 to 30-June-2026

 

AMA/ABIM MOC/AAPA/ANCC/ACPE Interactive Case Challenge (ICC) #1

Learn More
E-LEARNING

Slide Deck- Aligning the Patient-Provider Therapeutic Connection to Improve Clinical Outcomes in Progressive HR+/HER2- Metastatic Breast Cancer

Clinical Care Options, LLC

25-Nov-2025 to 30-June-2026

 

"Downloadable Living Slideset with Slide Notes (posting 11/21/25)"

Learn More
E-LEARNING

Web Case #2 - Aligning the Patient-Provider Therapeutic Connection to Improve Clinical Outcomes in Progressive HR+/HER2- Metastatic Breast Cancer

Clinical Care Options, LLC

31-Dec-2025 to 30-June-2026

 

AMA/ABIM MOC/AAPA/ANCC/ACPE Interactive Case Challenge (ICC) #2

Learn More
E-LEARNING

Live Aligning the Patient-Provider Therapeutic Connection to Improve Clinical Outcomes in Progressive HR+/HER2- Metastatic Breast Cancer

Clinical Care Options, LLC

14-Nov-2025 to 13-May-2026

 

6 CME/CE/CPE and ABIM-MOC certified InterAct Oncology Small-group interprofessional team trainings, 2 live CME/CE/CPE and ABIM MOC certified simulcasts, Enduring CME/CE/CPR and ABIM/MOC certified case simulation series, downloadable living slideset

Learn More
E-LEARNING

A Discussion on Strategies for New Therapies and Evolving Care in Chronic Lymphocytic Leukemia (CLL)

Blood Cancer United, Inc.

12-Nov-2025 to 17-Dec-2026

 

Join our webinar for a clinical update on CLL. Experts will review new therapies like BTK inhibitors and CAR T-cell therapy, offer patient selection guidance, and discuss treatment management, toxicity monitoring, and survivorship care.

Learn More
E-LEARNING

Interleukin-33 and Lower Tract Respiratory Diseases Moving From Pathophysiology to Management

Integritas Communications

23-Jun-2025 to 23-Jun-2026

 

Join experts Dr. Jonathan Hand, Prof. Dave Singh, and Prof. Tom Wilkinson as they discuss IL-33’s role in respiratory disease, its signaling pathways, therapeutic potential, and current clinical trials targeting IL-33-driven inflammation.

Learn More
E-LEARNING

Self Directed Data Dive, A New Target in Sight: Alarmin Cytokines and the Evolving Biologic Landscape in CRSwNP

Integrity CE, LLC

12-Dec-2025 to 12-Dec-2026

 

A Self-Directed/On-Demand activity

Learn More
E-LEARNING

Beyond the Airways: Recognizing Systemic Clues and Advancing Care with Emerging Therapies in Hypereosinophilic Syndromes

Integrity CE, LLC

28-Jan-2026 to 28-Jan-2027

 

On-Demand Data Dive Program

Learn More
E-LEARNING

Severe Asthma Bridge: Improving Clinical Outcomes For Patients with Severe or Uncontrolled Asthma

Montefiore Medical Center

12-Dec-2025 to 07-Feb-2026

 

Web-Based Program

Learn More
E-LEARNING

Stories Behind the Science in EGPA: Updated Strategies for Diagnosis, Treatment, and Reducing the Steroid Burden in Patients

PVI, PeerView Institute for Medical Education, Inc.

28-Feb-2025 to 27-Mar-2026

 

An on-demand enduring activity based on a recent live event, featuring expert faculty discussing the challenges of recognizing, diagnosing, and managing EGPA.

Learn More
E-LEARNING

Vasculitis 2025: Advances and Controversies

THE CLEVELAND CLINIC EDUCATIONAL FOUNDATION

10-Jul-2025 to 09-Jul-2027

 

This comprehensive education dives into the complexities and innovations in the treatment and diagnosis of various forms of vasculitis. 

Learn More
E-LEARNING

Rethinking CRSwNP: A Comprehensive Learning Experience for Optimized Patient Care

National Jewish Health

30-Jun-2025 to 30-Jun-2026

 

-Interactive infographic part of a three-part series
-Learners will review the definition and clinical features of CRSwNP, explore inflammatory pathways in a self-paced animation, and review management strategies and current and emerging therapies.

Learn More
E-LEARNING

Rethinking CRSwNP: A Visual Framework for Targeting Epithelial-Driven Inflammation

National Jewish Health

30-Jun-2025 to 30-Jun-2026

 

In this mobile-friendly, interactive infographic activity, learners will review the definition & clinical features of CRSwNP; explore inflammatory pathways in a self-paced animation of pathophysiology in CRSwNP; & review management strategies,

Learn More
E-LEARNING

Managing Upper and Lower Airway Diseases: The Role of Epithelial-Driven Inflammation

National Jewish Health

30-Jun-2025 to 30-Jun-2026

 

-1.5 online enduring activity

-Expert faculty from pulmonology, allergy, and otolaryngology explore the complexities of epithelial-driven inflammatory airway diseases.

-Clinical case scenarios

Learn More
E-LEARNING

Clinical Remission in Asthma: An Expert Consensus on the Current Criteria, Evidence, and Impact

National Jewish Health

29-Sep-2025 to 29-Sep-2026

 

Journal-based CME activity based on an article supplement from a panel of experts presenting the panel's definition of asthma remission and unresolved issues for further investigation.

Learn More
E-LEARNING

In Conversation: Multidisciplinary Perspectives on Chronic Airways Disease

National Jewish Health

19-Oct-2025 to 19-Oct-2025

 

Join National Jewish Health for a symposium where top pulmonologists and allergists explore new insights on chronic inflammatory airway diseases. Gain updates on treatment advances, immune cell roles, and strategies for managing airway conditions.

Learn More
E-LEARNING

Innovating Care for Chronic Respiratory Diseases: Targeting IL-33 and Epithelial Alarmins

National Jewish Health

20-Oct-2025 to 20-Oct-2025

 

This National Jewish Health program will explore IL-33 and epithelial alarmins in asthma, COPD, and viral infections. Faculty from multiple fields, will engage audiences through frontline perspectives and incorporate cases into their discussions.

Learn More
E-LEARNING

Rethinking Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): A Real-Time Clinical Decision-Making Tool

National Jewish Health

12-Sep-2025 to 30-Jun-2026

 

The decision aid component of the "Rethinking CRSwNP" education initiative is a case-based, algorithm-driven activity that simulates real-world patient encounters to enhance clinical decision-making.

Learn More
E-LEARNING

Medical Myth-busting: Unmasking the Role of Epithelial Cytokines and Emerging Biologics in CRSwNP

National Jewish Health

23-Dec-2025 to 23-Dec-2026

 

Experts bust common CRSwNP myths in an investigative-style program with interactive cases, animations, endoscopy footage, and patient videos—highlighting epithelial cytokines, guidelines, and emerging therapies.

Learn More
E-LEARNING

Web Transforming Asthma Management: The Role of Pharmacists in Implementing Combination Therapy

Postgraduate Healthcare Education, LLC

31-Mar-2025 to 31-Mar-2026

 

Monograph

Learn More
E-LEARNING

Tackling CRSwNP Management With Emerging Biologic Therapies Targeting Epithelial Cytokines: Game On!

PVI, PeerView Institute for Medical Education, Inc.

12-Dec-2025 to 12-Dec-2025

 

Interactive educational event held in conjunction with AAO-HNSF 2025 and focused on the role of epithelial cytokines in CRSwNP and the optimal use of biologic agents.

Learn More
E-LEARNING

Clearing the Way in CRSwNP: Targeting Upstream Drivers With Emerging Biologic Approaches

PVI, PeerView Institute for Medical Education, Inc.

06-Oct-2025 to 05-Oct-2025

 

This educational activity will test your knowledge and provide feedback on your skills for integrating available and emerging biologic agents into the management of CRSwNP.

Learn More
E-LEARNING

Addressing an Exacerbating Issue in COPD: Strategies for Individualized Targeted Biologic Therapy to Improve Quality of Life

PVI, PeerView Institute for Medical Education, Inc.

13-Nov-2025 to 12-Dec-2026

 

In this activity based on a live event at GOLD 2025, experts share the latest evidence that can guide the integration of highly efficacious, novel and emerging biologics into clinical practice.

Learn More
E-LEARNING

Use of Anti-Inflammatory Reliever (AIR) Therapy in Asthma for Healthcare Professionals in Primary Care and Specialty Practices

Regents of the University of Michigan

01-Nov-2025 to 31-Oct-2028

 

AIR therapy recommended by the worldwide GINA and US NAEPP asthma guidelines to better manage inflammation associated with respiratory symptoms and to reduce exacerbations. This is a paradigm change necessitating education of clinicians and patients

Learn More
E-LEARNING

ME Highlights: Navigating the Changing CRSwNP Landscape: From Mechanisms to Data-Driven Decisions in Biologic Therapy

Answers in CME Inc.

12-Dec-2025 to 11-Dec-2026

 

Summarize the most salient information from the Virtual Live, in a text- and slide-based format, divided into 5 sessions.

Learn More
Connessiallasalute.it

This site is intended for healthcare professionals practicing in the US.
©2026 AstraZeneca. All rights reserved.

US-107328
Last Updated 3/26

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities  

Survey Feedback

Your Privacy Choice

Consumer Health Data 
Privacy Notice

Privacy Notice | Legal Notice | Cookie Preferences

Welcome to AstraZeneca Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

 

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

 

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?
This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am not a healthcare professional practicing in the United States